0001493152-23-040898.txt : 20231114 0001493152-23-040898.hdr.sgml : 20231114 20231114130147 ACCESSION NUMBER: 0001493152-23-040898 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: China Foods Holdings Ltd. CENTRAL INDEX KEY: 0001310630 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 910974149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32522 FILM NUMBER: 231403415 BUSINESS ADDRESS: STREET 1: SUITE 3102, EVERBRIGHT CENTER STREET 2: 108 GLOUCESTER ROAD CITY: WANCHAI STATE: K3 ZIP: 0000 BUSINESS PHONE: 852-3618-8608 MAIL ADDRESS: STREET 1: SUITE 3102, EVERBRIGHT CENTER STREET 2: 108 GLOUCESTER ROAD CITY: WANCHAI STATE: K3 ZIP: 0000 FORMER COMPANY: FORMER CONFORMED NAME: China Foods Holdings, Ltd. DATE OF NAME CHANGE: 20190513 FORMER COMPANY: FORMER CONFORMED NAME: Trafalgar Resources, Inc. DATE OF NAME CHANGE: 20041203 10-Q 1 form10-q.htm
false --12-31 Q3 0001310630 0001310630 2023-01-01 2023-09-30 0001310630 2023-11-10 0001310630 2023-09-30 0001310630 2022-12-31 0001310630 srt:DirectorMember 2023-09-30 0001310630 srt:DirectorMember 2022-12-31 0001310630 us-gaap:RelatedPartyMember 2023-09-30 0001310630 us-gaap:RelatedPartyMember 2022-12-31 0001310630 2023-07-01 2023-09-30 0001310630 2022-07-01 2022-09-30 0001310630 2022-01-01 2022-09-30 0001310630 us-gaap:CommonStockMember 2022-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001310630 us-gaap:RetainedEarningsMember 2022-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001310630 us-gaap:CommonStockMember 2023-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001310630 us-gaap:RetainedEarningsMember 2023-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001310630 2023-03-31 0001310630 us-gaap:CommonStockMember 2023-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001310630 us-gaap:RetainedEarningsMember 2023-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001310630 2023-06-30 0001310630 us-gaap:CommonStockMember 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001310630 2021-12-31 0001310630 us-gaap:CommonStockMember 2022-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001310630 us-gaap:RetainedEarningsMember 2022-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001310630 2022-03-31 0001310630 us-gaap:CommonStockMember 2022-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001310630 us-gaap:RetainedEarningsMember 2022-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001310630 2022-06-30 0001310630 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001310630 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001310630 2023-01-01 2023-03-31 0001310630 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001310630 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001310630 2023-04-01 2023-06-30 0001310630 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001310630 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001310630 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001310630 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001310630 2022-01-01 2022-03-31 0001310630 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001310630 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001310630 2022-04-01 2022-06-30 0001310630 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001310630 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001310630 us-gaap:CommonStockMember 2023-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001310630 us-gaap:RetainedEarningsMember 2023-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001310630 us-gaap:CommonStockMember 2022-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001310630 us-gaap:RetainedEarningsMember 2022-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001310630 2022-09-30 0001310630 CFOO:EliteCreationGroupLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:AlphaWellnessHKLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2023-09-30 0001310630 CFOO:MotorVehiclesMember srt:MinimumMember 2023-09-30 0001310630 CFOO:MotorVehiclesMember srt:MaximumMember 2023-09-30 0001310630 CFOO:MotorVehiclesMember 2023-09-30 0001310630 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2023-01-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2022-01-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2022-01-01 2022-09-30 0001310630 country:HK 2023-07-01 2023-09-30 0001310630 country:HK 2022-07-01 2022-09-30 0001310630 country:CN 2023-07-01 2023-09-30 0001310630 country:CN 2022-07-01 2022-09-30 0001310630 country:HK 2023-01-01 2023-09-30 0001310630 country:HK 2022-01-01 2022-09-30 0001310630 country:CN 2023-01-01 2023-09-30 0001310630 country:CN 2022-01-01 2022-09-30 0001310630 CFOO:PeriodEndHKUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodEndHKUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodAverageHKUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodAverageHKUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodEndRMBUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodEndRMBUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodAverageRMBUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodAverageRMBUSExchangeRateMember 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2023-07-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2023-07-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2023-07-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SalesOfHealthcareProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:SalesOfHealthcareProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:WineSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2022-07-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2022-07-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SalesOfHealthcareProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:SalesOfHealthcareProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:WineSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2023-01-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2023-01-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SalesOfHealthcareProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:WineSegmentMember CFOO:SalesOfHealthcareProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:WineSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2022-01-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:ConsultancyServiceFeeIncomeMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SaleOfWineProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:SaleOfWineProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember CFOO:SalesOfHealthcareProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:WineSegmentMember CFOO:SalesOfHealthcareProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:WineSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareProductsMember 2023-09-30 0001310630 CFOO:HealthcareProductsMember 2022-12-31 0001310630 CFOO:WineProductsMember 2023-09-30 0001310630 CFOO:WineProductsMember 2022-12-31 0001310630 srt:MinimumMember 2023-09-30 0001310630 CFOO:MotorVehicleMember 2023-09-30 0001310630 CFOO:MotorVehicleMember 2022-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2022-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2023-09-30 0001310630 CFOO:ForeignTranslationDifferenceMember 2022-12-31 0001310630 country:US 2023-09-30 0001310630 country:CN 2023-09-30 0001310630 country:US 2022-12-31 0001310630 country:HK 2023-09-30 0001310630 country:HK 2022-12-31 0001310630 country:CN 2022-12-31 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2022-01-01 2022-09-30 0001310630 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember CFOO:VendorMember 2023-01-01 2023-09-30 0001310630 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember CFOO:VendorMember 2023-07-01 2023-09-30 0001310630 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CFOO:VendorMember 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:HKD iso4217:CNY CFOO:Integer CFOO:Segment xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023 or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________to _________

 

001-32522

Commission file number

 

China Foods Holdings Ltd.

(Exact name of registrant as specified in its charter)

 

Delaware   84-1735478
State or other jurisdiction of incorporation or organization   (I.R.S. Employer Identification No.)

 

Room 2301A, China Resources Building,

26 Harbour Road,

Wanchai, Hong Kong

  0000
(Address of principal executive offices)   (Zip Code)

 

(852) 3618-8608

Registrant’s telephone number, including area code

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date.

 

Class   Outstanding November 10, 2023
Common Stock, with $0.0001 par value   20,252,309 shares

 

 

 

 
 

 

NOTES REGARDING OUR COMPANY

 

Forward Looking Statements

 

This periodic report contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive positions, growth opportunities for existing products, plans and objectives of management. Statements in this periodic report that are not historical facts are hereby identified as forward-looking statements. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Quarterly Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward-looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

 

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest; changes in U.S., global or regional economic conditions; changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments; increased competitive pressures, both domestically and internationally; legal and regulatory developments, such as regulatory actions affecting environmental activities; the imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls; adverse weather conditions or natural disasters, such as hurricanes and earthquakes; and labor disputes, which may lead to increased costs or disruption of operations.

 

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

 

Disclosures Related to Our Chinese Operations

 

China Foods Holdings Ltd. (the “Company”, “CFOO”, or “we”) was incorporated in Delaware on January 10, 2019. The Company is a Delaware holding company and we conduct our primary operations in China through our wholly owned subsidiary Guangzhou Xiao Xiang Health Industry Company Limited, a limited liability company organized under the laws of China on March 8, 2017 (“GXXHIC”). GXXHIC is wholly owned by Alpha Wellness (HK) Limited, a limited liability company organized under the laws of Hong Kong on April 24, 2019, which is in turn wholly owned by Elite Creation Group, a limited liability company formed under the laws of the British Virgin Islands formed on September 5, 2018. Alpha Wellness (HK) Limited and Elite Creation Group are holding companies without operations and are wholly owned by the Company.

 

Substantially all of our operations are conducted in China, and are governed by Chinese laws, rules and regulations. Our subsidiary, GXXHIC, is subject to Chinese laws, rules, and regulations. Uncertainties with respect to the interpretation and enforcement of Chinese laws, rules and regulations could have a material adverse effect on us. Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding that the rules and regulations in China can change quickly with little advance notice and that the Chinese government may intervene or influence our operations at any time, could result in a material adverse change in our operations and the value of our securities.

 

We do not believe there GXXHIC is in violation of any laws, rules or regulations but since these newly enacted rules are still evolving, we cannot assure you that our business operations comply with such regulations and authorities’ requirements in all respects during the development of these new rules. However, in terms of business operation, GXXHIC expects to adapt to the newly issued rules and take dependent measures to comply with the laws and regulations of the Chinese authorities. The People’s Republic of China (the “PRC”) government’s authority in regulating our operations and its oversight and control over offerings and listings conducted overseas by, and foreign investment in, China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. Implementation of industry-wide regulations in this nature may cause the value of such securities to significantly decline or be worthless. Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and quickly evolving rules and regulations in China, could result in a material adverse change in our operations and the value of our securities. But so far, the current operation and securities value of CFOO are stable, and we believe that its risks are to the Company are manageable.

 

GXXHIC has received a Business License from the relevant department of the State Administration for Market Regulation. Apart from the Business License, GXXHIC may be subject to additional licensing requirements for our business operation due to the uncertainties of interpretation and implementation of relevant laws and regulations and the enforcement practice by relevant government authorities.

 

For more information on these risks and other risks relating to our company, please see our 2022 Annual Report on Form 10-K for the year ended December 31, 2022.

 

The Holding Foreign Companies Accountable Act

 

The Holding Foreign Companies Accountable Act (the “HFCAA”), was enacted on December 18, 2020. The HFCAA requires that the Public Company Accounting Oversight Board (the “PCAOB”) determine whether it is unable to inspect or investigate completely registered public accounting firms located in a non-U.S. jurisdiction because of a position taken by one or more authorities in that jurisdiction. Our auditor, ARK Pro CPA & Co (formerly HKCM & CPA Co.), is based in Hong Kong and is subject to the determinations announced by the PCOAB on December 16, 2021 and the HFCAA. On December 16, 2021, the PCAOB reported its determination that it was unable to inspect or investigate completely registered public accounting firms headquartered in the PRC and Hong Kong, because of positions taken by PRC authorities in those jurisdictions. On March 30, 2022, based on this determination, the Company was transferred to the SEC’s “Conclusive list of issuers identified under the HFCA.” Since our auditor is located in Hong Kong, a jurisdiction where the PCAOB has been unable to conduct inspections without the approval of the Chinese authorities, our auditor is not currently inspected by the PCAOB. The HFCAA states that if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for two consecutive years beginning in 2021, the SEC shall prohibit our shares from being traded on a national securities exchange or in the over-the-counter trading market in the United States. The related risks and uncertainties could cause the value of our shares to significantly decline or be worthless.

 

 
 

 

Table of Contents

 

    Page
    No.
     
  PART I – FINANCIAL INFORMATION  
     
Item 1. Unaudited Condensed Consolidated Financial Statements 3
     
  Notes to Unaudited Condensed Consolidated Financial Statements 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 28
     
Item 4. Controls and Procedures 28
     
  PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 28
     
Item 1A. Risk Factors 28
     
Item 2. Unregistered Sales of Equity Securities and Proceeds 28
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosure 29
     
Item 5. Other Information 29
     
Item 6. Exhibits 29
     
SIGNATURES 30

 

2
 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

China Foods Holdings Ltd.

Condensed Consolidated Balance Sheets

 

  

September 30,

2023

   December 31,
2022
 
         
   (Unaudited)   (Audited) 
ASSETS          
           
Current Assets          
Cash and cash equivalents  $157,446   $381,709 
Accounts receivable, net   5,107    5,120 
Deposits and other receivables   61,896    74,813 
Inventories, net   119,232    138,582 
Total Current Assets   343,681    600,224 
           
Non-Current Assets          
Plant and equipment, net   17,656    55,495 
Right-of-use assets, net   34,451    20,341 
Intangible assets, net   2,631    3,148 
Total Non-Current Assets   54,738    78,984 
           
TOTAL ASSETS  $398,419   $679,208 
           
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY          
           
Current Liabilities          
Accounts payable  $1,398   $8,013 
Accrued liabilities and other payables   186,324    122,660 
Customer deposits   66,748    73,602 
Lease liabilities   34,664    21,024 
Amount due to a director   235,400    220,794 
Amount due to a related company   199,964    199,964 
Income tax payable   15,683    15,722 
Total Current Liabilities   740,181    661,779 
           
Stockholders’ (Deficit) Equity          
Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively   2,025    2,025 
Additional paid-in capital   1,290,355    1,290,355 
Accumulated other comprehensive loss   (6,735)   (2,678)
Accumulated deficit   (1,627,407)   (1,272,273)
Total Stockholders’ (Deficit) Equity   (341,762)   17,429 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY  $398,419   $679,208 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3
 

 

China Foods Holdings Ltd.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

   Three Months Ended   Three Months Ended   Nine Months Ended   Nine Months Ended 
   September 30, 2023   September 30, 2022   September 30, 2023   September 30, 2022 
                 
Revenue, net  $5,293   $5,395   $24,338   $169,029 
                     
Cost of revenue   (1,619)   (22,498)   (12,654)   (69,809)
                     
Gross profit (loss)   3,674    (17,103)   11,684    99,220 
                     
Operating expenses:                    
Selling and distribution expenses   248    -    3,506    2,622 
General and administrative expenses   116,990    99,309    363,907    332,028 
Total operating expenses   117,238    99,309    367,413    334,650 
                     
Loss from operation   (113,564)   (116,412)   (355,729)   (235,430)
                     
Other Income:                    
Interest income   4    10    250    123 
Sundry income   9    19,612    345    30,543 
Total other income   13    19,622    595    30,666 
                     
Loss before income tax   (113,551)   (96,790)   (355,134)   (204,764)
                     
Income tax expenses   -    2,607    -    (3,966)
                     
Net loss   (113,551)   (94,183)   (355,134)   (208,730)
                     
Other comprehensive income (loss):                    
Foreign currency adjustment gain (loss)   23    (13,735)   (4,057)   (33,391)
                     
Comprehensive loss  $(113,528)  $(107,918)  $(359,191)  $(242,121)
                     
Net loss per common share                    
Basic and diluted*  $(0.01)  $(0.00)  $(0.02)  $(0.01)
                     
Weighted average number of common stock                    
Basic and diluted   20,252,309    20,252,309    20,252,309    20,252,309 

 

* denotes net loss per common share of less than $0.001 per share.

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4
 

 

China Foods Holdings Ltd.

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity

(Unaudited)

 

   Share   Amount   capital   deficit   loss   deficit 
   Three and nine months ended September 30, 2023 
   Common Stock   Additional
paid-in
   Accumulated   Accumulated
other
comprehensive
   Total stockholders’ 
   Share   Amount   capital   deficit   loss   deficit 
Balance at January 1, 2023   20,252,309   $2,025   $1,290,355   $(1,272,273)  $(2,678)  $17,429 
                               
Net loss for the period   -    -    -    (107,871)   -    (107,871)
                               
Foreign currency translation adjustment   -    -    -    -    (227)   (227)
                               
Balance at March 31, 2023   20,252,309    2,025    1,290,355    (1,380,144)   (2,905)   (90,669)
                               
Net loss for the period   -    -    -    (133,712)   -    (133,712)
                               
Foreign currency translation adjustment   -    -    -    -    (3,853)   (3,853)
                               
Balance at June 30, 2023   20,252,309    2,025    1,290,355    (1,513,856)   (6,758)   (228,234)
                               
Net loss for the period   -    -    -    (113,551)   -    (113,551)
                               
Foreign currency translation adjustment   -    -    -    -    23    23 
                               
Balance at September 30, 2023   20,252,309   $2,025   $1,290,355   $(1,627,407)  $(6,735)  $(341,762)

 

   Three and nine months ended September 30, 2022 
   Common Stock   Additional
paid-in
   Accumulated   Accumulated
other
comprehensive
   Total shareholders’ 
   Share   Amount   capital   deficit   income (loss)   equity 
                          
Balance at January 1, 2022   20,252,309   $2,025   $1,290,355    (918,195)  $26,516    400,701 
                               
Net loss for the period   -    -    -    (76,824)   -    (76,824)
                               
Foreign currency translation adjustment   -    -    -    -    (602)   (602)
                               
Balance at March 31, 2022   20,252,309    2,025    1,290,355    (995,019)   25,914    323,275 
                               
Net loss for the period   -    -    -    (37,723)   -    (37,723)
                               
Foreign currency translation adjustment   -    -    -    -    (19,054)   (19,054)
                               
Balance at June 30, 2022   20,252,309    2,025    1,290,355    (1,032,742)   6,860    266,498 
                               
Net loss for the period   -    -    -    (94,183)   -    (94,183)
                               
Foreign currency translation adjustment   -    -    -    -    (13,735)   (13,735)
                               
Balance at September 30, 2022   20,252,309   $2,025   $1,290,355   $(1,126,925)  $(6,875)  $158,580 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5
 

 

China Foods Holdings Ltd.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

         
   Nine months ended 
  

September 30,

2023

   September 30,
2022
 
Cash flows from operating activities:          
Net loss  $(355,134)  $(208,730)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation of plant and equipment   37,341    51,134 
Gain from sale of plant and equipment   -    (16,277)
Amortization of intangible assets   359    386 
Non-cash lease expense   36,910    70,986 
Adjustments to reconcile net loss to net cash used in operating activities, Total   (280,524)   (102,501)
Change in operating assets and liabilities:          
Accounts receivables   13    - 
Deposits and other receivables   12,917    41,567 
Inventories   19,350    49,364 
Accrued liabilities and other payables   63,664    (1,701)
Accounts payable   (6,615)   - 
Income tax recoverable   -    7,889 
Income tax payable   (39)   - 
Customer deposits   (6,854)   (108,265)
Lease liabilities   (37,427)   - 
Net cash used in operating activities   (235,515)   (113,647)
           
Cash flows from investing activities:          
Purchase of plant and equipment   (743)   - 
Proceeds from sale of plant and equipment   -    22,930 
Net cash (used in) provided by investing activities   (743)   22,930 
           
Cash flows from financing activities:          
Repayment of lease liabilities   -   (76,016)
Advances from (repayment to) a director   14,606    (1,974)
Net cash provided by (used in) financing activities   14,606   (77,990)
           
Foreign currency translation adjustment   (2,611)   (19,028)
           
Net change in cash and cash equivalents   (224,263)   (187,735)
           
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   381,709    609,434 
           
CASH AND CASH EQUIVALENTS, END OF PERIOD  $157,446   $421,699 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6
 

 

China Foods Holdings Ltd.

Notes to Unaudited Condensed Consolidated Financial Statements

For the Three and Nine Months Ended September 30, 2023

 

NOTE 1 – NATURE OF OPERATIONS

 

China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019.

 

The Company is a health and wellness company that develops, markets, promotes and distributes a variety of customized health and wellness care products and services, including supplements, healthy snacks, meal replacements, skincare products, and nutritional consultation services to consumers in China. The Company works with certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through sales agents and also through a network of e-commerce and social media platforms.

 

Due to the impact of the COVID-19 pandemic in the healthcare industry, the Company also offered a new line of high-end wine products in our online and offline sales platform, to diversify the market demand and customer needs.

 

The following table depicts the description of the Company’s subsidiaries:

Name  Place of incorporation and kind of legal entity  Principal activities  Particulars of registered/ paid up share capital  Effective interest held 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares for HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB 8,300,000   100%

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation and consolidation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 31, 2023.

 

7
 

 

The unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:

 

revenue recognition at point in time and over time;
sales returns at point in time and allowances;
inventory;
estimated lives for tangible and intangible assets; and
income tax valuation allowances

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of September 30, 2023 and December 31, 2022, there was no allowance for doubtful accounts.

 

Credit Losses – Measurement of Credit Losses on Financial Instruments

 

In March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, “Credit Losses – Measurement of Credit Losses on Financial Instruments (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial statements.

 

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of September 30, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

8
 

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5%
Motor vehicle  3.33 to 4 years   5%
Leasehold improvement  2 years   5%

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Depreciation expense for the three and nine months ended September 30, 2023 were $8,830 and $37,341, respectively, and for the three and nine months ended September 30, 2022 were $14,497 and $51,134, respectively.

 

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the three and nine months ended September 30, 2023 were $116 and $359, respectively.

 

Amortization expense for the three and nine months ended September 30, 2022 were $127 and $386, respectively.

 

Impairment of long-lived assets

 

In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the periods presented.

 

Revenue recognition

 

The Company adopted ASC 606 – “Revenue from Contracts with Customers” (“ASC Topic 606”). Under ASC Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC Topic 606, the Company performs the following five steps:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract; and
  recognize revenue as the performance obligation is satisfied.

 

9
 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded no product sales returns for the nine months ended September 30, 2023 and 2022. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Sale of wine products  $2,696   $5,395 
Sales of healthcare products   2,597    - 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Consultancy service fee income  $-   $135,452 
Sale of wine products   20,971    33,577 
Sales of healthcare products   3,367    - 
           
TOTAL  $24,338   $169,029 

 

The below revenues are based on the countries in which the customers are located. Summarized financial information concerning the geographic segments is shown in the following tables:

 SUMMARY OF GEOGRAPHIC SEGMENTS

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
PRC   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
PRC   24,338    33,577 
           
TOTAL  $24,338   $169,029 

 

10
 

 

Income taxes

 

The Company adopted the ASC Topic 740, “Income Taxes” (“ASC Topic 740”) provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

Uncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the nine months ended September 30, 2023 and 2022.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the PRC and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholders’ equity.

 

Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
Period-end HK$:US$ exchange rate   0.12767    0.12744 
Period average HK$:US$ exchange rate   0.12764    0.12779 
Period-end RMB:US$ exchange rate   0.13705    0.14930 
Period average RMB:US$ exchange rate   0.14229    0.15438 

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share”. Basic (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. Potential common stocks that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.

 

11
 

 

Comprehensive loss

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Leases

 

The Company adopted ASC Topic 842, “Leases” (“ASC Topic 842”). At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.

 

In accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g. land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.

 

Lease expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability. The amortized period for ROU assets is limited to the expected lease term.

 

The Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating leases with terms of 12 months or less.

 

Related parties

 

The Company follows the ASC Topic 850-10, “Related Party” for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

12
 

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Commitments and contingencies

 

The Company follows the ASC Topic 450-20, “Commitments” to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value Measurement

 

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC Topic 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, deposits and other receivables, accounts payable, accrued liabilities and other payables, customer deposits, amount due to a director, and amount due to a related company approximate their fair values because of the short maturity of these instruments.

 

13
 

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in two reportable operating segments in Hong Kong and China.

 

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company has evaluated that the impact of all recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

 

NOTE 3 – LIQUIDITY AND GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared using going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

For the nine months ended September 30, 2023, the Company incurred a net loss of $355,134 and suffered from a working capital deficit of $396,500 as of September 30, 2023. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders. Management believes the existing stockholders will provide the additional cash to meet with the Company’s obligations as they become due. However, there is no assurance that the Company will be successful in securing sufficient funds to sustain the operations.

 

These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

 

NOTE 4 – SEGMENT REPORTING

 

Currently, the Company has two reportable business segments:

 

(i) Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and
(ii) Wine Segment, mainly provides the wine products to the customers.

 

14
 

 

In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments.

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products     2,696   2,696 
Sale of healthcare products   2,597        2,597 
Total revenue   2,597    2,696    5,293 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (544)   (544)
Sale of healthcare products   (1,075)       (1,075)
Total cost of revenue   (1,075)   (544)   (1,619)
                
Gross profit   1,522    2,152    3,674 
                
Operating expenses:               
Selling and distribution       (248)   (248)
General and administrative   (76,826)   (40,164)   (116,990)
Total operating expenses   (76,826)   (40,412)   (117,238)
                
Segment loss  $(75,304)  $(38,260)  $(113,564)

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       5,395    5,395 
Sale of healthcare products            
Total revenue       5,395    5,395 
                
Cost of revenue:               
Consulting service income   (17,703)       (17,703)
Sale of wine products       (4,795)   (4,795)
Sale of healthcare products            
Total cost of revenue   (17,703)   (4,795)   (22,498)
                
Gross (loss) profit   (17,703)   600    (17,103)
                
Operating expenses:               
Selling and distribution   -    -    - 
General and administrative   (30,445)   (68,864)   (99,309)
Total operating expenses   (30,445)   (68,864)   (99,309)
                
Segment loss  $(48,148)  $(68,264)  $(116,412)

 

15
 

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       20,971    20,971 
Sale of healthcare products   3,367        3,367 
Total revenue   3,367    20,971    24,338 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (11,227)   (11,227)
Sale of healthcare products   (1,427)       (1,427)
Total cost of revenue   (1,427)   (11,227)   (12,654)
                
Gross profit   1,940    9,744    11,684 
                
Operating expenses:               
Selling and distribution       (3,506)   (3,506)
General and administrative   (232,021)   (131,886)   (363,907)
Total operating expenses   (232,021)   (135,392)   (367,413)
                
Segment loss  $(230,081)  $(125,648)  $(355,729)

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $135,452   $   $135,452 
Sale of wine products       33,577    33,577 
Sale of healthcare products            
Total revenue   135,452    33,577    169,029 
                
Cost of sales:               
Consulting service income   (45,971)   -    (45,971)
Sale of wine products   -    (23,838)   (23,838)
Sale of healthcare products            
Total cost of revenue   (45,971)   (23,838)   (69,809)
                
Gross profit   89,481    9,739    99,220 
                
Operating expenses:               
Selling and distribution   -    (2,622)   (2,622)
General and administrative   (94,979)   (237,049)   (332,028)
Total operating expenses   (94,979)   (239,671)   (334,650)
                
Segment loss  $(5,498)  $(229,932)  $(235,430)

 

16
 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables: 

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
China   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine

Months Ended

September 30,
2023

  

Nine Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
China   24,338    33,577 
           
TOTAL  $24,338   $169,029 

 

NOTE 5 – DEPOSITS AND OTHER RECEIVABLES

 

Deposits and other receivables consisted of the following:

 

   September 30,
2023
   December 31,
2022
 
         (Audited) 
Rental deposits  $40,751   $40,115 
Purchase deposits   17,967    23,835 
Other receivables   3,178    10,863 
 Deposits and other receivable  $61,896   $74,813 

 

NOTE 6 – INVENTORIES

 

Inventories consisted of the following:

 

           
   September 30,
2023
   December 31,
2022
 
       (Audited) 
Finished goods – Healthcare products  $-   $- 
Finished goods – Wine products   119,232    138,582 
 Finished goods  $119,232   $138,582 

 

For the three and nine months ended September 30, 2023 and 2022, no allowance for obsolete inventories was recorded by the Company.

 

NOTE 7 – LEASE

 

The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2 years, through May 16, 2023. Upon expiry, the Company renewed and leased an office premise under operating lease with a term of 1 year.

 

17
 

 

Right of use assets and lease liability – right of use are as follows:

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Right-of-use assets  $34,451   $20,341 

 

The lease liability – right of use is as follows:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Lease liabilities  $34,664   $21,024 

 

As of September 30, 2023, the operating lease payment of $34,664 will become matured in the next 12 months.

 

NOTE 8 – PLANT AND EQUIPMENT

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Motor vehicle  $284,255   $284,255 
Furniture, fixture and equipment   16,208    15,465 
Leasehold improvement   27,358    27,358 
Foreign translation adjustment   (18,083)   (4,095)
Plant and equipment, gross   309,738    322,983 
           
Less: accumulated depreciation   (296,006)   (258,665)
Foreign translation adjustment   3,924    (8,823)
Plant and equipment, net  $17,656   $55,495 

 

Depreciation expense for the three and nine months ended September 30, 2023 were $8,830 and $37,341, respectively.

 

Depreciation expense for the three and nine months ended September 30, 2022 were $14,497 and $51,134, respectively.

 

NOTE 9 – AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

 

As of September 30, 2023 and December 31, 2022, the amounts represented temporary advances to the Company by its director and a related company which were unsecured, interest-free and have no fixed terms of repayments.

 

NOTE 10 – STOCKHOLDERS’ (DEFICIT) EQUITY

 

Common Stock

 

The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to 100,000,000 shares of common stock with a par value of $0.0001.

 

Dividend Rights

 

Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.

 

18
 

 

Voting Rights

 

Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.

 

No Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.

 

As of September 30, 2023, and December 31, 2022, a total of 20,252,309 and 20,252,309 outstanding shares of common stock were issued, respectively.

 

Preferred Stock

 

The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.

 

NOTE 11 – INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Current tax  $   -   $3,966 
Deferred tax   -    - 
Income tax expense  $-   $3,966 

 

The Company mainly operates in the PRC that is subject to taxes in the governing jurisdictions in which it operates. The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate, as follows:

 

BVI

 

Under the current BVI law, the Company is not subject to tax on income.

 

19
 

 

The PRC

 

The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Loss before income taxes  $(156,322)  $(220,924)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (39,081)   (55,231)
Net operating loss   39,081    55,231 
Income tax expense  $-   $- 

 

Hong Kong

 

The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year. The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
(Loss) income before income tax  $(178,731)  $25,029 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   (14,745)   2,065 
Tax adjustments   1,334    1,901 
Net operating loss   13,411    - 
Income tax expense  $-   $3,966 

 

The following table sets forth the significant components of the deferred tax assets of the Company as of September 30, 2023 and December 31, 2022:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $154,092    149,874 
- Hong Kong   13,411    - 
- PRC   348,712    309,631 
Net operating loss carryforwards   516,215    459,505 
Less: valuation allowance   (516,215)   (459,505)
Deferred tax assets, net  $-   $- 

 

20
 

 

As of September 30, 2023, the operations in the United States of America incurred $733,771 of cumulative net operating losses which can be carried forward indefinitely to offset future taxable income, under The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) since 2021. The Company has provided for a full valuation allowance against the deferred tax assets of $154,092 on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Also, the operations in the PRC incurred $1,394,848 of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss carryforwards under PRC tax regime can be carried forward in 5 years, until 2027. the Company has provided for a full valuation allowance against the deferred tax assets of $348,712 on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Uncertain tax positions

 

The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of September 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the nine months ended September 30, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from September 30, 2023.

 

NOTE 12 – RELATED PARTY TRANSACTIONS

 

From time to time, the Company’s director advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

 

Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.

 

NOTE 13 – CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

  (a) Major customers

 

For the three and nine months ended September 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivables balance as at period-end dates, are presented as follows:

 

21
 

 

   Three months ended
September 30, 2023
 
Customer  Revenues   Percentage of
revenues
 
         
Customer A  $2,960    56%

 

   Nine months ended September 30, 2023      September 30, 2023 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $2,960    12%          -     - 
Customer C   10,220    42%      -    - 
                        
Total:  $13,180    54%  Total   -    - 

 

   Three months ended
September 30, 2022
 
Customer  Revenues   Percentage of
revenues
 
         
Customer B  $5,297    98%

 

   Nine months ended September 30, 2022      September 30, 2022 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $135,452    80%      -    - 
Customer B   19,395    12%      -    - 
                        
Total:  $154,847    92%  Total   -    - 

 

The Company’s major customers are located in the PRC and Hong Kong.

 

(b) Major vendors

 

For the three months ended September 30, 2023, there is no single vendor representing more than 10% of the Company’s purchases. For the nine months ended September 30, 2023, a single vendor represented more than 10% of the Company’s purchases. This vendor accounted for 11% of the Company’s purchases amounting to $1,398, with accounts payable of $0 as of September 30, 2023.

 

For the three and nine months ended September 30, 2022, there is no single vendor representing more than 10% of the Company’s purchases.

 

All of the Company’s vendors are located in the PRC.

 

22
 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Economic and political risk

 

The Company’s major operations are conducted in the PRC. Accordingly, the political, economic, and legal environments in the PRC, as well as the general state of the PRC’s economy may influence the Company’s business, financial condition, and results of operations.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

NOTE 14 - COMMITMENTS AND CONTINGENCIES

 

As of September 30, 2023, the Company has no material commitments or contingencies.

 

NOTE 15 - SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2023 up through the date the Company issued the unaudited condensed consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.

 

23
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This periodic report contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive positions, growth opportunities for existing products, plans and objectives of management. Statements in this periodic report that are not historical facts are hereby identified as forward-looking statements. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Quarterly Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward-looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

 

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest; changes in U.S., global or regional economic conditions; changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments; increased competitive pressures, both domestically and internationally; legal and regulatory developments, such as regulatory actions affecting environmental activities; the imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls; adverse weather conditions or natural disasters, such as hurricanes and earthquakes; and labor disputes, which may lead to increased costs or disruption of operations.

 

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

 

Business Overview

 

We are a health and wellness company that develops, markets, promotes and distributes a variety of customized health and wellness care products and services, including supplements, healthy snacks, meal replacements, skincare products, and nutritional consultation services to consumers in China and Hong Kong. We work with certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through sales agents and also through a network of e-commerce and social media platforms.

 

In addition to products, we are committed to providing customized science based wellness consultation and service programs to customers. Our diverse products and services target health conscious customers and differentiate based upon age and gender and seek to manage different conditions. We reach out to customers fitting certain health and lifestyle profiles through our offline and online consultation services, and track eating habits and health indicators to provide customized products such as supplements. We believe this will facilitate the ability of customers to monitor, understand and adjust their health practices and lifestyle anytime and anywhere for increased customer engagement and retention.

 

Due to the impact of the COVID-19 pandemic in the healthcare industry, we have also offered a new line of high-end wine products in our online and offline sales platform, to diversify the market demand and customer needs.

 

We conduct our business through our wholly owned subsidiary Guangzhou Xiao Xiang Health Industry Company Limited, a limited liability company organized under the laws of China on March 8, 2017 and Alpha Wellness (HK) Limited, a limited liability company organized under the laws of Hong Kong on April 24, 2019. Elite Creation Group, a limited liability company formed under the laws of the British Virgin Islands formed on September 5, 2018, is holding companies without operations.

 

24
 

 

RESULTS OF OPERATIONS

 

We have been significantly impacted by COVID-19 global pandemic. In addition to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets. China and many other countries have issued policies intended to stop or slow the further spread of the disease.

 

COVID-19 and China’s response to the pandemic are significantly affecting the economy. Even the COVID-19 pandemic was ended, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent of the effects on the economy, the markets we serve, our business or our operations.

 

The following table sets forth certain operational data for the three and nine months ended September 30, 2023 and 2022:

 

   Three Months Ended   Three Months Ended 
   September 30,
2023
   September 30,
2022
 
Revenue, net  $5,293   $5,395 
Cost of revenue   (1,619)   (22,498)
Gross profit (loss)   3,674    (17,103)
Total operating expenses   (117,238)   (99,309)
Total other income   13    19,622 
Loss before income tax   (113,551)   (96,790)
Income tax expenses   -    2,607 
Net loss   (113,551)   (94,183)

 

   Nine Months Ended   Nine Months Ended 
   September 30,
2023
   September 30,
2022
 
Revenue, net  $24,338   $169,029 
Cost of revenue   (12,654)   (69,809)
Gross profit   11,684    99,220 
Total operating expenses   (367,413)   (334,650)
Total other income   595    30,666 
Loss before income tax   (355,134)   (204,764)
Income tax expenses   -    (3,966)
Net loss   (355,134)   (208,730)

 

Revenue. For the three and nine months ended September 30, 2023, we generated revenues of $5,293 and $24,338, respectively. For the comparative three and nine months ended September 30, 2022, we generated revenues of $5,395 and $169,029, respectively. There was a significant decrease in revenue because of a significant decline in sales of $135,452 in the healthcare consulting business in Hong Kong.

 

Cost of Revenue. For the three and nine months ended September 30, 2023, the cost of revenue was $1,619 and $12,654, respectively, and as a percentage of net revenue, approximately 31% and 52%. Cost of revenue for the three and nine months ended September 30, 2022 was $22,498 and $69,809, respectively, and as a percentage of net revenue, approximately 417% and 41%, respectively. The cost of revenue decreased due to a significant decline in the sales in Hong Kong mentioned above.

 

Gross Profit (Loss). For the three months ended September 30, 2023 and 2022, the gross profit (loss) was $3,674 and $(17,103), respectively, the gross profit (loss) margin was 69% and (317)%, respectively.

 

25
 

 

For the nine months ended September 30, 2023 and 2022, the gross profit was $11,684 and $99,220, respectively, the gross profit margin was 48% and 59%, respectively. The gross profit decreased due to a significant decline in the sales in Hong Kong mentioned above.

 

Operating Expenses. For the three and nine months ended September 30, 2023, the operating cost was $117,238 and $367,413, respectively, and while for the three and nine months ended September 30, 2022, the operating cost was $99,309 and $334,650, respectively. The operating expenses increased due to an increase in administrative expenses.

 

Other Income. For the three and nine months ended September 30, 2023, the total other income was $13 and $595, respectively and while for the three and nine months ended September 30, 2022, the other income was $19,622 and $30,666, respectively. The total other income decreased due to receipt of government subsidies during the period ended September 30, 2022 while nil during the period ended September 30, 2023.

 

Net Loss. For the three and nine months ended September 30, 2023, we incurred a net loss of $113,551 and $355,134, respectively and for the three and nine months ended September 30, 2022, we incurred a net loss of $94,183 and $208,730, respectively. The increase in net loss was primarily attributable to the decrease in revenue in the healthcare consulting business in Hong Kong.

 

Liquidity and Capital Resources

 

As of September 30, 2023, we had cash and cash equivalents of $157,446.

 

As of December 31, 2022, we had cash and cash equivalents of $381,709.

 

The Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial support from its major shareholders. Management believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they become due. Despite the amount of funds that the Company has raised, no assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its shareholders, in the case of equity financing.

 

   Nine Months Ended September 30, 
   2023   2022 
Net cash used in operating activities  $(235,515)  $(113,647)
Net cash (used in) provided by investing activities   (743)   22,930)
Net cash provided by (used in) financing activities   14,606    (77,990 

 

Net Cash Used In Operating Activities.

 

For the nine months ended September 30, 2023, net cash used in operating activities was $235,515, which primarily consisted of a net loss of $355,134, non-cash adjustments of depreciation of plant and equipment of $37,341, amortization of intangible asset of $359, non-cash lease expense of $36,910, increase in accrued liabilities and other payables of $63,664, decrease in accounts receivable of $13, decrease in deposits and other receivables of $12,917, decrease in inventories of $19,350, and offset by decrease in accounts payable of $6,615, decrease in customer deposits of $6,854, decrease in income tax payable of $39, and decrease in lease liabilities of $37,427  .

 

For the nine months ended September 30, 2022, net cash used in operating activities was $113,647, which primarily consisted of a net loss of $208,730, non-cash adjustments of depreciation of plant and equipment of $51,134, amortization of intangible asset of $386, non-cash lease expense of $70,986, gain from sale of plant and equipment of $16,277, decrease in deposits and other receivables of $41,567, decrease in inventories of $49,364, decrease in income tax recoverable of $7,889, and offset by decrease in accrued liabilities and other payables of $1,701, and decrease in customers deposits of $108,265.  

 

We expect to continue to rely on cash generated through financing from our existing stockholders and private placements of our securities, however, to finance our operations and future acquisitions.

 

Net Cash (Used In) Provided By Investing Activities.

 

For the nine months ended September 30, 2023, net cash used in investing activities was $743, which consisted of purchase of plant and equipment.

 

For the nine months ended September 30, 2022, net cash provided by investing activities was $22,930, which consisted of proceeds from sale of motor vehicle.

 

Net Cash Used In Financing Activities.

 

For the nine months ended September 30, 2023, net cash provided by financing activities was $14,606, which consisted of advances from a director of $14,606.

 

26
 

 

For the nine months ended September 30, 2022, net cash used in financing activities was $77,990, which primarily consisted of repayment to a director of $1,974 and repayment of lease liabilities of $76,016.

 

Off Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements and it is not anticipated that the Company will enter into any off-balance sheet arrangements.

 

Critical Accounting Policies, Judgments and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires our management to make assumptions, estimates and judgments that affect the amounts reported, including the notes thereto, and related disclosures of commitments and contingencies, if any. We have identified certain accounting policies that are significant to the preparation of our financial statements. These accounting policies are important for an understanding of our financial condition and results of operations. Critical accounting policies are those that are most important to the presentation of our financial condition and results of operations and require management’s subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Certain accounting estimates are particularly sensitive because of their significance to financial statements and because of the possibility that future events affecting the estimate may differ significantly from management’s current judgments. We believe the following accounting policies are critical in the preparation of our financial statements.

 

The Company’s accounting policies are more fully described in Note 2 of the unaudited condensed consolidated financial statements. As discussed in Note 2, the preparation of the unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about the future events that affect the amounts reported in the financial statements and the accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual differences could differ from these estimates under different assumptions or conditions. The Company believes that the following addresses the Company’s most critical accounting policies.

 

Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized. A valuation allowance has currently been recorded to reduce our deferred tax asset to $0.

 

Forward-looking Statements

 

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of our Company. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward-looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

 

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest; changes in U.S., global or regional economic conditions; changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments; increased competitive pressures, both domestically and internationally; legal and regulatory developments, such as regulatory actions affecting environmental activities; the imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls; adverse weather conditions or natural disasters, such as hurricanes and earthquakes; and labor disputes, which may lead to increased costs or disruption of operations.

 

27
 

 

This list of factors that may affect future performance and the accuracy of forward-looking statements is illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining disclosure controls and procedures for the Company.

 

(a) Evaluation of Disclosure Controls and Procedures

 

Our management evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our President and Principal Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were not effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management as appropriate to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected but we believe the controls and procedures do provide a reasonable assurance.

 

(b) Changes in the Company’s Internal Controls Over Financial Reporting

 

There have been no changes in internal control over financial reporting that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the internal control over financial reporting.

 

Part II - Other Information

 

Item 1. Legal Proceedings

 

There are no legal proceedings, which are pending or have been threatened against us or any of our officers, directors or control persons of which management is aware.

 

Item 1A. Risk Factors

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Proceeds

 

Recent Sales of Unregistered Securities

 

We have not sold any restricted securities during the three and nine months ended September 30, 2023.

 

Use of Proceeds of Registered Securities

 

None; not applicable.

 

28
 

 

Purchases of Equity Securities by Us and Affiliated Purchasers

 

During the three and nine months ended September 30, 2023, we have not purchased any equity securities nor have any officers or directors of the Company.

 

Item 3. Defaults Upon Senior Securities

 

We are not aware of any defaults upon senior securities. Management has indicated they do not, at this time, intend to pursue the defaults.

 

Item 4. Mine Safety Disclosure

 

None; not applicable.

 

Item 5. Other Information

 

None; not applicable.

 

Item 6. Exhibits

 

  Exhibits No.    
       
  31.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  101.INS*   Inline XBRL Instance Document
  101.SCH*   Inline XBRL Taxonomy Extension Schema Document
  101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
  101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
  101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
  101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
  104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

  * These interactive data files are deemed “furnished” and not “filed” or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, or deemed “furnished” and not “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

29
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

China Foods Holdings Ltd.  
   
Dated: November 14, 2023 By: /s/ Kong Xiao Jun
    Kong Xiao Jun
    Chief Executive Officer & Chief Financial Officer

 

30

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Rule 13a-14(a) Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. 1350

(Section 302 of the Sarbanes-Oxley Act of 2002)

 

I, Kong Xiao Jun, certify that:

 

  1. I have reviewed this report on Form 10-Q of China Foods Holdings Ltd.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

  5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023 By: /s/ Kong Xiao Jun
    Kong Xiao Jun
    Chief Executive Officer & Chief Financial Officer

 

 

 

EX-32.1 3 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Kong Xiao Jun, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of China Foods Holdings Ltd. on Form 10-Q for the period ended September 30, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of China Foods Holdings Ltd.

 

Date: November 14, 2023 By: /s/ Kong Xiao Jun
    Kong Xiao Jun
    Chief Executive Officer & Chief Financial Officer

 

 

 

EX-101.SCH 4 cfoo-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - LIQUIDITY AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - DEPOSITS AND OTHER RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - LEASE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ (DEFICIT) EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - CONCENTRATIONS OF RISK link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - NATURE OF OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - DEPOSITS AND OTHER RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - LEASE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - CONCENTRATIONS OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - LIQUIDITY AND GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SUMMARY OF REPORTABLE SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SEGMENT REPORTING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - LEASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - STOCKHOLDERS’ (DEFICIT) EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - CONCENTRATIONS OF RISK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 cfoo-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 cfoo-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 7 cfoo-20230930_lab.xml XBRL LABEL FILE Related Party, Type [Axis] Director [Member] Related Party [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Consolidated Entities [Axis] Elite Creation Group Limited [Member] Alpha Wellness (HK) Limited [Member] Guangzhou Xiao Xiang Health Industry Company Limited [Member] Long-Lived Tangible Asset [Axis] Furniture, Fixture and Equipment [Member] Motor Vehicles [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Leasehold Improvements [Member] Product and Service [Axis] Sale of Wine Products [Member] Sales of Healthcare Products [Member] Consultancy Service Fee Income [Member] Geographical [Axis] HONG KONG CHINA Derivative Instrument [Axis] Period-end HK$:US$ Exchange Rate [Member] Period Average HK$:US$ Exchange Rate [Member] Period-end RMB:US$ Exchange Rate [Member] Period Average RMB:US$ Exchange Rate [Member] Segments [Axis] Healthcare Segment [Member] Wine Segment [Member] Healthcare Products [Member] Wine Products [Member] Motor Vehicle [Member] Foreign Translation Difference [Member] UNITED STATES Customer [Axis] Customer A [Member] Concentration Risk Benchmark [Axis] Revenue from Contract with Customer Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] Customer C [Member] Customer [Member] Customer B [Member] Cost of Goods and Service Benchmark [Member] Supplier Concentration Risk [Member] Vendor [Member] Accounts Payable [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net Deposits and other receivables Inventories, net Total Current Assets Non-Current Assets Plant and equipment, net Right-of-use assets, net Intangible assets, net Total Non-Current Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Current Liabilities Accounts payable Accrued liabilities and other payables Customer deposits Lease liabilities Amount due to a related party Income tax payable Total Current Liabilities Stockholders’ (Deficit) Equity Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total Stockholders’ (Deficit) Equity TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Statement of Financial Position [Abstract] Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit (loss) Operating expenses: Selling and distribution expenses General and administrative expenses Total operating expenses Loss from operation Other Income: Interest income Sundry income Total other income Loss before income tax Income tax expenses Net loss Other comprehensive income (loss): Foreign currency adjustment gain (loss) Comprehensive loss Net loss per common share Basic Diluted Weighted average number of common stock Basic Diluted Statement [Table] Statement [Line Items] Beginning balance, value Balance, shares Net loss for the period Foreign currency translation adjustment Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities Depreciation of plant and equipment Gain from sale of plant and equipment Amortization of intangible assets Non-cash lease expense Adjustments to reconcile net loss to net cash used in operating activities, Total Change in operating assets and liabilities: Accounts receivables Deposits and other receivables Inventories Accrued liabilities and other payables Accounts payable Income tax recoverable Income tax payable Customer deposits Lease liabilities Net cash used in operating activities Cash flows from investing activities: Purchase of plant and equipment Proceeds from sale of plant and equipment Net cash (used in) provided by investing activities Cash flows from financing activities: Repayment of lease liabilities Advances from (repayment to) a director Net cash provided by (used in) financing activities Foreign currency translation adjustment Net change in cash and cash equivalents CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid for interest Cash paid for income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Liquidity And Going Concern LIQUIDITY AND GOING CONCERN Segment Reporting [Abstract] SEGMENT REPORTING Deposits And Other Receivables DEPOSITS AND OTHER RECEIVABLES Inventory Disclosure [Abstract] INVENTORIES Lease LEASE Property, Plant and Equipment [Abstract] PLANT AND EQUIPMENT Amounts Due To Director And Related Company AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Equity [Abstract] STOCKHOLDERS’ (DEFICIT) EQUITY Income Tax Disclosure [Abstract] INCOME TAXES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISK Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation and consolidation Use of estimates Cash and cash equivalents Accounts receivable Inventories Plant and equipment Intangible assets Impairment of long-lived assets Revenue recognition Income taxes Uncertain tax positions Foreign currencies translation Net loss per share Comprehensive loss Leases Related parties Commitments and contingencies Fair value Measurement Segment Reporting Recent accounting pronouncements SCHEDULE OF SUBSIDIARIES INFORMATION SCHEDULE OF ESTIMATED USEFUL LIVES SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES SUMMARY OF REPORTABLE SEGMENTS SUMMARY OF GEOGRAPHIC SEGMENTS SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF CONCENTRATIONS OF RISK Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Place of incorporation and kind of legal entity Principal activities Stock issued during period, shares, new issues Stock issued during period, value, new issues Effective interest held percentage Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful lives Residual value Schedule of Product Information [Table] Product Information [Line Items] TOTAL Offsetting Assets [Table] Offsetting Assets [Line Items] Foreign currency translation exchange rates Allowance for doubtful accounts Depreciation expense Intangible assets amortization period Sales tax percentage Product sales returns Income Tax Examination, Likelihood of Unfavorable Settlement Net income loss Working capital Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Total revenue Total cost of revenue Selling and distribution General and administrative Total operating expenses Number of reportable segments Schedule Of Deposits And Other Receivable Rental deposits Purchase deposits Other receivables  Deposits and other receivable  Finished goods Allowance for obsolete inventories Schedule Of Right Of Use Assets And Liability Right-of-use assets Operating lease, description Lease term Operating lease payment Plant and equipment, gross Foreign translation adjustment Less: accumulated depreciation Foreign translation adjustment Plant and equipment, net Common stock, shares, issued mon stock, shares, outstanding Current tax Deferred tax Income tax expense (Loss) income before income tax Statutory income tax rate Income tax expense at statutory rate Net operating loss Income tax expense Tax adjustments Net operating loss carryforwards Less: valuation allowance Deferred tax assets, net Income tax description Cumulative net operating losses Deferred tax assets Net operating loss carryforwards term Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Accounts receivable Concentration Risk, Percentage Purchase Accounts payable Deposits and other receivables. Non cash lease expenses. Adjustment noncash items to reconcile net income loss to cash provided by used in operating activities. Increase decrease in deposits and other receivables. Increase decrease in income tax recoverable. Schedule of subsidiaries information [Table Text Block] Healthcare Segment [Member] Wine Segment [Member] Deposits and Other Receivables [Text Block] Rental deposits. Purchase deposits. Allowance for obsolete inventories. Place of incorporation and kind of legal entity. Elite Creation Group Limited [Member] Alpha Wellness (HK) Limited [Member] Guangzhou Xiao Xiang Health Industry Company Limited [Member] Principal activities. Schedule Of Right Of Use Assets And Liability [Table Text Block] Effective interest held percentage. Foreign translation adjustment. Foreign translation difference, net. Amounts Due To Director And Related Company [Text Block] Schedule Of Estimated Useful Lives [Table Text Block] Furniture, Fixture and Equipment [Member] Motor Vehicles [Member] Sales tax percentage. Product sales returns. Net operating loss carryforwards term Customer C [Member] Period-end HK$:US$ Exchange Rate [Member] Period Average HK$:US$ Exchange Rate [Member] Period-end RMB:US$ Exchange Rate [Member] Period Average RMB:US$ Exchange Rate [Member] Related Parties [Policy Text Block] Customer A [Member] Customer B [Member] Customer [Member] Liquidity and going concern disclosure. Working capital. Vendor [Member] Loss income before income tax. Customers [Member] Consultancy Service Fee Income [Member] Sale of Wine Products [Member] Sales of Healthcare Products [Member] Foreign Translation Difference [Member] Healthcare Products [Member] Wine Products [Member] Motor Vehicle [Member] Assets, Current Assets, Noncurrent Assets Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Increase (Decrease) in Accounts Receivable IncreaseDecreaseInDepositsAndOtherReceivables Increase (Decrease) in Inventories Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable Increase (Decrease) in Income Taxes Payable Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Operating Lease Liability Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash and Cash Equivalents, Policy [Policy Text Block] Prepaid Expense and Other Assets Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment ForeignTranslationDifferenceNet Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Accounts Receivable, after Allowance for Credit Loss Accounts Payable EX-101.PRE 8 cfoo-20230930_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 10, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-32522  
Entity Registrant Name China Foods Holdings Ltd.  
Entity Central Index Key 0001310630  
Entity Tax Identification Number 84-1735478  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One Room 2301A  
Entity Address, Address Line Two China Resources Building  
Entity Address, Address Line Three 26 Harbour Road  
Entity Address, City or Town Wanchai  
Entity Address, Country HK  
Entity Address, Postal Zip Code 0000  
City Area Code 852  
Local Phone Number 3618-8608  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   20,252,309
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 157,446 $ 381,709
Accounts receivable, net 5,107 5,120
Deposits and other receivables 61,896 74,813
Inventories, net 119,232 138,582
Total Current Assets 343,681 600,224
Non-Current Assets    
Plant and equipment, net 17,656 55,495
Right-of-use assets, net 34,451 20,341
Intangible assets, net 2,631 3,148
Total Non-Current Assets 54,738 78,984
TOTAL ASSETS 398,419 679,208
Current Liabilities    
Accounts payable 1,398 8,013
Accrued liabilities and other payables 186,324 122,660
Customer deposits 66,748 73,602
Lease liabilities 34,664 21,024
Income tax payable 15,683 15,722
Total Current Liabilities 740,181 661,779
Stockholders’ (Deficit) Equity    
Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 2,025 2,025
Additional paid-in capital 1,290,355 1,290,355
Accumulated other comprehensive loss (6,735) (2,678)
Accumulated deficit (1,627,407) (1,272,273)
Total Stockholders’ (Deficit) Equity (341,762) 17,429
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY 398,419 679,208
Director [Member]    
Current Liabilities    
Amount due to a related party 235,400 220,794
Related Party [Member]    
Current Liabilities    
Amount due to a related party $ 199,964 $ 199,964
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 20,252,309 20,252,309
Common stock, shares outstanding 20,252,309 20,252,309
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 5,293 $ 5,395 $ 24,338 $ 169,029
Cost of revenue (1,619) (22,498) (12,654) (69,809)
Gross profit (loss) 3,674 (17,103) 11,684 99,220
Operating expenses:        
Selling and distribution expenses 248 3,506 2,622
General and administrative expenses 116,990 99,309 363,907 332,028
Total operating expenses 117,238 99,309 367,413 334,650
Loss from operation (113,564) (116,412) (355,729) (235,430)
Other Income:        
Interest income 4 10 250 123
Sundry income 9 19,612 345 30,543
Total other income 13 19,622 595 30,666
Loss before income tax (113,551) (96,790) (355,134) (204,764)
Income tax expenses 2,607 (3,966)
Net loss (113,551) (94,183) (355,134) (208,730)
Other comprehensive income (loss):        
Foreign currency adjustment gain (loss) 23 (13,735) (4,057) (33,391)
Comprehensive loss $ (113,528) $ (107,918) $ (359,191) $ (242,121)
Net loss per common share        
Basic [1] $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Diluted [1] $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Weighted average number of common stock        
Basic 20,252,309 20,252,309 20,252,309 20,252,309
Diluted 20,252,309 20,252,309 20,252,309 20,252,309
[1] denotes net loss per common share of less than $0.001 per share.
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 2,025 $ 1,290,355 $ (918,195) $ 26,516 $ 400,701
Balance, shares at Dec. 31, 2021 20,252,309        
Net loss for the period (76,824) (76,824)
Foreign currency translation adjustment (602) (602)
Balance at Mar. 31, 2022 $ 2,025 1,290,355 (995,019) 25,914 323,275
Balance, shares at Mar. 31, 2022 20,252,309        
Beginning balance, value at Dec. 31, 2021 $ 2,025 1,290,355 (918,195) 26,516 400,701
Balance, shares at Dec. 31, 2021 20,252,309        
Net loss for the period         (208,730)
Foreign currency translation adjustment         (33,391)
Balance at Sep. 30, 2022 $ 2,025 1,290,355 (1,126,925) (6,875) 158,580
Balance, shares at Sep. 30, 2022 20,252,309        
Beginning balance, value at Mar. 31, 2022 $ 2,025 1,290,355 (995,019) 25,914 323,275
Balance, shares at Mar. 31, 2022 20,252,309        
Net loss for the period (37,723) (37,723)
Foreign currency translation adjustment (19,054) (19,054)
Balance at Jun. 30, 2022 $ 2,025 1,290,355 (1,032,742) 6,860 266,498
Balance, shares at Jun. 30, 2022 20,252,309        
Net loss for the period (94,183) (94,183)
Foreign currency translation adjustment (13,735) (13,735)
Balance at Sep. 30, 2022 $ 2,025 1,290,355 (1,126,925) (6,875) 158,580
Balance, shares at Sep. 30, 2022 20,252,309        
Beginning balance, value at Dec. 31, 2022 $ 2,025 1,290,355 (1,272,273) (2,678) 17,429
Balance, shares at Dec. 31, 2022 20,252,309        
Net loss for the period (107,871) (107,871)
Foreign currency translation adjustment (227) (227)
Balance at Mar. 31, 2023 $ 2,025 1,290,355 (1,380,144) (2,905) (90,669)
Balance, shares at Mar. 31, 2023 20,252,309        
Beginning balance, value at Dec. 31, 2022 $ 2,025 1,290,355 (1,272,273) (2,678) 17,429
Balance, shares at Dec. 31, 2022 20,252,309        
Net loss for the period         (355,134)
Foreign currency translation adjustment         (4,057)
Balance at Sep. 30, 2023 $ 2,025 1,290,355 (1,627,407) (6,735) (341,762)
Balance, shares at Sep. 30, 2023 20,252,309        
Beginning balance, value at Mar. 31, 2023 $ 2,025 1,290,355 (1,380,144) (2,905) (90,669)
Balance, shares at Mar. 31, 2023 20,252,309        
Net loss for the period (133,712) (133,712)
Foreign currency translation adjustment (3,853) (3,853)
Balance at Jun. 30, 2023 $ 2,025 1,290,355 (1,513,856) (6,758) (228,234)
Balance, shares at Jun. 30, 2023 20,252,309        
Net loss for the period (113,551) (113,551)
Foreign currency translation adjustment 23 23
Balance at Sep. 30, 2023 $ 2,025 $ 1,290,355 $ (1,627,407) $ (6,735) $ (341,762)
Balance, shares at Sep. 30, 2023 20,252,309        
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (355,134) $ (208,730)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation of plant and equipment 37,341 51,134
Gain from sale of plant and equipment (16,277)
Amortization of intangible assets 359 386
Non-cash lease expense 36,910 70,986
Adjustments to reconcile net loss to net cash used in operating activities, Total (280,524) (102,501)
Change in operating assets and liabilities:    
Accounts receivables 13
Deposits and other receivables 12,917 41,567
Inventories 19,350 49,364
Accrued liabilities and other payables 63,664 (1,701)
Accounts payable (6,615)
Income tax recoverable 7,889
Income tax payable (39)
Customer deposits (6,854) (108,265)
Lease liabilities (37,427)
Net cash used in operating activities (235,515) (113,647)
Cash flows from investing activities:    
Purchase of plant and equipment (743)
Proceeds from sale of plant and equipment 22,930
Net cash (used in) provided by investing activities (743) 22,930
Cash flows from financing activities:    
Repayment of lease liabilities (76,016)
Advances from (repayment to) a director 14,606 (1,974)
Net cash provided by (used in) financing activities 14,606 (77,990)
Foreign currency translation adjustment (2,611) (19,028)
Net change in cash and cash equivalents (224,263) (187,735)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 381,709 609,434
CASH AND CASH EQUIVALENTS, END OF PERIOD 157,446 421,699
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest
Cash paid for income taxes
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.23.3
NATURE OF OPERATIONS
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF OPERATIONS

NOTE 1 – NATURE OF OPERATIONS

 

China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019.

 

The Company is a health and wellness company that develops, markets, promotes and distributes a variety of customized health and wellness care products and services, including supplements, healthy snacks, meal replacements, skincare products, and nutritional consultation services to consumers in China. The Company works with certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through sales agents and also through a network of e-commerce and social media platforms.

 

Due to the impact of the COVID-19 pandemic in the healthcare industry, the Company also offered a new line of high-end wine products in our online and offline sales platform, to diversify the market demand and customer needs.

 

The following table depicts the description of the Company’s subsidiaries:

Name  Place of incorporation and kind of legal entity  Principal activities  Particulars of registered/ paid up share capital  Effective interest held 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares for HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB 8,300,000   100%

 

XML 16 R8.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation and consolidation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 31, 2023.

 

 

The unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:

 

revenue recognition at point in time and over time;
sales returns at point in time and allowances;
inventory;
estimated lives for tangible and intangible assets; and
income tax valuation allowances

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of September 30, 2023 and December 31, 2022, there was no allowance for doubtful accounts.

 

Credit Losses – Measurement of Credit Losses on Financial Instruments

 

In March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, “Credit Losses – Measurement of Credit Losses on Financial Instruments (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial statements.

 

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of September 30, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

 

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5%
Motor vehicle  3.33 to 4 years   5%
Leasehold improvement  2 years   5%

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Depreciation expense for the three and nine months ended September 30, 2023 were $8,830 and $37,341, respectively, and for the three and nine months ended September 30, 2022 were $14,497 and $51,134, respectively.

 

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the three and nine months ended September 30, 2023 were $116 and $359, respectively.

 

Amortization expense for the three and nine months ended September 30, 2022 were $127 and $386, respectively.

 

Impairment of long-lived assets

 

In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the periods presented.

 

Revenue recognition

 

The Company adopted ASC 606 – “Revenue from Contracts with Customers” (“ASC Topic 606”). Under ASC Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC Topic 606, the Company performs the following five steps:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract; and
  recognize revenue as the performance obligation is satisfied.

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded no product sales returns for the nine months ended September 30, 2023 and 2022. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Sale of wine products  $2,696   $5,395 
Sales of healthcare products   2,597    - 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Consultancy service fee income  $-   $135,452 
Sale of wine products   20,971    33,577 
Sales of healthcare products   3,367    - 
           
TOTAL  $24,338   $169,029 

 

The below revenues are based on the countries in which the customers are located. Summarized financial information concerning the geographic segments is shown in the following tables:

 SUMMARY OF GEOGRAPHIC SEGMENTS

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
PRC   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
PRC   24,338    33,577 
           
TOTAL  $24,338   $169,029 

 

 

Income taxes

 

The Company adopted the ASC Topic 740, “Income Taxes” (“ASC Topic 740”) provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

Uncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the nine months ended September 30, 2023 and 2022.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the PRC and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholders’ equity.

 

Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
Period-end HK$:US$ exchange rate   0.12767    0.12744 
Period average HK$:US$ exchange rate   0.12764    0.12779 
Period-end RMB:US$ exchange rate   0.13705    0.14930 
Period average RMB:US$ exchange rate   0.14229    0.15438 

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share”. Basic (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. Potential common stocks that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.

 

 

Comprehensive loss

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Leases

 

The Company adopted ASC Topic 842, “Leases” (“ASC Topic 842”). At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.

 

In accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g. land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.

 

Lease expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability. The amortized period for ROU assets is limited to the expected lease term.

 

The Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating leases with terms of 12 months or less.

 

Related parties

 

The Company follows the ASC Topic 850-10, “Related Party” for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Commitments and contingencies

 

The Company follows the ASC Topic 450-20, “Commitments” to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value Measurement

 

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC Topic 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, deposits and other receivables, accounts payable, accrued liabilities and other payables, customer deposits, amount due to a director, and amount due to a related company approximate their fair values because of the short maturity of these instruments.

 

 

Segment Reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in two reportable operating segments in Hong Kong and China.

 

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company has evaluated that the impact of all recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

 

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.23.3
LIQUIDITY AND GOING CONCERN
9 Months Ended
Sep. 30, 2023
Liquidity And Going Concern  
LIQUIDITY AND GOING CONCERN

NOTE 3 – LIQUIDITY AND GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared using going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

For the nine months ended September 30, 2023, the Company incurred a net loss of $355,134 and suffered from a working capital deficit of $396,500 as of September 30, 2023. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders. Management believes the existing stockholders will provide the additional cash to meet with the Company’s obligations as they become due. However, there is no assurance that the Company will be successful in securing sufficient funds to sustain the operations.

 

These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

 

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 4 – SEGMENT REPORTING

 

Currently, the Company has two reportable business segments:

 

(i) Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and
(ii) Wine Segment, mainly provides the wine products to the customers.

 

 

In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments.

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products     2,696   2,696 
Sale of healthcare products   2,597        2,597 
Total revenue   2,597    2,696    5,293 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (544)   (544)
Sale of healthcare products   (1,075)       (1,075)
Total cost of revenue   (1,075)   (544)   (1,619)
                
Gross profit   1,522    2,152    3,674 
                
Operating expenses:               
Selling and distribution       (248)   (248)
General and administrative   (76,826)   (40,164)   (116,990)
Total operating expenses   (76,826)   (40,412)   (117,238)
                
Segment loss  $(75,304)  $(38,260)  $(113,564)

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       5,395    5,395 
Sale of healthcare products            
Total revenue       5,395    5,395 
                
Cost of revenue:               
Consulting service income   (17,703)       (17,703)
Sale of wine products       (4,795)   (4,795)
Sale of healthcare products            
Total cost of revenue   (17,703)   (4,795)   (22,498)
                
Gross (loss) profit   (17,703)   600    (17,103)
                
Operating expenses:               
Selling and distribution   -    -    - 
General and administrative   (30,445)   (68,864)   (99,309)
Total operating expenses   (30,445)   (68,864)   (99,309)
                
Segment loss  $(48,148)  $(68,264)  $(116,412)

 

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       20,971    20,971 
Sale of healthcare products   3,367        3,367 
Total revenue   3,367    20,971    24,338 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (11,227)   (11,227)
Sale of healthcare products   (1,427)       (1,427)
Total cost of revenue   (1,427)   (11,227)   (12,654)
                
Gross profit   1,940    9,744    11,684 
                
Operating expenses:               
Selling and distribution       (3,506)   (3,506)
General and administrative   (232,021)   (131,886)   (363,907)
Total operating expenses   (232,021)   (135,392)   (367,413)
                
Segment loss  $(230,081)  $(125,648)  $(355,729)

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $135,452   $   $135,452 
Sale of wine products       33,577    33,577 
Sale of healthcare products            
Total revenue   135,452    33,577    169,029 
                
Cost of sales:               
Consulting service income   (45,971)   -    (45,971)
Sale of wine products   -    (23,838)   (23,838)
Sale of healthcare products            
Total cost of revenue   (45,971)   (23,838)   (69,809)
                
Gross profit   89,481    9,739    99,220 
                
Operating expenses:               
Selling and distribution   -    (2,622)   (2,622)
General and administrative   (94,979)   (237,049)   (332,028)
Total operating expenses   (94,979)   (239,671)   (334,650)
                
Segment loss  $(5,498)  $(229,932)  $(235,430)

 

 

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables: 

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
China   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine

Months Ended

September 30,
2023

  

Nine Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
China   24,338    33,577 
           
TOTAL  $24,338   $169,029 

 

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.23.3
DEPOSITS AND OTHER RECEIVABLES
9 Months Ended
Sep. 30, 2023
Deposits And Other Receivables  
DEPOSITS AND OTHER RECEIVABLES

NOTE 5 – DEPOSITS AND OTHER RECEIVABLES

 

Deposits and other receivables consisted of the following:

 

   September 30,
2023
   December 31,
2022
 
         (Audited) 
Rental deposits  $40,751   $40,115 
Purchase deposits   17,967    23,835 
Other receivables   3,178    10,863 
 Deposits and other receivable  $61,896   $74,813 

 

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 6 – INVENTORIES

 

Inventories consisted of the following:

 

           
   September 30,
2023
   December 31,
2022
 
       (Audited) 
Finished goods – Healthcare products  $-   $- 
Finished goods – Wine products   119,232    138,582 
 Finished goods  $119,232   $138,582 

 

For the three and nine months ended September 30, 2023 and 2022, no allowance for obsolete inventories was recorded by the Company.

 

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.23.3
LEASE
9 Months Ended
Sep. 30, 2023
Lease  
LEASE

NOTE 7 – LEASE

 

The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2 years, through May 16, 2023. Upon expiry, the Company renewed and leased an office premise under operating lease with a term of 1 year.

 

 

Right of use assets and lease liability – right of use are as follows:

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Right-of-use assets  $34,451   $20,341 

 

The lease liability – right of use is as follows:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Lease liabilities  $34,664   $21,024 

 

As of September 30, 2023, the operating lease payment of $34,664 will become matured in the next 12 months.

 

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.23.3
PLANT AND EQUIPMENT
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
PLANT AND EQUIPMENT

NOTE 8 – PLANT AND EQUIPMENT

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Motor vehicle  $284,255   $284,255 
Furniture, fixture and equipment   16,208    15,465 
Leasehold improvement   27,358    27,358 
Foreign translation adjustment   (18,083)   (4,095)
Plant and equipment, gross   309,738    322,983 
           
Less: accumulated depreciation   (296,006)   (258,665)
Foreign translation adjustment   3,924    (8,823)
Plant and equipment, net  $17,656   $55,495 

 

Depreciation expense for the three and nine months ended September 30, 2023 were $8,830 and $37,341, respectively.

 

Depreciation expense for the three and nine months ended September 30, 2022 were $14,497 and $51,134, respectively.

 

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.23.3
AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY
9 Months Ended
Sep. 30, 2023
Amounts Due To Director And Related Company  
AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

NOTE 9 – AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY

 

As of September 30, 2023 and December 31, 2022, the amounts represented temporary advances to the Company by its director and a related company which were unsecured, interest-free and have no fixed terms of repayments.

 

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS’ (DEFICIT) EQUITY
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ (DEFICIT) EQUITY

NOTE 10 – STOCKHOLDERS’ (DEFICIT) EQUITY

 

Common Stock

 

The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to 100,000,000 shares of common stock with a par value of $0.0001.

 

Dividend Rights

 

Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.

 

 

Voting Rights

 

Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.

 

No Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.

 

As of September 30, 2023, and December 31, 2022, a total of 20,252,309 and 20,252,309 outstanding shares of common stock were issued, respectively.

 

Preferred Stock

 

The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.

 

XML 25 R17.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 11 – INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Current tax  $   -   $3,966 
Deferred tax   -    - 
Income tax expense  $-   $3,966 

 

The Company mainly operates in the PRC that is subject to taxes in the governing jurisdictions in which it operates. The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate, as follows:

 

BVI

 

Under the current BVI law, the Company is not subject to tax on income.

 

 

The PRC

 

The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Loss before income taxes  $(156,322)  $(220,924)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (39,081)   (55,231)
Net operating loss   39,081    55,231 
Income tax expense  $-   $- 

 

Hong Kong

 

The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year. The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
(Loss) income before income tax  $(178,731)  $25,029 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   (14,745)   2,065 
Tax adjustments   1,334    1,901 
Net operating loss   13,411    - 
Income tax expense  $-   $3,966 

 

The following table sets forth the significant components of the deferred tax assets of the Company as of September 30, 2023 and December 31, 2022:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $154,092    149,874 
- Hong Kong   13,411    - 
- PRC   348,712    309,631 
Net operating loss carryforwards   516,215    459,505 
Less: valuation allowance   (516,215)   (459,505)
Deferred tax assets, net  $-   $- 

 

 

As of September 30, 2023, the operations in the United States of America incurred $733,771 of cumulative net operating losses which can be carried forward indefinitely to offset future taxable income, under The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) since 2021. The Company has provided for a full valuation allowance against the deferred tax assets of $154,092 on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Also, the operations in the PRC incurred $1,394,848 of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss carryforwards under PRC tax regime can be carried forward in 5 years, until 2027. the Company has provided for a full valuation allowance against the deferred tax assets of $348,712 on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.

 

Uncertain tax positions

 

The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of September 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the nine months ended September 30, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from September 30, 2023.

 

XML 26 R18.htm IDEA: XBRL DOCUMENT v3.23.3
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 12 – RELATED PARTY TRANSACTIONS

 

From time to time, the Company’s director advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

 

Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.

 

XML 27 R19.htm IDEA: XBRL DOCUMENT v3.23.3
CONCENTRATIONS OF RISK
9 Months Ended
Sep. 30, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISK

NOTE 13 – CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

  (a) Major customers

 

For the three and nine months ended September 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivables balance as at period-end dates, are presented as follows:

 

 

   Three months ended
September 30, 2023
 
Customer  Revenues   Percentage of
revenues
 
         
Customer A  $2,960    56%

 

   Nine months ended September 30, 2023      September 30, 2023 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $2,960    12%          -     - 
Customer C   10,220    42%      -    - 
                        
Total:  $13,180    54%  Total   -    - 

 

   Three months ended
September 30, 2022
 
Customer  Revenues   Percentage of
revenues
 
         
Customer B  $5,297    98%

 

   Nine months ended September 30, 2022      September 30, 2022 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $135,452    80%      -    - 
Customer B   19,395    12%      -    - 
                        
Total:  $154,847    92%  Total   -    - 

 

The Company’s major customers are located in the PRC and Hong Kong.

 

(b) Major vendors

 

For the three months ended September 30, 2023, there is no single vendor representing more than 10% of the Company’s purchases. For the nine months ended September 30, 2023, a single vendor represented more than 10% of the Company’s purchases. This vendor accounted for 11% of the Company’s purchases amounting to $1,398, with accounts payable of $0 as of September 30, 2023.

 

For the three and nine months ended September 30, 2022, there is no single vendor representing more than 10% of the Company’s purchases.

 

All of the Company’s vendors are located in the PRC.

 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Economic and political risk

 

The Company’s major operations are conducted in the PRC. Accordingly, the political, economic, and legal environments in the PRC, as well as the general state of the PRC’s economy may influence the Company’s business, financial condition, and results of operations.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 14 - COMMITMENTS AND CONTINGENCIES

 

As of September 30, 2023, the Company has no material commitments or contingencies.

 

XML 29 R21.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 15 - SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2023 up through the date the Company issued the unaudited condensed consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.

XML 30 R22.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of presentation and consolidation

Basis of presentation and consolidation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 31, 2023.

 

 

The unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of estimates

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:

 

revenue recognition at point in time and over time;
sales returns at point in time and allowances;
inventory;
estimated lives for tangible and intangible assets; and
income tax valuation allowances

 

These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.

 

Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Accounts receivable

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of September 30, 2023 and December 31, 2022, there was no allowance for doubtful accounts.

 

Credit Losses – Measurement of Credit Losses on Financial Instruments

 

In March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, “Credit Losses – Measurement of Credit Losses on Financial Instruments (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial statements.

 

Inventories

Inventories

 

Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of September 30, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.

 

 

Plant and equipment

Plant and equipment

 

Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5%
Motor vehicle  3.33 to 4 years   5%
Leasehold improvement  2 years   5%

 

Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Depreciation expense for the three and nine months ended September 30, 2023 were $8,830 and $37,341, respectively, and for the three and nine months ended September 30, 2022 were $14,497 and $51,134, respectively.

 

Intangible assets

Intangible assets

 

Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.

 

Amortization expense for the three and nine months ended September 30, 2023 were $116 and $359, respectively.

 

Amortization expense for the three and nine months ended September 30, 2022 were $127 and $386, respectively.

 

Impairment of long-lived assets

Impairment of long-lived assets

 

In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, “Impairment or Disposal of Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the periods presented.

 

Revenue recognition

Revenue recognition

 

The Company adopted ASC 606 – “Revenue from Contracts with Customers” (“ASC Topic 606”). Under ASC Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC Topic 606, the Company performs the following five steps:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract; and
  recognize revenue as the performance obligation is satisfied.

 

 

Currently, the Company operates two business segments.

 

Healthcare Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.

 

Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.

 

The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Wine Business mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded no product sales returns for the nine months ended September 30, 2023 and 2022. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.

 

Disaggregation of Revenue

 

The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Sale of wine products  $2,696   $5,395 
Sales of healthcare products   2,597    - 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Consultancy service fee income  $-   $135,452 
Sale of wine products   20,971    33,577 
Sales of healthcare products   3,367    - 
           
TOTAL  $24,338   $169,029 

 

The below revenues are based on the countries in which the customers are located. Summarized financial information concerning the geographic segments is shown in the following tables:

 SUMMARY OF GEOGRAPHIC SEGMENTS

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
PRC   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
PRC   24,338    33,577 
           
TOTAL  $24,338   $169,029 

 

 

Income taxes

Income taxes

 

The Company adopted the ASC Topic 740, “Income Taxes” (“ASC Topic 740”) provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

Uncertain tax positions

Uncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the nine months ended September 30, 2023 and 2022.

 

Foreign currencies translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.

 

The reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the PRC and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholders’ equity.

 

Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
Period-end HK$:US$ exchange rate   0.12767    0.12744 
Period average HK$:US$ exchange rate   0.12764    0.12779 
Period-end RMB:US$ exchange rate   0.13705    0.14930 
Period average RMB:US$ exchange rate   0.14229    0.15438 

 

Net loss per share

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share”. Basic (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. Potential common stocks that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.

 

 

Comprehensive loss

Comprehensive loss

 

ASC Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.

 

Leases

Leases

 

The Company adopted ASC Topic 842, “Leases” (“ASC Topic 842”). At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.

 

In accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g. land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.

 

Lease expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability. The amortized period for ROU assets is limited to the expected lease term.

 

The Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating leases with terms of 12 months or less.

 

Related parties

Related parties

 

The Company follows the ASC Topic 850-10, “Related Party” for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Commitments and contingencies

Commitments and contingencies

 

The Company follows the ASC Topic 450-20, “Commitments” to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair value Measurement

Fair value Measurement

 

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC Topic 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
  Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
  Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

 

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, deposits and other receivables, accounts payable, accrued liabilities and other payables, customer deposits, amount due to a director, and amount due to a related company approximate their fair values because of the short maturity of these instruments.

 

 

Segment Reporting

Segment Reporting

 

ASC Topic 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in two reportable operating segments in Hong Kong and China.

 

Recent accounting pronouncements

Recent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company has evaluated that the impact of all recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.3
NATURE OF OPERATIONS (Tables)
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF SUBSIDIARIES INFORMATION

The following table depicts the description of the Company’s subsidiaries:

Name  Place of incorporation and kind of legal entity  Principal activities  Particulars of registered/ paid up share capital  Effective interest held 
              
Elite Creation Group Limited  BVI, a limited liability company  Investment holding  50,000 issued shares of US$1each   100%
               
Alpha Wellness (HK) Limited  Hong Kong, a limited liability company  Investment holding  300,000 issued shares for HK$300,000   100%
               
Guangzhou Xiao Xiang Health Industry Company Limited  The PRC, a limited liability company  Sales of healthcare products  RMB 8,300,000   100%
XML 32 R24.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES

 

   Expected useful lives  Residual value 
Furniture, fixture and equipment  3 years   5%
Motor vehicle  3.33 to 4 years   5%
Leasehold improvement  2 years   5%
SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS

The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Sale of wine products  $2,696   $5,395 
Sales of healthcare products   2,597    - 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Consultancy service fee income  $-   $135,452 
Sale of wine products   20,971    33,577 
Sales of healthcare products   3,367    - 
           
TOTAL  $24,338   $169,029 
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES

Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:

 

   2023   2022 
Period-end HK$:US$ exchange rate   0.12767    0.12744 
Period average HK$:US$ exchange rate   0.12764    0.12779 
Period-end RMB:US$ exchange rate   0.13705    0.14930 
Period average RMB:US$ exchange rate   0.14229    0.15438 
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
SUMMARY OF REPORTABLE SEGMENTS

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products     2,696   2,696 
Sale of healthcare products   2,597        2,597 
Total revenue   2,597    2,696    5,293 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (544)   (544)
Sale of healthcare products   (1,075)       (1,075)
Total cost of revenue   (1,075)   (544)   (1,619)
                
Gross profit   1,522    2,152    3,674 
                
Operating expenses:               
Selling and distribution       (248)   (248)
General and administrative   (76,826)   (40,164)   (116,990)
Total operating expenses   (76,826)   (40,412)   (117,238)
                
Segment loss  $(75,304)  $(38,260)  $(113,564)

 

   Healthcare Segment   Wine Segment   Total 
   Three months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       5,395    5,395 
Sale of healthcare products            
Total revenue       5,395    5,395 
                
Cost of revenue:               
Consulting service income   (17,703)       (17,703)
Sale of wine products       (4,795)   (4,795)
Sale of healthcare products            
Total cost of revenue   (17,703)   (4,795)   (22,498)
                
Gross (loss) profit   (17,703)   600    (17,103)
                
Operating expenses:               
Selling and distribution   -    -    - 
General and administrative   (30,445)   (68,864)   (99,309)
Total operating expenses   (30,445)   (68,864)   (99,309)
                
Segment loss  $(48,148)  $(68,264)  $(116,412)

 

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2023 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $   $   $ 
Sale of wine products       20,971    20,971 
Sale of healthcare products   3,367        3,367 
Total revenue   3,367    20,971    24,338 
                
Cost of revenue:               
Consulting service income            
Sale of wine products       (11,227)   (11,227)
Sale of healthcare products   (1,427)       (1,427)
Total cost of revenue   (1,427)   (11,227)   (12,654)
                
Gross profit   1,940    9,744    11,684 
                
Operating expenses:               
Selling and distribution       (3,506)   (3,506)
General and administrative   (232,021)   (131,886)   (363,907)
Total operating expenses   (232,021)   (135,392)   (367,413)
                
Segment loss  $(230,081)  $(125,648)  $(355,729)

 

   Healthcare Segment   Wine Segment   Total 
   Nine months ended September 30, 2022 
   Healthcare Segment   Wine Segment   Total 
Revenue from external customers:               
Consulting service income  $135,452   $   $135,452 
Sale of wine products       33,577    33,577 
Sale of healthcare products            
Total revenue   135,452    33,577    169,029 
                
Cost of sales:               
Consulting service income   (45,971)   -    (45,971)
Sale of wine products   -    (23,838)   (23,838)
Sale of healthcare products            
Total cost of revenue   (45,971)   (23,838)   (69,809)
                
Gross profit   89,481    9,739    99,220 
                
Operating expenses:               
Selling and distribution   -    (2,622)   (2,622)
General and administrative   (94,979)   (237,049)   (332,028)
Total operating expenses   (94,979)   (239,671)   (334,650)
                
Segment loss  $(5,498)  $(229,932)  $(235,430)
SUMMARY OF GEOGRAPHIC SEGMENTS

The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables: 

 

  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
China   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine

Months Ended

September 30,
2023

  

Nine Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
China   24,338    33,577 
           
TOTAL  $24,338   $169,029 
SUMMARY OF GEOGRAPHIC SEGMENTS
  

Three
Months Ended

September 30,
2023

  

Three
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $- 
PRC   5,293    5,395 
           
TOTAL  $5,293   $5,395 

 

  

Nine
Months Ended

September 30,
2023

  

Nine
Months Ended

September 30,
2022

 
         
Hong Kong  $-   $135,452 
PRC   24,338    33,577 
           
TOTAL  $24,338   $169,029 
 
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.23.3
DEPOSITS AND OTHER RECEIVABLES (Tables)
9 Months Ended
Sep. 30, 2023
Deposits And Other Receivables  
SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE

Deposits and other receivables consisted of the following:

 

   September 30,
2023
   December 31,
2022
 
         (Audited) 
Rental deposits  $40,751   $40,115 
Purchase deposits   17,967    23,835 
Other receivables   3,178    10,863 
 Deposits and other receivable  $61,896   $74,813 
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES (Tables)
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

Inventories consisted of the following:

 

           
   September 30,
2023
   December 31,
2022
 
       (Audited) 
Finished goods – Healthcare products  $-   $- 
Finished goods – Wine products   119,232    138,582 
 Finished goods  $119,232   $138,582 
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.23.3
LEASE (Tables)
9 Months Ended
Sep. 30, 2023
Lease  
SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY

Right of use assets and lease liability – right of use are as follows:

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Right-of-use assets  $34,451   $20,341 

 

The lease liability – right of use is as follows:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Lease liabilities  $34,664   $21,024 
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.23.3
PLANT AND EQUIPMENT (Tables)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 

  

September 30,

2023

   December 31,
2022
 
       (Audited) 
Motor vehicle  $284,255   $284,255 
Furniture, fixture and equipment   16,208    15,465 
Leasehold improvement   27,358    27,358 
Foreign translation adjustment   (18,083)   (4,095)
Plant and equipment, gross   309,738    322,983 
           
Less: accumulated depreciation   (296,006)   (258,665)
Foreign translation adjustment   3,924    (8,823)
Plant and equipment, net  $17,656   $55,495 
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES (Tables)
9 Months Ended
Sep. 30, 2023
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

The provision for income taxes consisted of the following:

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Current tax  $   -   $3,966 
Deferred tax   -    - 
Income tax expense  $-   $3,966 
SCHEDULE OF DEFERRED TAX ASSETS

The following table sets forth the significant components of the deferred tax assets of the Company as of September 30, 2023 and December 31, 2022:

 

   September 30,
2023
   December 31,
2022
 
       (Audited) 
Deferred tax assets:          
Net operating loss carryforwards          
- United States  $154,092    149,874 
- Hong Kong   13,411    - 
- PRC   348,712    309,631 
Net operating loss carryforwards   516,215    459,505 
Less: valuation allowance   (516,215)   (459,505)
Deferred tax assets, net  $-   $- 
CHINA  
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
Loss before income taxes  $(156,322)  $(220,924)
Statutory income tax rate   25%   25%
Income tax expense at statutory rate   (39,081)   (55,231)
Net operating loss   39,081    55,231 
Income tax expense  $-   $- 
HONG KONG  
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE

 

   2023   2022 
   Nine months ended September 30, 
   2023   2022 
         
(Loss) income before income tax  $(178,731)  $25,029 
Statutory income tax rate   8.25%   8.25%
Income tax expense at statutory rate   (14,745)   2,065 
Tax adjustments   1,334    1,901 
Net operating loss   13,411    - 
Income tax expense  $-   $3,966 
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.23.3
CONCENTRATIONS OF RISK (Tables)
9 Months Ended
Sep. 30, 2023
Risks and Uncertainties [Abstract]  
SCHEDULE OF CONCENTRATIONS OF RISK

 

   Three months ended
September 30, 2023
 
Customer  Revenues   Percentage of
revenues
 
         
Customer A  $2,960    56%

 

   Nine months ended September 30, 2023      September 30, 2023 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $2,960    12%          -     - 
Customer C   10,220    42%      -    - 
                        
Total:  $13,180    54%  Total   -    - 

 

   Three months ended
September 30, 2022
 
Customer  Revenues   Percentage of
revenues
 
         
Customer B  $5,297    98%

 

   Nine months ended September 30, 2022      September 30, 2022 
Customer  Revenues   Percentage of
revenues
      Accounts
receivable
   Percentage of
Accounts
Receivable
 
                    
Customer A  $135,452    80%      -    - 
Customer B   19,395    12%      -    - 
                        
Total:  $154,847    92%  Total   -    - 
XML 40 R32.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF SUBSIDIARIES INFORMATION (Details) - 9 months ended Sep. 30, 2023
USD ($)
shares
HKD ($)
shares
CNY (¥)
shares
Elite Creation Group Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity BVI, a limited liability company BVI, a limited liability company BVI, a limited liability company
Principal activities Investment holding Investment holding Investment holding
Stock issued during period, shares, new issues | shares 50,000 50,000 50,000
Stock issued during period, value, new issues | $ $ 1    
Effective interest held percentage 100.00% 100.00% 100.00%
Alpha Wellness (HK) Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity Hong Kong, a limited liability company Hong Kong, a limited liability company Hong Kong, a limited liability company
Principal activities Investment holding Investment holding Investment holding
Stock issued during period, shares, new issues | shares 300,000 300,000 300,000
Stock issued during period, value, new issues | $   $ 300,000  
Effective interest held percentage 100.00% 100.00% 100.00%
Guangzhou Xiao Xiang Health Industry Company Limited [Member]      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]      
Place of incorporation and kind of legal entity The PRC, a limited liability company The PRC, a limited liability company The PRC, a limited liability company
Principal activities Sales of healthcare products Sales of healthcare products Sales of healthcare products
Stock issued during period, value, new issues | ¥     ¥ 8,300,000
Effective interest held percentage 100.00% 100.00% 100.00%
XML 41 R33.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF ESTIMATED USEFUL LIVES (Details)
Sep. 30, 2023
Furniture, Fixture and Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
Residual value 5.00%
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Residual value 5.00%
Motor Vehicles [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years 3 months 29 days
Motor Vehicles [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 4 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 2 years
Residual value 5.00%
XML 42 R34.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Product Information [Line Items]        
TOTAL $ 5,293 $ 5,395 $ 24,338 $ 169,029
Sale of Wine Products [Member]        
Product Information [Line Items]        
TOTAL 2,696 5,395 20,971 33,577
Sales of Healthcare Products [Member]        
Product Information [Line Items]        
TOTAL 2,597 3,367
Consultancy Service Fee Income [Member]        
Product Information [Line Items]        
TOTAL $ 135,452
XML 43 R35.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF GEOGRAPHIC SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
TOTAL $ 5,293 $ 5,395 $ 24,338 $ 169,029
HONG KONG        
TOTAL 135,452
CHINA        
TOTAL $ 5,293 $ 5,395 $ 24,338 $ 33,577
XML 44 R36.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)
Sep. 30, 2023
Sep. 30, 2022
Period-end HK$:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.12767 0.12744
Period Average HK$:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.12764 0.12779
Period-end RMB:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.13705 0.14930
Period Average RMB:US$ Exchange Rate [Member]    
Offsetting Assets [Line Items]    
Foreign currency translation exchange rates 0.14229 0.15438
XML 45 R37.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Accounting Policies [Abstract]          
Allowance for doubtful accounts $ 0   $ 0   $ 0
Depreciation expense $ 8,830 $ 14,497 $ 37,341 $ 51,134  
Intangible assets amortization period 10 years   10 years    
Amortization of intangible assets $ 116 $ 127 $ 359 386  
Sales tax percentage     17.00%    
Product sales returns     $ 0 $ 0  
Income Tax Examination, Likelihood of Unfavorable Settlement     greater than fifty percent (50%) likelihood of being realized upon ultimate settlement    
XML 46 R38.htm IDEA: XBRL DOCUMENT v3.23.3
LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Liquidity And Going Concern                
Net income loss $ 113,551 $ 133,712 $ 107,871 $ 94,183 $ 37,723 $ 76,824 $ 355,134 $ 208,730
Working capital $ 396,500           $ 396,500  
XML 47 R39.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF REPORTABLE SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Total revenue $ 5,293 $ 5,395 $ 24,338 $ 169,029
Total cost of revenue (1,619) (22,498) (12,654) (69,809)
Gross profit (loss) 3,674 (17,103) 11,684 99,220
Selling and distribution (248) (3,506) (2,622)
General and administrative (116,990) (99,309) (363,907) (332,028)
Total operating expenses (117,238) (99,309) (367,413) (334,650)
Loss from operation (113,564) (116,412) (355,729) (235,430)
Consultancy Service Fee Income [Member]        
Segment Reporting Information [Line Items]        
Total revenue 135,452
Total cost of revenue (17,703) (45,971)
Sale of Wine Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,696 5,395 20,971 33,577
Total cost of revenue (544) (4,795) (11,227) (23,838)
Sales of Healthcare Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,597 3,367
Total cost of revenue (1,075) (1,427)
Healthcare Segment [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,597 3,367 135,452
Total cost of revenue (1,075) (17,703) (1,427) (45,971)
Gross profit (loss) 1,522 (17,703) 1,940 89,481
Selling and distribution
General and administrative (76,826) (30,445) (232,021) (94,979)
Total operating expenses (76,826) (30,445) (232,021) (94,979)
Loss from operation (75,304) (48,148) (230,081) (5,498)
Healthcare Segment [Member] | Consultancy Service Fee Income [Member]        
Segment Reporting Information [Line Items]        
Total revenue 135,452
Total cost of revenue (17,703) (45,971)
Healthcare Segment [Member] | Sale of Wine Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue
Total cost of revenue
Healthcare Segment [Member] | Sales of Healthcare Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,597 3,367
Total cost of revenue (1,075) (1,427)
Wine Segment [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,696 5,395 20,971 33,577
Total cost of revenue (544) (4,795) (11,227) (23,838)
Gross profit (loss) 2,152 600 9,744 9,739
Selling and distribution (248) (3,506) (2,622)
General and administrative (40,164) (68,864) (131,886) (237,049)
Total operating expenses (40,412) (68,864) (135,392) (239,671)
Loss from operation (38,260) (68,264) (125,648) (229,932)
Wine Segment [Member] | Consultancy Service Fee Income [Member]        
Segment Reporting Information [Line Items]        
Total revenue
Total cost of revenue
Wine Segment [Member] | Sale of Wine Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue 2,696 5,395 20,971 33,577
Total cost of revenue (544) (4,795) (11,227) (23,838)
Wine Segment [Member] | Sales of Healthcare Products [Member]        
Segment Reporting Information [Line Items]        
Total revenue
Total cost of revenue
XML 48 R40.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING (Details Narrative)
9 Months Ended
Sep. 30, 2023
Segment
Segment Reporting [Abstract]  
Number of reportable segments 2
XML 49 R41.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Deposits And Other Receivables    
Rental deposits $ 40,751 $ 40,115
Purchase deposits 17,967 23,835
Other receivables 3,178 10,863
 Deposits and other receivable $ 61,896 $ 74,813
XML 50 R42.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF INVENTORIES (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
 Finished goods $ 119,232 $ 138,582
Healthcare Products [Member]    
 Finished goods
Wine Products [Member]    
 Finished goods $ 119,232 $ 138,582
XML 51 R43.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Inventory Disclosure [Abstract]        
Allowance for obsolete inventories $ 0 $ 0 $ 0 $ 0
XML 52 R44.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Lease    
Right-of-use assets $ 34,451 $ 20,341
Lease liabilities $ 34,664 $ 21,024
XML 53 R45.htm IDEA: XBRL DOCUMENT v3.23.3
LEASE (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
Operating lease, description The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2
Lease term 2 years
Operating lease payment $ 34,664
Minimum [Member]  
Lease term 1 year
XML 54 R46.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross $ 309,738 $ 322,983
Less: accumulated depreciation (296,006) (258,665)
Foreign translation adjustment 3,924 (8,823)
Plant and equipment, net 17,656 55,495
Motor Vehicle [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 284,255 284,255
Furniture, Fixture and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 16,208 15,465
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Plant and equipment, gross 27,358 27,358
Foreign Translation Difference [Member]    
Property, Plant and Equipment [Line Items]    
Foreign translation adjustment $ (18,083) $ (4,095)
XML 55 R47.htm IDEA: XBRL DOCUMENT v3.23.3
PLANT AND EQUIPMENT (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 8,830 $ 14,497 $ 37,341 $ 51,134
XML 56 R48.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS’ (DEFICIT) EQUITY (Details Narrative) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
Common stock, shares authorized 100,000,000 100,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares, issued 20,252,309 20,252,309
mon stock, shares, outstanding 20,252,309 20,252,309
XML 57 R49.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Current tax     $ 3,966
Deferred tax    
Income tax expense $ (2,607) $ 3,966
XML 58 R50.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income tax expense $ (2,607) $ 3,966
CHINA        
(Loss) income before income tax     $ (156,322) $ (220,924)
Statutory income tax rate     25.00% 25.00%
Income tax expense at statutory rate     $ (39,081) $ (55,231)
Net operating loss     39,081 55,231
Income tax expense    
HONG KONG        
(Loss) income before income tax     $ (178,731) $ 25,029
Statutory income tax rate     8.25% 8.25%
Income tax expense at statutory rate     $ (14,745) $ 2,065
Net operating loss     13,411
Income tax expense     3,966
Tax adjustments     $ 1,334 $ 1,901
XML 59 R51.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Net operating loss carryforwards $ 516,215 $ 459,505
Less: valuation allowance (516,215) (459,505)
Deferred tax assets, net
UNITED STATES    
Net operating loss carryforwards 154,092 149,874
HONG KONG    
Net operating loss carryforwards 13,411
CHINA    
Net operating loss carryforwards $ 348,712 $ 309,631
XML 60 R52.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Deferred tax assets $ 516,215 $ 459,505
CHINA    
Income tax description The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%.  
Cumulative net operating losses $ 1,394,848  
Deferred tax assets $ 348,712 309,631
Net operating loss carryforwards term 5 years  
HONG KONG    
Income tax description The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year.  
Deferred tax assets $ 13,411
UNITED STATES    
Cumulative net operating losses 733,771  
Deferred tax assets $ 154,092 $ 149,874
XML 61 R53.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF CONCENTRATIONS OF RISK (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Concentration Risk [Line Items]        
Revenue, net $ 5,293 $ 5,395 $ 24,338 $ 169,029
Customer A [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Revenue, net $ 2,960   $ 2,960 $ 135,452
Concentration risk, percentage 56.00%   12.00% 80.00%
Customer A [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage      
Accounts receivable
Customer C [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Revenue, net     $ 10,220  
Concentration risk, percentage     42.00%  
Customer C [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage      
Accounts receivable    
Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Revenue, net     $ 13,180 $ 154,847
Concentration risk, percentage     54.00% 92.00%
Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage    
Accounts receivable
Customer B [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Revenue, net   $ 5,297   $ 19,395
Concentration risk, percentage   98.00%   12.00%
Customer B [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentration risk, percentage      
Accounts receivable    
XML 62 R54.htm IDEA: XBRL DOCUMENT v3.23.3
CONCENTRATIONS OF RISK (Details Narrative) - Supplier Concentration Risk [Member] - Vendor [Member]
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
Cost of Goods and Service Benchmark [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage   11.00%
Purchase $ 1,398 $ 1,398
Accounts Payable [Member]    
Concentration Risk [Line Items]    
Accounts payable $ 0 $ 0
XML 63 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001310630 2023-01-01 2023-09-30 0001310630 2023-11-10 0001310630 2023-09-30 0001310630 2022-12-31 0001310630 srt:DirectorMember 2023-09-30 0001310630 srt:DirectorMember 2022-12-31 0001310630 us-gaap:RelatedPartyMember 2023-09-30 0001310630 us-gaap:RelatedPartyMember 2022-12-31 0001310630 2023-07-01 2023-09-30 0001310630 2022-07-01 2022-09-30 0001310630 2022-01-01 2022-09-30 0001310630 us-gaap:CommonStockMember 2022-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001310630 us-gaap:RetainedEarningsMember 2022-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001310630 us-gaap:CommonStockMember 2023-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001310630 us-gaap:RetainedEarningsMember 2023-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001310630 2023-03-31 0001310630 us-gaap:CommonStockMember 2023-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001310630 us-gaap:RetainedEarningsMember 2023-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001310630 2023-06-30 0001310630 us-gaap:CommonStockMember 2021-12-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001310630 us-gaap:RetainedEarningsMember 2021-12-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001310630 2021-12-31 0001310630 us-gaap:CommonStockMember 2022-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001310630 us-gaap:RetainedEarningsMember 2022-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001310630 2022-03-31 0001310630 us-gaap:CommonStockMember 2022-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001310630 us-gaap:RetainedEarningsMember 2022-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001310630 2022-06-30 0001310630 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001310630 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001310630 2023-01-01 2023-03-31 0001310630 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001310630 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001310630 2023-04-01 2023-06-30 0001310630 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001310630 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001310630 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001310630 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001310630 2022-01-01 2022-03-31 0001310630 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001310630 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001310630 2022-04-01 2022-06-30 0001310630 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001310630 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001310630 us-gaap:CommonStockMember 2023-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001310630 us-gaap:RetainedEarningsMember 2023-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001310630 us-gaap:CommonStockMember 2022-09-30 0001310630 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001310630 us-gaap:RetainedEarningsMember 2022-09-30 0001310630 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001310630 2022-09-30 0001310630 CFOO:EliteCreationGroupLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:AlphaWellnessHKLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember 2023-01-01 2023-09-30 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2023-09-30 0001310630 srt:MinimumMember CFOO:MotorVehiclesMember 2023-09-30 0001310630 srt:MaximumMember CFOO:MotorVehiclesMember 2023-09-30 0001310630 CFOO:MotorVehiclesMember 2023-09-30 0001310630 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2023-07-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2023-01-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2022-01-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember 2022-01-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2023-01-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember 2022-01-01 2022-09-30 0001310630 country:HK 2023-07-01 2023-09-30 0001310630 country:HK 2022-07-01 2022-09-30 0001310630 country:CN 2023-07-01 2023-09-30 0001310630 country:CN 2022-07-01 2022-09-30 0001310630 country:HK 2023-01-01 2023-09-30 0001310630 country:HK 2022-01-01 2022-09-30 0001310630 country:CN 2023-01-01 2023-09-30 0001310630 country:CN 2022-01-01 2022-09-30 0001310630 CFOO:PeriodEndHKUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodEndHKUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodAverageHKUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodAverageHKUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodEndRMBUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodEndRMBUSExchangeRateMember 2022-09-30 0001310630 CFOO:PeriodAverageRMBUSExchangeRateMember 2023-09-30 0001310630 CFOO:PeriodAverageRMBUSExchangeRateMember 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:HealthcareSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:WineSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2023-07-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:HealthcareSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:WineSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:WineSegmentMember 2023-07-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:HealthcareSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:WineSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember 2022-07-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:HealthcareSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:WineSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:WineSegmentMember 2022-07-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:HealthcareSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:WineSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:HealthcareSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:WineSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:HealthcareSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:WineSegmentMember 2023-01-01 2023-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:HealthcareSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:ConsultancyServiceFeeIncomeMember CFOO:WineSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:HealthcareSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:SaleOfWineProductsMember CFOO:WineSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:HealthcareSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:SalesOfHealthcareProductsMember CFOO:WineSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:WineSegmentMember 2022-01-01 2022-09-30 0001310630 CFOO:HealthcareProductsMember 2023-09-30 0001310630 CFOO:HealthcareProductsMember 2022-12-31 0001310630 CFOO:WineProductsMember 2023-09-30 0001310630 CFOO:WineProductsMember 2022-12-31 0001310630 srt:MinimumMember 2023-09-30 0001310630 CFOO:MotorVehicleMember 2023-09-30 0001310630 CFOO:MotorVehicleMember 2022-12-31 0001310630 CFOO:FurnitureFixtureAndEquipmentMember 2022-12-31 0001310630 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001310630 CFOO:ForeignTranslationDifferenceMember 2023-09-30 0001310630 CFOO:ForeignTranslationDifferenceMember 2022-12-31 0001310630 country:US 2023-09-30 0001310630 country:CN 2023-09-30 0001310630 country:US 2022-12-31 0001310630 country:HK 2023-09-30 0001310630 country:HK 2022-12-31 0001310630 country:CN 2022-12-31 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-09-30 0001310630 CFOO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001310630 CFOO:VendorMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-09-30 0001310630 CFOO:VendorMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2023-09-30 0001310630 CFOO:VendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-09-30 iso4217:USD shares iso4217:USD shares iso4217:HKD iso4217:CNY CFOO:Integer CFOO:Segment pure false --12-31 Q3 0001310630 10-Q true 2023-09-30 2023 false 001-32522 China Foods Holdings Ltd. DE 84-1735478 Room 2301A China Resources Building 26 Harbour Road Wanchai HK 0000 852 3618-8608 Yes Yes Non-accelerated Filer true false false 20252309 157446 381709 5107 5120 61896 74813 119232 138582 343681 600224 17656 55495 34451 20341 2631 3148 54738 78984 398419 679208 1398 8013 186324 122660 66748 73602 34664 21024 235400 220794 199964 199964 199964 199964 15683 15722 740181 661779 0.0001 0.0001 100000000 100000000 20252309 20252309 20252309 20252309 2025 2025 1290355 1290355 -6735 -2678 -1627407 -1272273 -341762 17429 398419 679208 5293 5395 24338 169029 1619 22498 12654 69809 3674 -17103 11684 99220 248 3506 2622 116990 99309 363907 332028 117238 99309 367413 334650 -113564 -116412 -355729 -235430 4 10 250 123 9 19612 345 30543 13 19622 595 30666 -113551 -96790 -355134 -204764 -2607 3966 -113551 -94183 -355134 -208730 23 -13735 -4057 -33391 -113528 -107918 -359191 -242121 -0.01 -0.01 -0.00 -0.00 -0.02 -0.02 -0.01 -0.01 20252309 20252309 20252309 20252309 20252309 20252309 20252309 20252309 20252309 2025 1290355 -1272273 -2678 17429 -107871 -107871 -227 -227 20252309 2025 1290355 -1380144 -2905 -90669 -133712 -133712 -3853 -3853 20252309 2025 1290355 -1513856 -6758 -228234 -113551 -113551 23 23 20252309 2025 1290355 -1627407 -6735 -341762 20252309 2025 1290355 -918195 26516 400701 -76824 -76824 -602 -602 20252309 2025 1290355 -995019 25914 323275 -37723 -37723 -19054 -19054 20252309 2025 1290355 -1032742 6860 266498 -94183 -94183 -13735 -13735 20252309 2025 1290355 -1126925 -6875 158580 20252309 2025 1290355 -1126925 -6875 158580 -355134 -208730 37341 51134 16277 359 386 36910 70986 -280524 -102501 -13 -12917 -41567 -19350 -49364 63664 -1701 -6615 7889 -39 -6854 -108265 -37427 -235515 -113647 743 22930 -743 22930 76016 14606 -1974 14606 -77990 -2611 -19028 -224263 -187735 381709 609434 157446 421699 <p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z4LT2MvuuGY7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_821_zxLXyIeJuIwi">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China Foods Holdings Ltd. (the “Company” or “CFOO”) was incorporated in Delaware on January 10, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a health and wellness company that develops, markets, promotes and distributes a variety of customized health and wellness care products and services, including supplements, healthy snacks, meal replacements, skincare products, and nutritional consultation services to consumers in China. The Company works with certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through sales agents and also through a network of e-commerce and social media platforms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the impact of the COVID-19 pandemic in the healthcare industry, the Company also offered a new line of high-end wine products in our online and offline sales platform, to diversify the market demand and customer needs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--ScheduleOfSubsidiariesInformationTableTextBlock_zypHipAUqqLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table depicts the description of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zYRFBoBOUVd2" style="display: none">SCHEDULE OF SUBSIDIARIES INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place of incorporation and kind of legal entity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of registered/ paid up share capital</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Effective interest held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: left">Elite Creation Group Limited</td><td style="width: 2%"> </td> <td style="width: 20%; text-align: left"><span id="xdx_90F_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zq91rXp4Cd9d">BVI, a limited liability company</span></td><td style="width: 2%"> </td> <td style="width: 20%; text-align: left"><span id="xdx_903_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zYNGwRbULLk8">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 17%"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zzxRJIRT9YXf">50,000</span> issued shares of US$<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uUSD_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zgiRDLitIrLg" title="Stock issued during period, value, new issues">1</span>each</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_903_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_z59qv24Lz6g1">100</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Alpha Wellness (HK) Limited</td><td> </td> <td style="text-align: left"><span id="xdx_908_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zaXtwWnf3fvj">Hong Kong, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zj2cDkTYZ3eg">Investment holding</span></td><td> </td> <td><span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zj5aO7Fw2C5k" title="Stock issued during period, shares, new issues">300,000</span> issued shares for HK$<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uHKD_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zOYeTKwzoPo5" title="Stock issued during period, value, new issues">300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zEz19aGdFXSi">100</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Guangzhou Xiao Xiang Health Industry Company Limited</td><td> </td> <td style="text-align: left"><span id="xdx_909_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z4ZR6mm54ZL1" title="Place of incorporation and kind of legal entity">The PRC, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_902_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z52OsOr6HYC7" title="Principal activities">Sales of healthcare products</span></td><td> </td> <td>RMB <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uRMB_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zJBT4d02hyf2" title="Stock issued during period, value, new issues">8,300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zvAyO1ZiAU81" title="Effective interest held percentage">100</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AC_z0WajvGEmb23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--ScheduleOfSubsidiariesInformationTableTextBlock_zypHipAUqqLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table depicts the description of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zYRFBoBOUVd2" style="display: none">SCHEDULE OF SUBSIDIARIES INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Name</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Place of incorporation and kind of legal entity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Particulars of registered/ paid up share capital</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid">Effective interest held</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: left">Elite Creation Group Limited</td><td style="width: 2%"> </td> <td style="width: 20%; text-align: left"><span id="xdx_90F_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zq91rXp4Cd9d">BVI, a limited liability company</span></td><td style="width: 2%"> </td> <td style="width: 20%; text-align: left"><span id="xdx_903_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zYNGwRbULLk8">Investment holding</span></td><td style="width: 2%"> </td> <td style="width: 17%"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zzxRJIRT9YXf">50,000</span> issued shares of US$<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uUSD_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_zgiRDLitIrLg" title="Stock issued during period, value, new issues">1</span>each</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_903_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--EliteCreationGroupLimitedMember_fKDEp_z59qv24Lz6g1">100</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Alpha Wellness (HK) Limited</td><td> </td> <td style="text-align: left"><span id="xdx_908_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zaXtwWnf3fvj">Hong Kong, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zj2cDkTYZ3eg">Investment holding</span></td><td> </td> <td><span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zj5aO7Fw2C5k" title="Stock issued during period, shares, new issues">300,000</span> issued shares for HK$<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uHKD_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zOYeTKwzoPo5" title="Stock issued during period, value, new issues">300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--AlphaWellnessHKLimitedMember_fKDEp_zEz19aGdFXSi">100</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Guangzhou Xiao Xiang Health Industry Company Limited</td><td> </td> <td style="text-align: left"><span id="xdx_909_ecustom--EntityPlaceOfIncorporationAndKindOfLegalEntity_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z4ZR6mm54ZL1" title="Place of incorporation and kind of legal entity">The PRC, a limited liability company</span></td><td> </td> <td style="text-align: left"><span id="xdx_902_ecustom--EntityPrincipalActivities_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_z52OsOr6HYC7" title="Principal activities">Sales of healthcare products</span></td><td> </td> <td>RMB <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uRMB_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zJBT4d02hyf2" title="Stock issued during period, value, new issues">8,300,000</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveInterestHeldPercentage_dp_uPure_c20230101__20230930__srt--ConsolidatedEntitiesAxis__custom--GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember_fKDEp_zvAyO1ZiAU81" title="Effective interest held percentage">100</span></td><td style="text-align: left">%</td></tr> </table> BVI, a limited liability company Investment holding 50000 1 1 Hong Kong, a limited liability company Investment holding 300000 300000 1 The PRC, a limited liability company Sales of healthcare products 8300000 1 <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zeV8DZ0LWiY2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82A_zxSLtYC3ySpa">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zGw1cyTx5g2b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: -0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zNHtvXPsEQOa">Basis of presentation and consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--UseOfEstimates_zBFCb8ojnOua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zJ1gT6ghDL69">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue recognition at point in time and over time;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales returns at point in time and allowances;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inventory;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimated lives for tangible and intangible assets; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income tax valuation allowances</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33j0hrASdpb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zOPBt2DF4UEi">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z7vPcm3RfaP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zgYewtbReYu9">Accounts receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of September 30, 2023 and December 31, 2022, there was <span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20230930_zhhcRlkZBxDb" title="Allowance for doubtful accounts"><span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20221231_zAxC2T4fIB02" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit Losses – Measurement of Credit Losses on Financial Instruments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, <i>“Credit Losses – Measurement of Credit Losses on Financial Instruments</i> (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zh12U8qz4oz4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z8syqkmRGsW9">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of September 30, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFOY6oIh7Dbi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zrCYT64Par5f">Plant and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:</span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zEeDzCrvul0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BC_zqJdodOjHBai" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Expected useful lives</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: justify">Residual value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: justify">Furniture, fixture and equipment</td><td style="width: 2%"> </td> <td style="width: 30%; text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zjznEs9cVN65" title="Estimated useful lives">3</span> years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zYGMwZxk1nU2" title="Residual value">5</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Motor vehicle</td><td> </td> <td style="text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zqjLzKCjK2t" title="Estimated useful lives">3.33</span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zTtLKS4R6ct1" title="Estimated useful lives">4</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z8APAWvLD7w3" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Leasehold improvement</td><td> </td> <td style="text-align: justify"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zunBhUawEm05" title="Estimated useful lives">2</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zz3WYpylcHC9" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A4_zAh7RGMkYJcg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three and nine months ended September 30, 2023 were $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20230701__20230930_zdxey7kHb66b" title="Depreciation expense">8,830</span> and $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20230101__20230930_zglW9fIzBxwg" title="Depreciation expense">37,341</span>, respectively, and for the three and nine months ended September 30, 2022 were $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20220701__20220930_zFjIwWQceKo8" title="Depreciation expense">14,497</span> and $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220101__20220930_zpcvcMOgjcH8" title="Depreciation expense">51,134</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zqMhly8puMnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zmmWaXBcwWG1">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230930_zROhjxlbtve2" title="Intangible assets amortization period">10</span> years and will expire in 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the three and nine months ended September 30, 2023 were $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20230930_zcdO8RWsxAOe" title="Amortization of intangible assets">116</span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230930_zrAvUpH3Dyig" title="Amortization of intangible assets">359</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the three and nine months ended September 30, 2022 were $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20220930_zrJlhIan8Vc1" title="Amortization of intangible assets">127</span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220930_znAm3mHgFEw5" title="Amortization of intangible assets">386</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHppYpeQCX0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zmWL6vVcuQBh">Impairment of long-lived assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, <i>“Impairment or Disposal of Long-Lived Assets”</i>, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zVpzjKO23zFi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zJ6sWKvQzUR8">Revenue recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 606 – <i>“Revenue from Contracts with Customers”</i> (“ASC Topic 606”). Under ASC Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC Topic 606, the Company performs the following five steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the Company operates two business segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Healthcare Business</i> mainly provides health consulting advisory services and healthcare and wellness products to the customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_907_ecustom--SalesTaxPercentage_pid_dp_c20230101__20230930_zgxaBSEblEk5" title="Sales tax percentage">17</span>% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Wine Business</i> mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90D_ecustom--SalesTaxPercentage_pid_dp_c20230101__20230930_zCzPDXZQlspa">17</span>% on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded <span id="xdx_906_ecustom--ProductSalesReturns_do_c20230101__20230930_ztCfAVvRuE67" title="Product sales returns"><span id="xdx_90D_ecustom--ProductSalesReturns_do_c20220101__20220930_zHBSf9Xcgh76" title="Product sales returns">no</span></span> product sales returns for the nine months ended September 30, 2023 and 2022. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disaggregation of Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZ5Z32pxYpfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B3_zTNfKQM8nfH1" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230701__20230930_z92dq44nWWRb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220701__20220930_zClqS2IuqOi2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zaV3IIGrpysk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zdWzFwy73pH3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sales of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbV6yjFsuoCd" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20230930_zLo8bLE7nHB6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20220101__20220930_z8ewIj4D0CTf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zTVo2XGzX2i6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultancy service fee income</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zSx4zcGN7pb5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale of wine products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,577</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zuP2tapzYo41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of healthcare products</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,367</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zQyz1HqkYD3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,338</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,029</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zd3SeYvketha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customers are located. Summarized financial information concerning the geographic segments is shown in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_C09_gL3SORFECATFC-GA_z62qM5NVxDG1"><span style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span></span></span></p> <div id="xdx_C00_gL3SORFECATFC-GA_zTXzafbHQtI2"><table cellpadding="0" cellspacing="0" id="xdx_307_134_zPuCfqoVsXo6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%" summary="xdx: Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zXgOcTHHd5bi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220701__20220930_zIxpNCwiuSB9" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zdL0oEzaZWY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zsvik7epnk2c" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt">PRC</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,293</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,395</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ziRKAVRtvhe3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_z9A4zN7bqaGh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220930_zppUoZLPSwTl" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z8kK9WzZhiP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zS6rAyFH3ek6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zw4ZvByypT6k" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,338</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">169,029</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0C_gL3SORFECATFC-GA_zpmXLprT6KNg"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zEtC4dEbJIqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_861_zocbCPjU1Iz2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the ASC Topic 740, <i>“Income Taxes”</i> (“ASC Topic 740”) provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230930_zlmv7H1GWkw6">greater than fifty percent (50%) likelihood of being realized upon ultimate settlement</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxUncertaintiesPolicy_zKiIvtkYTCah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zRtYVDQTGCre">Uncertain tax positions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zsDFpz0hWeV2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_ztkUaswaTgv4">Foreign currencies translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the PRC and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zXxH0qUBehJk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BA_zvbSjAa0sGg2" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Period-end HK$:US$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zTTNHGHlDXP" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12767</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zWS3vqWhpTA9" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12744</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average HK$:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_zfPGTozRSrtd" style="text-align: right" title="Foreign currency translation exchange rates">0.12764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_z2H3OEn1NVJg" style="text-align: right" title="Foreign currency translation exchange rates">0.12779</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Period-end RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zd3pVgAIzDK1" style="text-align: right" title="Foreign currency translation exchange rates">0.13705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zR3CiEYcL4Zh" style="text-align: right" title="Foreign currency translation exchange rates">0.14930</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_zo2WMpNeRNx7" style="text-align: right" title="Foreign currency translation exchange rates">0.14229</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_z0MIS6mVUJ9h" style="text-align: right" title="Foreign currency translation exchange rates">0.15438</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zOfMntyAgLc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zM5Cn1KNqKjc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z8SCHWF7ERob">Net loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net loss per share in accordance with ASC Topic 260, <i>“Earnings per Share”.</i> Basic (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. Potential common stocks that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zSAM47f4N0tk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zd28CQ5DzSIk">Comprehensive loss</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 220, “<i>Comprehensive Income</i>”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zRtGXRX3l489" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zXjdsOdV1Y05">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC Topic 842, “<i>Leases”</i> (“ASC Topic 842”). At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g. land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability. The amortized period for ROU assets is limited to the expected lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating leases with terms of 12 months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--RelatedPartiesPolicyTextBlock_z9M9PTcmoJB5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zcbOGwy9yQlf">Related parties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC Topic 850-10, <i>“Related Party”</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_z5ZjWVRa8CNl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zMM0xZRXssc8">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC Topic 450-20, <i>“Commitments”</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztITqW9iKAYl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zfCoLPpPubjk">Fair value Measurement</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures”</i> (“ASC Topic 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs that are generally observable inputs and not corroborated by market data.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, deposits and other receivables, accounts payable, accrued liabilities and other payables, customer deposits, amount due to a director, and amount due to a related company approximate their fair values because of the short maturity of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zoYwAhlZsuS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zuDrZqnwTuU4">Segment Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in two reportable operating segments in Hong Kong and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmTzL1gut1C4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zQTuSFvx4ii6">Recent accounting pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company has evaluated that the impact of all recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></p> <p id="xdx_85A_zofc4m3vtILi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zGw1cyTx5g2b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: -0.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zNHtvXPsEQOa">Basis of presentation and consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--UseOfEstimates_zBFCb8ojnOua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zJ1gT6ghDL69">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue recognition at point in time and over time;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales returns at point in time and allowances;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inventory;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">estimated lives for tangible and intangible assets; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">income tax valuation allowances</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z33j0hrASdpb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zOPBt2DF4UEi">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z7vPcm3RfaP9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zgYewtbReYu9">Accounts receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30 to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers. As of September 30, 2023 and December 31, 2022, there was <span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20230930_zhhcRlkZBxDb" title="Allowance for doubtful accounts"><span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20221231_zAxC2T4fIB02" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit Losses – Measurement of Credit Losses on Financial Instruments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, <i>“Credit Losses – Measurement of Credit Losses on Financial Instruments</i> (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zh12U8qz4oz4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z8syqkmRGsW9">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined principally by customer demand. As of September 30, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories, nor have there been any write-offs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFOY6oIh7Dbi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zrCYT64Par5f">Plant and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking into account their estimated residual values:</span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zEeDzCrvul0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BC_zqJdodOjHBai" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Expected useful lives</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: justify">Residual value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: justify">Furniture, fixture and equipment</td><td style="width: 2%"> </td> <td style="width: 30%; text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zjznEs9cVN65" title="Estimated useful lives">3</span> years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zYGMwZxk1nU2" title="Residual value">5</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Motor vehicle</td><td> </td> <td style="text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zqjLzKCjK2t" title="Estimated useful lives">3.33</span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zTtLKS4R6ct1" title="Estimated useful lives">4</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z8APAWvLD7w3" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Leasehold improvement</td><td> </td> <td style="text-align: justify"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zunBhUawEm05" title="Estimated useful lives">2</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zz3WYpylcHC9" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A4_zAh7RGMkYJcg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three and nine months ended September 30, 2023 were $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20230701__20230930_zdxey7kHb66b" title="Depreciation expense">8,830</span> and $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20230101__20230930_zglW9fIzBxwg" title="Depreciation expense">37,341</span>, respectively, and for the three and nine months ended September 30, 2022 were $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20220701__20220930_zFjIwWQceKo8" title="Depreciation expense">14,497</span> and $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220101__20220930_zpcvcMOgjcH8" title="Depreciation expense">51,134</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zEeDzCrvul0k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BC_zqJdodOjHBai" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Expected useful lives</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: justify">Residual value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: justify">Furniture, fixture and equipment</td><td style="width: 2%"> </td> <td style="width: 30%; text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zjznEs9cVN65" title="Estimated useful lives">3</span> years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zYGMwZxk1nU2" title="Residual value">5</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Motor vehicle</td><td> </td> <td style="text-align: justify"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MinimumMember_zqjLzKCjK2t" title="Estimated useful lives">3.33</span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember__srt--RangeAxis__srt--MaximumMember_zTtLKS4R6ct1" title="Estimated useful lives">4</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_z8APAWvLD7w3" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Leasehold improvement</td><td> </td> <td style="text-align: justify"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zunBhUawEm05" title="Estimated useful lives">2</span> years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentSalvageValuePercentage_iI_pid_dp_uPure_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zz3WYpylcHC9" title="Residual value">5</span></td><td style="text-align: left">%</td></tr> </table> P3Y 0.05 P3Y3M29D P4Y 0.05 P2Y 0.05 8830 37341 14497 51134 <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zqMhly8puMnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zmmWaXBcwWG1">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss. Amortization is provided over the term of their registrations on a straight-line basis, which is <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230930_zROhjxlbtve2" title="Intangible assets amortization period">10</span> years and will expire in 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the three and nine months ended September 30, 2023 were $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20230930_zcdO8RWsxAOe" title="Amortization of intangible assets">116</span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230930_zrAvUpH3Dyig" title="Amortization of intangible assets">359</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the three and nine months ended September 30, 2022 were $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220701__20220930_zrJlhIan8Vc1" title="Amortization of intangible assets">127</span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220930_znAm3mHgFEw5" title="Amortization of intangible assets">386</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y 116 359 127 386 <p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHppYpeQCX0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zmWL6vVcuQBh">Impairment of long-lived assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, <i>“Impairment or Disposal of Long-Lived Assets”</i>, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment charge for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zVpzjKO23zFi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zJ6sWKvQzUR8">Revenue recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 606 – <i>“Revenue from Contracts with Customers”</i> (“ASC Topic 606”). Under ASC Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC Topic 606, the Company performs the following five steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the Company operates two business segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Healthcare Business</i> mainly provides health consulting advisory services and healthcare and wellness products to the customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and (iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_907_ecustom--SalesTaxPercentage_pid_dp_c20230101__20230930_zgxaBSEblEk5" title="Sales tax percentage">17</span>% on the invoiced value of sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Wine Business</i> mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of <span id="xdx_90D_ecustom--SalesTaxPercentage_pid_dp_c20230101__20230930_zCzPDXZQlspa">17</span>% on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded <span id="xdx_906_ecustom--ProductSalesReturns_do_c20230101__20230930_ztCfAVvRuE67" title="Product sales returns"><span id="xdx_90D_ecustom--ProductSalesReturns_do_c20220101__20220930_zHBSf9Xcgh76" title="Product sales returns">no</span></span> product sales returns for the nine months ended September 30, 2023 and 2022. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records its cost including taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disaggregation of Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZ5Z32pxYpfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B3_zTNfKQM8nfH1" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230701__20230930_z92dq44nWWRb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220701__20220930_zClqS2IuqOi2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zaV3IIGrpysk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zdWzFwy73pH3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sales of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbV6yjFsuoCd" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20230930_zLo8bLE7nHB6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20220101__20220930_z8ewIj4D0CTf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zTVo2XGzX2i6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultancy service fee income</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zSx4zcGN7pb5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale of wine products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,577</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zuP2tapzYo41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of healthcare products</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,367</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zQyz1HqkYD3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,338</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,029</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zd3SeYvketha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customers are located. Summarized financial information concerning the geographic segments is shown in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_C09_gL3SORFECATFC-GA_z62qM5NVxDG1"><span style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span></span></span></p> <div id="xdx_C00_gL3SORFECATFC-GA_zTXzafbHQtI2"><table cellpadding="0" cellspacing="0" id="xdx_307_134_zPuCfqoVsXo6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%" summary="xdx: Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zXgOcTHHd5bi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220701__20220930_zIxpNCwiuSB9" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zdL0oEzaZWY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zsvik7epnk2c" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt">PRC</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,293</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,395</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ziRKAVRtvhe3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_z9A4zN7bqaGh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220930_zppUoZLPSwTl" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z8kK9WzZhiP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zS6rAyFH3ek6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zw4ZvByypT6k" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,338</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">169,029</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0C_gL3SORFECATFC-GA_zpmXLprT6KNg"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.17 0.17 0 0 <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZ5Z32pxYpfi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic regions, and includes a reconciliation of the disaggregated revenue with reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B3_zTNfKQM8nfH1" style="display: none">SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230701__20230930_z92dq44nWWRb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220701__20220930_zClqS2IuqOi2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zaV3IIGrpysk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zdWzFwy73pH3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sales of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0626">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbV6yjFsuoCd" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230101__20230930_zLo8bLE7nHB6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20220101__20220930_z8ewIj4D0CTf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zTVo2XGzX2i6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultancy service fee income</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zSx4zcGN7pb5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale of wine products</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,577</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zuP2tapzYo41" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of healthcare products</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,367</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zQyz1HqkYD3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,338</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,029</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2696 5395 2597 5293 5395 135452 20971 33577 3367 24338 169029 5293 5395 5293 5395 135452 24338 33577 24338 169029 <p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zEtC4dEbJIqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_861_zocbCPjU1Iz2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the ASC Topic 740, <i>“Income Taxes”</i> (“ASC Topic 740”) provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such a position should be measured based on the largest benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230930_zlmv7H1GWkw6">greater than fifty percent (50%) likelihood of being realized upon ultimate settlement</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than fifty percent (50%) likelihood of being realized upon ultimate settlement <p id="xdx_84E_eus-gaap--IncomeTaxUncertaintiesPolicy_zKiIvtkYTCah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zRtYVDQTGCre">Uncertain tax positions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC Topic 740 provisions of Section 740-10-25 for the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zsDFpz0hWeV2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_ztkUaswaTgv4">Foreign currencies translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the unaudited condensed consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the PRC and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi (“RMB”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the statements of changes in shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zXxH0qUBehJk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BA_zvbSjAa0sGg2" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Period-end HK$:US$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zTTNHGHlDXP" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12767</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zWS3vqWhpTA9" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12744</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average HK$:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_zfPGTozRSrtd" style="text-align: right" title="Foreign currency translation exchange rates">0.12764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_z2H3OEn1NVJg" style="text-align: right" title="Foreign currency translation exchange rates">0.12779</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Period-end RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zd3pVgAIzDK1" style="text-align: right" title="Foreign currency translation exchange rates">0.13705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zR3CiEYcL4Zh" style="text-align: right" title="Foreign currency translation exchange rates">0.14930</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_zo2WMpNeRNx7" style="text-align: right" title="Foreign currency translation exchange rates">0.14229</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_z0MIS6mVUJ9h" style="text-align: right" title="Foreign currency translation exchange rates">0.15438</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zOfMntyAgLc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zXxH0qUBehJk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the nine months ended September 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BA_zvbSjAa0sGg2" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Period-end HK$:US$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zTTNHGHlDXP" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12767</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndHKUSExchangeRateMember_zWS3vqWhpTA9" style="width: 16%; text-align: right" title="Foreign currency translation exchange rates">0.12744</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average HK$:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_zfPGTozRSrtd" style="text-align: right" title="Foreign currency translation exchange rates">0.12764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageHKUSExchangeRateMember_z2H3OEn1NVJg" style="text-align: right" title="Foreign currency translation exchange rates">0.12779</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Period-end RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zd3pVgAIzDK1" style="text-align: right" title="Foreign currency translation exchange rates">0.13705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodEndRMBUSExchangeRateMember_zR3CiEYcL4Zh" style="text-align: right" title="Foreign currency translation exchange rates">0.14930</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Period average RMB:US$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_zo2WMpNeRNx7" style="text-align: right" title="Foreign currency translation exchange rates">0.14229</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220930__us-gaap--DerivativeInstrumentRiskAxis__custom--PeriodAverageRMBUSExchangeRateMember_z0MIS6mVUJ9h" style="text-align: right" title="Foreign currency translation exchange rates">0.15438</td><td style="text-align: left"> </td></tr> </table> 0.12767 0.12744 0.12764 0.12779 0.13705 0.14930 0.14229 0.15438 <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zM5Cn1KNqKjc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z8SCHWF7ERob">Net loss per share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates net loss per share in accordance with ASC Topic 260, <i>“Earnings per Share”.</i> Basic (loss) income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. Potential common stocks that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zSAM47f4N0tk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zd28CQ5DzSIk">Comprehensive loss</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 220, “<i>Comprehensive Income</i>”, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the computation of income tax expense or benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zRtGXRX3l489" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zXjdsOdV1Y05">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC Topic 842, “<i>Leases”</i> (“ASC Topic 842”). At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g. land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability. The amortized period for ROU assets is limited to the expected lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating leases with terms of 12 months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--RelatedPartiesPolicyTextBlock_z9M9PTcmoJB5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zcbOGwy9yQlf">Related parties</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC Topic 850-10, <i>“Related Party”</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_z5ZjWVRa8CNl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zMM0xZRXssc8">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the ASC Topic 450-20, <i>“Commitments”</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztITqW9iKAYl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zfCoLPpPubjk">Fair value Measurement</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance of the ASC Topic 820-10, “<i>Fair Value Measurements and Disclosures”</i> (“ASC Topic 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing inputs that are generally observable inputs and not corroborated by market data.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, deposits and other receivables, accounts payable, accrued liabilities and other payables, customer deposits, amount due to a director, and amount due to a related company approximate their fair values because of the short maturity of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zoYwAhlZsuS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zuDrZqnwTuU4">Segment Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 280, “<i>Segment Reporting</i>” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in consolidated financial statements. Currently, the Company operates in two reportable operating segments in Hong Kong and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmTzL1gut1C4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zQTuSFvx4ii6">Recent accounting pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company has evaluated that the impact of all recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></p> <p id="xdx_805_ecustom--LiquidityAndGoingConcernDisclosureTextBlock_z8Z1qBXg3Lu5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_829_zYUvX4fu0iPb">LIQUIDITY AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared using going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2023, the Company incurred a net loss of $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_di_c20230101__20230930_ze227iwcI0D4" title="Net income loss">355,134</span> and suffered from a working capital deficit of $<span id="xdx_90F_ecustom--WorkingCapital_iI_c20230930_zw2D9VsaWbyh" title="Working capital">396,500</span> as of September 30, 2023. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders. Management believes the existing stockholders will provide the additional cash to meet with the Company’s obligations as they become due. However, there is no assurance that the Company will be successful in securing sufficient funds to sustain the operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -355134 396500 <p id="xdx_80A_eus-gaap--SegmentReportingDisclosureTextBlock_ziOPTwvthgya" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82E_zsRg4xKrVAF">SEGMENT REPORTING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the Company has <span id="xdx_906_eus-gaap--NumberOfReportableSegments_dc_uSegment_c20230101__20230930_zHpYaFSAZ8ok" title="Number of reportable segments">two</span> reportable business segments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare Segment, mainly provides health consulting advisory services and healthcare and wellness products to the customers; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wine Segment, mainly provides the wine products to the customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue with the reportable segments.</span></p> <p id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zglQCokwhBsj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B1_z0aDGgpw5gJa" style="display: none">SUMMARY OF REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_z98SMuBnPP22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zp7W33g5lXzk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230701__20230930_zGYzd6e6jVi5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_z13epjBa8XM7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0716">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_z3VcWhTl80B5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zaz75H225L8k" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zVRzQthaN4ug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,696</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zG8mMSTzzSi2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0731">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zuYB9Qy49jvf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0734">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(544</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(544</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zA43LQ8Fid12" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0739">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zDrznUgoElZb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(544</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,619</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_zHHQIdtA2hmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,522</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,674</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zLFTxAlY0JTd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0750">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(248</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(248</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_z1C3IQi2V3K7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,826</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,164</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(116,990</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zPybYbZxvSxk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,826</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(117,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_z9xV4KimeaLk" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(75,304</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(38,260</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(113,564</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_ze9RmZQ1XGU3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z22wYHsReSsk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220701__20220930_zVW1myWidx66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zJ1ryLPxOlG" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0767">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zxnE8Kvb7Dtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zlsf0Zsl5qWd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0776">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zTzpZtx6bFG4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zs9Z4x3pcYNc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zPOmsFQxz8L5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0786">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,795</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,795</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_znMXlpiNc3L4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0790">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0791">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zD1RUn62WPTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,703</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,795</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,498</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_ziu3gzehY3p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross (loss) profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,103</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_z8o1t8CaeD6a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_zhoTbA883HVb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,864</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,309</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zf7FNgIO8oNd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,864</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,309</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_z1k5iLucBHV9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(48,148</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(68,264</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(116,412</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zkeAYPLWRKwa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zrLov2qX1xil" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230930_z2m23OI40TUg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_z8fmiWUCoaU6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0819">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zHVYLbBIn3u7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0822">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">20,971</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">20,971</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zkoTIoKOCTE4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0827">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zUCzhcX4sf1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zjMP6vmq5Mef" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0834">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0836">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zC4leToGJoFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0838">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,227</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,227</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_z3pqTb2sOaWl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0843">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_z8QvvIdBhP8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,227</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,654</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_zGK7vnbdk5yi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,744</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,684</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zUxwFXc9dzH1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,506</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,506</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_ztoHAijbteh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(232,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,886</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(363,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zpCNoZ898IH3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(232,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,392</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(367,413</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_zC4FU8WAUeE8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(230,081</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125,648</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(355,729</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_znV4J4Yojpi7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zeN1ob75ZTn1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20220930_zJQOuEt1dQBa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_ztNTgyne2EC3" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0871">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zncTfw1ILJo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0874">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,577</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,577</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zHbMe49KQA2g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0878">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0879">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0880">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zUZ9vTueG3tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,452</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">169,029</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zVnU9TGSG1Rj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,971</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0887">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,971</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_z40T75i8pjM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,838</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,838</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_z5Dz2LAAstG1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0894">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zhfzKL16vU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(45,971</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,838</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,809</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_z4zO925CHmmf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,739</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zW1VxCRBzlj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,622</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,622</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_z4PXTLpVXJR2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,979</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(237,049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(332,028</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zkSAZMur2kh6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,979</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(239,671</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(334,650</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_zeAVcQOAHCI2" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,498</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(229,932</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(235,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A7_z1vkRcH8XNyl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_gL3SORFECATFC-GA_zD3dWi2mNc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8B1_zQ2itvs5O7Cj" style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zAEfktLAsGN7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220701__20220930_zqgXPA1BCPh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zaXdgc60YT9c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_z6mKlu0QLX63" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt">China</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,293</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,395</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zzN9kXu9zR38" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230930_zP8KfDgtBnH2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Nine</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930_zZPcqwiwmcBi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zRDsWydE2S0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zHDi3CUrgGb9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">China</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z0WpQIdT66E5" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,338</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">169,029</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zUbRkurCvTlc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2 <p id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zglQCokwhBsj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B1_z0aDGgpw5gJa" style="display: none">SUMMARY OF REPORTABLE SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_z98SMuBnPP22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zp7W33g5lXzk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230701__20230930_zGYzd6e6jVi5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_z13epjBa8XM7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0716">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_z3VcWhTl80B5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"></td><td style="width: 14%; text-align: right">2,696</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zaz75H225L8k" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zVRzQthaN4ug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,696</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zG8mMSTzzSi2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0731">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zuYB9Qy49jvf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0734">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(544</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(544</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zA43LQ8Fid12" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0739">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zDrznUgoElZb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,075</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(544</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,619</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_zHHQIdtA2hmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,522</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,674</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zLFTxAlY0JTd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0750">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(248</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(248</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_z1C3IQi2V3K7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,826</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,164</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(116,990</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zPybYbZxvSxk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(76,826</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(117,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_z9xV4KimeaLk" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(75,304</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(38,260</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(113,564</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_ze9RmZQ1XGU3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220701__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_z22wYHsReSsk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220701__20220930_zVW1myWidx66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zJ1ryLPxOlG" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0767">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zxnE8Kvb7Dtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">5,395</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zlsf0Zsl5qWd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0775">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0776">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zTzpZtx6bFG4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zs9Z4x3pcYNc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zPOmsFQxz8L5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0786">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,795</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,795</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_znMXlpiNc3L4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0790">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0791">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zD1RUn62WPTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,703</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,795</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,498</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_ziu3gzehY3p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross (loss) profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,703</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,103</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_z8o1t8CaeD6a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_zhoTbA883HVb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,864</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,309</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zf7FNgIO8oNd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,864</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,309</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_z1k5iLucBHV9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(48,148</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(68,264</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(116,412</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_zkeAYPLWRKwa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zrLov2qX1xil" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230930_z2m23OI40TUg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_z8fmiWUCoaU6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0819">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zHVYLbBIn3u7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Sale of wine products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0822">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">20,971</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">20,971</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zkoTIoKOCTE4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0827">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zUCzhcX4sf1l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,367</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,971</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zjMP6vmq5Mef" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0834">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0836">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zC4leToGJoFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0838">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,227</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,227</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_z3pqTb2sOaWl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0843">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_z8QvvIdBhP8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,427</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,227</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,654</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_zGK7vnbdk5yi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,940</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,744</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,684</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zUxwFXc9dzH1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,506</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,506</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_ztoHAijbteh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(232,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,886</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(363,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zpCNoZ898IH3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(232,021</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,392</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(367,413</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_zC4FU8WAUeE8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(230,081</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(125,648</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(355,729</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--HealthcareSegmentMember_znV4J4Yojpi7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--WineSegmentMember_zeN1ob75ZTn1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20220930_zJQOuEt1dQBa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine months ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Healthcare Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Wine Segment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenue from external customers:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_ztNTgyne2EC3" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Consulting service income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0871">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_zncTfw1ILJo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0874">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,577</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,577</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_zHbMe49KQA2g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0878">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0879">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0880">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzZcz_zUZ9vTueG3tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,452</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">169,029</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cost of sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--ConsultancyServiceFeeIncomeMember_zVnU9TGSG1Rj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consulting service income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,971</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0887">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(45,971</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--CostOfRevenue_iN_pp0p0_di_hsrt--ProductOrServiceAxis__custom--SaleOfWineProductsMember_z40T75i8pjM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of wine products</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0890">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,838</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,838</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--CostOfRevenue_iN_di_hsrt--ProductOrServiceAxis__custom--SalesOfHealthcareProductsMember_z5Dz2LAAstG1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Sale of healthcare products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0894">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0896">–</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CostOfRevenue_iN_di_msGPzZcz_zhfzKL16vU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(45,971</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,838</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,809</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtGPzZcz_maOILzG7K_z4zO925CHmmf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,739</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SellingAndMarketingExpense_iN_di_maOEzQfm_zW1VxCRBzlj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Selling and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,622</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,622</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--GeneralAndAdministrativeExpense_iN_di_maOEzQfm_z4PXTLpVXJR2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,979</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(237,049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(332,028</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtOEzQfm_msOILzG7K_zkSAZMur2kh6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,979</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(239,671</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(334,650</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtOILzG7K_zeAVcQOAHCI2" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,498</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(229,932</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(235,430</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 2696 2696 2597 2597 2597 2696 5293 544 544 1075 1075 1075 544 1619 1522 2152 3674 248 248 76826 40164 116990 76826 40412 117238 -75304 -38260 -113564 5395 5395 5395 5395 17703 17703 4795 4795 17703 4795 22498 -17703 600 -17103 30445 68864 99309 30445 68864 99309 -48148 -68264 -116412 20971 20971 3367 3367 3367 20971 24338 11227 11227 1427 1427 1427 11227 12654 1940 9744 11684 3506 3506 232021 131886 363907 232021 135392 367413 -230081 -125648 -355729 135452 135452 33577 33577 135452 33577 169029 45971 45971 23838 23838 45971 23838 69809 89481 9739 99220 2622 2622 94979 237049 332028 94979 239671 334650 -5498 -229932 -235430 <p id="xdx_891_eus-gaap--ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_gL3SORFECATFC-GA_zD3dWi2mNc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic segments is shown in the following tables: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8B1_zQ2itvs5O7Cj" style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zAEfktLAsGN7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220701__20220930_zqgXPA1BCPh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Three<br/> Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zaXdgc60YT9c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_z6mKlu0QLX63" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt">China</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,293</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,395</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zzN9kXu9zR38" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230930_zP8KfDgtBnH2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Nine</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930_zZPcqwiwmcBi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zRDsWydE2S0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zHDi3CUrgGb9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">China</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z0WpQIdT66E5" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,338</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">169,029</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <span style="display: none">SUMMARY OF GEOGRAPHIC SEGMENTS</span><table cellpadding="0" cellspacing="0" id="xdx_307_134_zPuCfqoVsXo6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%" summary="xdx: Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230701__20230930_zXgOcTHHd5bi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220701__20220930_zIxpNCwiuSB9" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_zdL0oEzaZWY6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zsvik7epnk2c" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt">PRC</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,293</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">5,395</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ziRKAVRtvhe3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,293</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,395</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_z9A4zN7bqaGh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220930_zppUoZLPSwTl" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine<br/> Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,<br/> 2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--HK_z8kK9WzZhiP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Hong Kong</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">135,452</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__country--CN_zS6rAyFH3ek6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,338</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zw4ZvByypT6k" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">TOTAL</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">24,338</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">169,029</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>   5293 5395 5293 5395 135452 24338 33577 24338 169029 <p id="xdx_800_ecustom--DepositsAndOtherReceivablesTextBlock_z9YqOD7KRbtj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82E_zX4D0L8rl03i">DEPOSITS AND OTHER RECEIVABLES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zWPDJOAU7ZB9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits and other receivables consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z7w4nd8aE0B" style="display: none">SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230930_z1Wd8GT8LeL5" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zloLfBvaArJf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Audited)</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RentalDeposits_iI_pp0p0_maPEAOAzh0u_z8StQK3h9vXd" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Rental deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,751</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,115</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--PurchaseDeposits_iI_pp0p0_maPEAOAzh0u_znVqoHhWUvcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Purchase deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,967</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,835</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherReceivablesNetCurrent_iI_maPEAOAzh0u_zaaxFPKkCMRk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,178</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,863</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzh0u_zeodpjp7Loq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deposits and other receivable</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">61,896</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">74,813</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zIbZfOB96SJ2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zWPDJOAU7ZB9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits and other receivables consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z7w4nd8aE0B" style="display: none">SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230930_z1Wd8GT8LeL5" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231_zloLfBvaArJf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Audited)</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RentalDeposits_iI_pp0p0_maPEAOAzh0u_z8StQK3h9vXd" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Rental deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,751</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40,115</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--PurchaseDeposits_iI_pp0p0_maPEAOAzh0u_znVqoHhWUvcd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Purchase deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,967</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,835</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherReceivablesNetCurrent_iI_maPEAOAzh0u_zaaxFPKkCMRk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,178</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,863</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzh0u_zeodpjp7Loq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Deposits and other receivable</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">61,896</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">74,813</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 40751 40115 17967 23835 3178 10863 61896 74813 <p id="xdx_803_eus-gaap--InventoryDisclosureTextBlock_zPI39dF5RFCb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_823_zKfVa9E1sa5f">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJV5a05VmSO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_zF2KTbTKL5kb" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_495_20230930_zvnTKxcUSnLl" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_490_20221231_zacNEpM2F0Qe" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_hsrt--ProductOrServiceAxis__custom--HealthcareProductsMember_zyhYRu8VpkB7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finished goods – Healthcare products</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_hsrt--ProductOrServiceAxis__custom--WineProductsMember_zsvuDQ2rihYc" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Finished goods – Wine products</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">119,232</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">138,582</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_zTqvsxs5uz53" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">119,232</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,582</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z1K18hVAtBwh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and nine months ended September 30, 2023 and 2022, <span id="xdx_90F_ecustom--AllowanceForObsoleteInventories_do_c20230701__20230930_zXGgrHGuPz89" title="Allowance for obsolete inventories"><span id="xdx_90B_ecustom--AllowanceForObsoleteInventories_do_c20230101__20230930_zomxoxmsO1f1" title="Allowance for obsolete inventories"><span id="xdx_90C_ecustom--AllowanceForObsoleteInventories_do_c20220701__20220930_zU2UKGac54rc" title="Allowance for obsolete inventories"><span id="xdx_908_ecustom--AllowanceForObsoleteInventories_do_c20220101__20220930_z7uU8aUmWM6h" title="Allowance for obsolete inventories">no</span></span></span></span> allowance for obsolete inventories was recorded by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJV5a05VmSO7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_zF2KTbTKL5kb" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_495_20230930_zvnTKxcUSnLl" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_490_20221231_zacNEpM2F0Qe" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_hsrt--ProductOrServiceAxis__custom--HealthcareProductsMember_zyhYRu8VpkB7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finished goods – Healthcare products</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_hsrt--ProductOrServiceAxis__custom--WineProductsMember_zsvuDQ2rihYc" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Finished goods – Wine products</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">119,232</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">138,582</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pp0p0_zTqvsxs5uz53" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> <span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">119,232</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">138,582</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 119232 138582 119232 138582 0 0 0 0 <p id="xdx_80D_eus-gaap--LesseeOperatingLeasesTextBlock_zJeVRJB5yuA5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_82A_z56h4lhyxLyf">LEASE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20230101__20230930_zSfW97f8lXT1" title="Operating lease, description">The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of <span id="xdx_902_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20230930__srt--RangeAxis__srt--MinimumMember_zO5iiNdyVMe6" title="Lease term">1</span> to <span id="xdx_907_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20230930_zHM98ADcwUg6" title="Lease term">2</span></span> years, through May 16, 2023. Upon expiry, the Company renewed and leased an office premise under operating lease with a term of 1 year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock_znYuadsv9lef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets and lease liability – right of use are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zCgByMW0cJ77" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_z298cUmqkz46" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zMM60hM9LFW5" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zOn1FkavbwNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 2.5pt">Right-of-use assets</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">34,451</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">20,341</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease liability – right of use is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_zWOnG5O9GYae" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zeiSLuhkpDk5" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzeBf_zFQMh9dS4oi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Lease liabilities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">34,664</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">21,024</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zx1D9U7eh274" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the operating lease payment of $<span id="xdx_906_eus-gaap--OperatingLeasePayments_pp0p0_c20230101__20230930_zdpByDrlJSx" title="Operating lease payment">34,664</span> will become matured in the next 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2 P1Y P2Y <p id="xdx_890_ecustom--ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock_znYuadsv9lef" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets and lease liability – right of use are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zCgByMW0cJ77" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_z298cUmqkz46" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zMM60hM9LFW5" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zOn1FkavbwNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 2.5pt">Right-of-use assets</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">34,451</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">20,341</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease liability – right of use is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_zWOnG5O9GYae" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zeiSLuhkpDk5" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzeBf_zFQMh9dS4oi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Lease liabilities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">34,664</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">21,024</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 34451 20341 34664 21024 34664 <p id="xdx_80D_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zueYwMIK4Vyh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82B_z41iaL45flTe">PLANT AND EQUIPMENT</span></b></span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQTZLYtlXkx5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zh2wy20qaAGa" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_zC3ZftMPm3yd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zZMtKKjJ6bK9" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehicleMember_z8oyTfmXOI63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Motor vehicle</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">284,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">284,255</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zi239Dm8AWqj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture, fixture and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,465</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z1XaQYzmHOc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,358</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,358</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ForeignTranslationAdjustment_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ForeignTranslationDifferenceMember_zKK0jKfqDeP1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign translation adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,083</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzYob_zWrTETgqWS13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, gross</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,738</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">322,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzYob_zMtILNWIwv0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(296,006</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(258,665</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--ForeignTranslationDifferenceNet_iNI_di_msPPAENzYob_zwZ773TySKac" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign translation adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,924</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzYob_z6LZsZ4ybQp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Plant and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,656</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,495</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zIt0wAzGoPUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three and nine months ended September 30, 2023 were $<span id="xdx_902_eus-gaap--Depreciation_pp0p0_c20230701__20230930_zH0ghhmNEGR2" title="Depreciation expense">8,830</span> and $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20230101__20230930_zIQhp1cxce51" title="Depreciation expense">37,341</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three and nine months ended September 30, 2022 were $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20220701__20220930_zGMTNKwrYyQ1" title="Depreciation expense">14,497</span> and $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20220101__20220930_zhr09Yz0CVug" title="Depreciation expense">51,134</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQTZLYtlXkx5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zh2wy20qaAGa" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230930_zC3ZftMPm3yd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zZMtKKjJ6bK9" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehicleMember_z8oyTfmXOI63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Motor vehicle</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">284,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">284,255</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureFixtureAndEquipmentMember_zi239Dm8AWqj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture, fixture and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,465</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z1XaQYzmHOc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,358</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,358</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ForeignTranslationAdjustment_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ForeignTranslationDifferenceMember_zKK0jKfqDeP1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign translation adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,083</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,095</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzYob_zWrTETgqWS13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant and equipment, gross</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,738</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">322,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzYob_zMtILNWIwv0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(296,006</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(258,665</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--ForeignTranslationDifferenceNet_iNI_di_msPPAENzYob_zwZ773TySKac" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign translation adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,924</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzYob_z6LZsZ4ybQp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Plant and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17,656</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,495</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 284255 284255 16208 15465 27358 27358 -18083 -4095 309738 322983 296006 258665 -3924 8823 17656 55495 8830 37341 14497 51134 <p id="xdx_80C_ecustom--AmountsDueToDirectorAndRelatedCompanyTextBlock_zagB2mSyEDfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_820_z99sznz2kBtb">AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023 and December 31, 2022, the amounts represented temporary advances to the Company by its director and a related company which were unsecured, interest-free and have no fixed terms of repayments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zp2vIArn3Vaa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_82A_zitYZjGhPmo1">STOCKHOLDERS’ (DEFICIT) EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized, subject to limitations prescribed by Delaware law, to issue up to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230930_zZWWNPqi3Po1" title="Common stock, shares authorized">100,000,000</span> shares of common stock with a par value of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230930_zMxyPSvJK7Zf" title="Common stock, par value">0.0001</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and only then at the times and in the amounts that our board of directors may determine.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No Preemptive or Similar Rights</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right to Receive Liquidation Distributions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, and December 31, 2022, a total of <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20230930_zE741kmKvEFg" title="Common stock, shares, issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20230930_zpVvOfiB9ew8" title="mon stock, shares, outstanding">20,252,309</span></span> and <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zMzAy4awWB5j" title="Common stock, shares, issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zEtPehabcysj" title="mon stock, shares, outstanding">20,252,309</span></span> outstanding shares of common stock were issued, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000000 0.0001 20252309 20252309 20252309 20252309 <p id="xdx_80F_eus-gaap--IncomeTaxDisclosureTextBlock_zcJI7ckGCL57" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_829_zA40ux99KWnh">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zThsYkvWL6q8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zGAPrI7aKxPh" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930_zrAzJOdPdC7h" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220930_zIl3Siu2bk8j" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzqWI_zgb06Gno8cQb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Current tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">   <span style="-sec-ix-hidden: xdx2ixbrl1056">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,966</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_maITEBzqWI_zttiPxoR82n6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzqWI_zhuo39MRVBse" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1062">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,966</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zQ3HDXwj98A1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mainly operates in the PRC that is subject to taxes in the governing jurisdictions in which it operates. The effective tax rate in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BVI</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the current BVI law, the Company is not subject to tax on income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PRC</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--IncomeTaxExaminationDescription_c20230101__20230930__srt--StatementGeographicalAxis__country--CN_z1JyA8xv6Bp" title="Income tax description">The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%.</span> The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--CN_zaXEhpBeEWg8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zc3cuG97w0w7">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__srt--StatementGeographicalAxis__country--CN_zr2HJ0L6hpLc" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930__srt--StatementGeographicalAxis__country--CN_zB3zHRiX69Sh" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40D_ecustom--LossIncomeBeforeIncomeTax_zwb1ckb9mEk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loss before income taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(156,322</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(220,924</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zIlrg4A3tI4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z8I2uBzjmiGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,081</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(55,231</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zDm8HWV6zCX6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">39,081</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">55,231</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_zDkIJ5ZIjcs8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zz9yMOzAQ1f9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--IncomeTaxExaminationDescription_c20230101__20230930__srt--StatementGeographicalAxis__country--HK_zPhwb9SiBlef" title="Income tax description">The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year.</span> The reconciliation of income tax rate to the effective income tax rate for the nine months ended September 30, 2023 and 2022 is as follows:</span></p> <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--HK_zO71Knzxa19e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zGnjKxIFq9xd" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930__srt--StatementGeographicalAxis__country--HK_zrUYQACChCO2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__srt--StatementGeographicalAxis__country--HK_zjDwnvTH79v4" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_ecustom--LossIncomeBeforeIncomeTax_zU9UWYA1MhW4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">(Loss) income before income tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(178,731</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,029</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zC9xw4s0ob05" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8.25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8.25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z5RfxM5SJMi1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,745</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,065</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_di_zKEWxmPw4mY1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,901</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zcyp0hvIxFQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,411</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1101">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_ze11JGCI0ZR7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1103">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,966</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zgyQ4gsCdLle" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ziVXDXk27Vmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the deferred tax assets of the Company as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zHAILh3D9gwk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230930_zNn9zFqPsyP7" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_zrmn92dGG1ef" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net operating loss carryforwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--US_zTnSz5HGLqLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">- United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">154,092</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">149,874</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--HK_zJjlo4mFELU9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">- Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,411</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--CN_zwSHbMmfbbOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">- PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,712</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,631</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzbJb_z9McYPWalDp8" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,215</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">459,505</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzbJb_zsV6qk5nRF02" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(516,215</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(459,505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzbJb_zcAe4cD4hUe1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1124">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zuxc2HGz4hzl" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the operations in the United States of America incurred $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_c20230930__srt--StatementGeographicalAxis__country--US_znmcxFOeyzE4" title="Cumulative net operating losses">733,771</span> of cumulative net operating losses which can be carried forward indefinitely to offset future taxable income, under The U.S. Tax Cuts and Jobs Act (the “Tax Reform Act”) since 2021. The Company has provided for a full valuation allowance against the deferred tax assets of $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20230930__srt--StatementGeographicalAxis__country--US_zlhzPODGKTSd" title="Deferred tax assets">154,092</span> on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also, the operations in the PRC incurred $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20230930__srt--StatementGeographicalAxis__country--CN_zeUpxBZ5XD71" title="Cumulative net operating losses">1,394,848</span> of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss carryforwards under PRC tax regime can be carried forward in <span id="xdx_90B_ecustom--NetOperatingLossCarryforwardsTerm_dtY_c20230101__20230930__srt--StatementGeographicalAxis__country--CN_zCY6gW8tCcyg" title="Net operating loss carryforwards term">5</span> years, until 2027. the Company has provided for a full valuation allowance against the deferred tax assets of $<span id="xdx_907_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20230930__srt--StatementGeographicalAxis__country--CN_z7B6WJV3lDfh" title="Deferred tax assets">348,712</span> on the expected future tax benefits from the net operating loss carryforwards as the management believes it is more likely than not that these assets will not be realized in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Uncertain tax positions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.15pt; text-align: justify; text-indent: -2.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of September 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the nine months ended September 30, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zThsYkvWL6q8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zGAPrI7aKxPh" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930_zrAzJOdPdC7h" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220930_zIl3Siu2bk8j" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_maITEBzqWI_zgb06Gno8cQb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Current tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">   <span style="-sec-ix-hidden: xdx2ixbrl1056">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,966</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_maITEBzqWI_zttiPxoR82n6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzqWI_zhuo39MRVBse" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1062">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,966</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 3966 3966 The Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the PRC at a unified income tax rate of 25%. <p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--CN_zaXEhpBeEWg8" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zc3cuG97w0w7">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230930__srt--StatementGeographicalAxis__country--CN_zr2HJ0L6hpLc" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930__srt--StatementGeographicalAxis__country--CN_zB3zHRiX69Sh" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40D_ecustom--LossIncomeBeforeIncomeTax_zwb1ckb9mEk6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Loss before income taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(156,322</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(220,924</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zIlrg4A3tI4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z8I2uBzjmiGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,081</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(55,231</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zDm8HWV6zCX6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">39,081</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">55,231</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_zDkIJ5ZIjcs8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> -156322 -220924 0.25 0.25 -39081 -55231 39081 55231 The Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25% to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax year. <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_hsrt--StatementGeographicalAxis__country--HK_zO71Knzxa19e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zGnjKxIFq9xd" style="display: none">SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230930__srt--StatementGeographicalAxis__country--HK_zrUYQACChCO2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__srt--StatementGeographicalAxis__country--HK_zjDwnvTH79v4" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_ecustom--LossIncomeBeforeIncomeTax_zU9UWYA1MhW4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">(Loss) income before income tax</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(178,731</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,029</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zC9xw4s0ob05" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Statutory income tax rate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8.25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8.25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_z5RfxM5SJMi1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income tax expense at statutory rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,745</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,065</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_iN_di_zKEWxmPw4mY1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax adjustments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,901</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_zcyp0hvIxFQ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Net operating loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,411</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1101">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_ze11JGCI0ZR7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Income tax expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1103">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,966</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> -178731 25029 0.0825 0.0825 -14745 2065 -1334 -1901 13411 3966 <p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ziVXDXk27Vmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the deferred tax assets of the Company as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zHAILh3D9gwk" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230930_zNn9zFqPsyP7" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, <br/> 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_zrmn92dGG1ef" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net operating loss carryforwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--US_zTnSz5HGLqLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">- United States</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">154,092</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">149,874</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--HK_zJjlo4mFELU9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">- Hong Kong</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,411</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_hsrt--StatementGeographicalAxis__country--CN_zwSHbMmfbbOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">- PRC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,712</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,631</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzbJb_z9McYPWalDp8" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,215</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">459,505</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzbJb_zsV6qk5nRF02" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(516,215</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(459,505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzbJb_zcAe4cD4hUe1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1124">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 154092 149874 13411 348712 309631 516215 459505 516215 459505 733771 154092 1394848 P5Y 348712 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zOsybc0Ayyz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_821_zKEQ9S8niAsb">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company’s director advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_805_eus-gaap--ConcentrationRiskDisclosureTextBlock_zaFV0xlx9nJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_828_zyI625DQeN9a">CONCENTRATIONS OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to the following concentrations of risk:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major customers</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and nine months ended September 30, 2023 and 2022, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivables balance as at period-end dates, are presented as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ziNWIXhDIvQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zQqTnsK3UwTe" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three months ended <br/> September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Customer A</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zx8z4tmsWEya" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenues">2,960</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwfDX35P9qZi" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Concentration risk, percentage">56</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Accounts <br/> receivable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> Accounts <br/> Receivable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmCjPwKI0eci" style="width: 9%; text-align: right" title="Revenues">2,960</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zct5WpIsEZU6" style="width: 9%; text-align: right" title="Concentration risk, percentage">12</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 11%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpT6aV5A3Ta6" style="width: 9%; text-align: right" title="Accounts receivable">    <span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zWLHl2PfOqva" style="width: 9%; text-align: right" title="Concentration risk, percentage"> -</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzAwlhiGfEj5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">10,220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6ThRqe1ciP9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">42</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvT94RAiDPFa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7eZniDTZmo6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt">Total:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJ7rVgvSGXF4" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">13,180</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z56YTzqiVDb2" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">54</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zziwVfTtQFu1" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9LSzyCHA9jd" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three months ended <br/> September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Customer B</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zY5USje8m7lc" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenues">5,297</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zEneSABILqP1" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Concentration risk, percentage">98</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Accounts <br/> receivable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> Accounts <br/> Receivable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxHZmdTOpvbf" style="width: 9%; text-align: right" title="Revenues">135,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwZbCWXbXhZi" style="width: 9%; text-align: right" title="Concentration risk, percentage">80</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 11%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkqGGH5qqdEl" style="width: 9%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zPULMFlqSoq3" style="width: 9%; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer B</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zz8ZMl7rh8g4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">19,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgbkU1X5PAn6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPpYd3fRbu0d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zKxaRadcjkh9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt">Total:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTAS2rusmxAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">154,847</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zly666tCggBf" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">92</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvqFIrW6TB4f" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zc1FYDqtAms9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zkIjIsqIfnce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s major customers are located in the PRC and Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended September 30, 2023, there is no single vendor representing more than 10% of the Company’s purchases. For the nine months ended September 30, 2023, a single vendor represented more than 10% of the Company’s purchases. This vendor accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_zIbczv3TXKSk">11</span>% of the Company’s purchases amounting to $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_zGaz85wiPPC" title="Purchase"><span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_zACysX08OV3a" title="Purchase">1,398</span></span>, with accounts payable of $<span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorMember_zJe8D6J2jpxb" title="Accounts payable">0</span> as of September 30, 2023. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and nine months ended September 30, 2022, there is no single vendor representing more than 10% of the Company’s purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s vendors are located in the PRC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Economic and political risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s major operations are conducted in the PRC. Accordingly, the political, economic, and legal environments in the PRC, as well as the general state of the PRC’s economy may influence the Company’s business, financial condition, and results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ziNWIXhDIvQ4" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zQqTnsK3UwTe" style="display: none">SCHEDULE OF CONCENTRATIONS OF RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three months ended <br/> September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Customer A</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zx8z4tmsWEya" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenues">2,960</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwfDX35P9qZi" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Concentration risk, percentage">56</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Accounts <br/> receivable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> Accounts <br/> Receivable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmCjPwKI0eci" style="width: 9%; text-align: right" title="Revenues">2,960</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zct5WpIsEZU6" style="width: 9%; text-align: right" title="Concentration risk, percentage">12</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 11%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpT6aV5A3Ta6" style="width: 9%; text-align: right" title="Accounts receivable">    <span style="-sec-ix-hidden: xdx2ixbrl1150">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zWLHl2PfOqva" style="width: 9%; text-align: right" title="Concentration risk, percentage"> -</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzAwlhiGfEj5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">10,220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6ThRqe1ciP9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">42</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvT94RAiDPFa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7eZniDTZmo6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt">Total:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJ7rVgvSGXF4" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">13,180</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z56YTzqiVDb2" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">54</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zziwVfTtQFu1" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9LSzyCHA9jd" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three months ended <br/> September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Customer B</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zY5USje8m7lc" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenues">5,297</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zEneSABILqP1" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Concentration risk, percentage">98</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customer</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> revenues</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Accounts <br/> receivable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Percentage of <br/> Accounts <br/> Receivable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxHZmdTOpvbf" style="width: 9%; text-align: right" title="Revenues">135,452</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwZbCWXbXhZi" style="width: 9%; text-align: right" title="Concentration risk, percentage">80</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 11%"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkqGGH5qqdEl" style="width: 9%; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zPULMFlqSoq3" style="width: 9%; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Customer B</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zz8ZMl7rh8g4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenues">19,395</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgbkU1X5PAn6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage">12</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPpYd3fRbu0d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zKxaRadcjkh9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt">Total:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTAS2rusmxAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">154,847</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zly666tCggBf" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage">92</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: right; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvqFIrW6TB4f" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zc1FYDqtAms9" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk, percentage"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2960 0.56 2960 0.12 10220 0.42 13180 0.54 5297 0.98 135452 0.80 19395 0.12 154847 0.92 0.11 1398 1398 0 <p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zNthRUeNb9W" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - <span id="xdx_82C_z3jhvhTxrDMl">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company has no material commitments or contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_z6PfvKI020N9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 - <span id="xdx_823_z7AxAD9STuLa">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2023 up through the date the Company issued the unaudited condensed consolidated financial statements. During the period, the Company did not have any material recognizable subsequent events.</span></p> denotes net loss per common share of less than $0.001 per share. EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ù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

5(@? 0W\ID; M!&\CX[H15:X:@0S6^:L>M-7"OEI.R%P[ B=@?A@8-T@MF?$BA;RL!7_!UL8= M,B^(=A^#VI>:LP*J<26+N%.#]!]JKM9XX$3,CCPX@X'/[%$ 9\;;+>GC,F,C MN)24X8@-O0@\UV6CR","4EZ0N"1-V1 VIJ0)=,Q)WL49N*.0D4!J=#>(6!AJ M_%\P\MC(]6$0L8A.\C@;J$BP/X(S9&$0TB"@XR#J\X/8!KZ2=$L$DFY0&=)/ M8'>:%5T1*+N>1=VS<*2$6Q2Z1,3"L\&CH_2=_Q'?W>,[/C$?0N PQ_/A6--8 M!_)6HMBT(BXAX4VE.J7K5_MW8M;)XYMY]\CM6+%=.A3:@/;7G*O]1 ?H7\_IOU!+ P04 " U:&Y7"K[? M5*X" &!@ &0 'AL+W=OXRMV+ON[AJ'O^_LVKA4(DB5^H)W M9N><.;/#3+\2\DTEB!K>\XRK@9-H73RZK@H3S)FZ$05RNHF%S)DF4VY=54AD MD07EF>M[WIV;LY0[P[[U+>2P+TJ=I1P7$E29YTSN1YB):N!TG(-CF6X3;1SN ML%^P+:Y0OQ8+29;;LD1ICERE@H/$>. $G<=1S\3;@.\I5NKH#*:2C1!OQGB. M!HYG!&&&H38,C#X['&.6&2*2\:OA=-J4!GA\/K!_L;53+1NF<"RR'VFDDX%S M[T"$,2LSO1355VSJN35\HC%\A% MR;6"28FP%C!))?UAA(2 1[#$C&F,8"SR@O']J>IK\MYI:Z7WSK'_C^:=37!:_FR^GEX\P-7EO=_I/,$_BH! 78@8 MJ(L:\PW*MI7 Z,$G&#;>CO7ZUZ 3!-;T2**5P4U/"%X(28L$6+1C/$0%6MCH MIENPV4-*H.C049. $8?MZ4781%5)&B90H40HN<*PE!A=0THY*)7^%$M$BTS8 M#H$+B--WFUWF"J@0DL3VM*5H-<*IEKI'LYFCW-H-I" T!=5CVGK;)1?4L_TG MO-Z0+TQN4ZX@PYB@WLWG6P=DO75J0XO"3OI&:-H;]IC0HD9I N@^%D(?#).@ M7?W#WU!+ P04 " U:&Y76L$#W'>Z'M4M[ MN&\:KZ3&2PNNJ2IA-\>HS/I@-!UU"U=R57I>F!SNUV*%<_0W]:6EMTF/4L@* MM9-&@\7EP>AH^NYXE^6#P%>):S=X!HYD8()* M,1"Y\:W%'/4F67'XW*%_"+%3+ OA\,2HWV7ARX/1FQ$4N!2-\E=F_1';>/88 M+S?*A?^PCK([9#%OG#=5JTSOE=3Q5WQO>1@HO,F>4)BU"K/@=S04O#P57ASN M6[,&R]*$Q@\AU*!-SDG-29E[2[N2]/SA_/KBY->/%Y].SZ[F+U^\F4U?OX>? M3L\^G)^<7_\,9[_=G%__L3_Q9(GE)WF+>AQ19T^@OH7/1OO2P9DNL'BH/R$/ M>S=GG9O'LVN5KD>#"B=G!H[W!T^/+%]%7V_AD'=WL'=Y]#_]]Y>19UN\]? M+J[/DFD&PE -+XT5OZ#14K-OOB; M&A"\ 24KZ07WH@.VGENYP (6&SA%)=;"(M!/RJ+2N0:AJ?EYFF5I%O\@&]/_ M*9S*.UF@+I(P0QS,HY&$I EXB19UC@Y\*3SUR@9$7:L-8[F2K#@PRU;.DGT7 M0J!YY;S0A=0K("U?(G@:/FEX*HTJT :]H=P]FFDLY(&1")=P,*B]](HLD&&+ M.=+T@:+UW#$0:RX;?E&X$HI<%'="*K%0"#*"+HRP!;0T'3CHCKW>5$+N@M',0(EZ&!VEBK8(CQ=$91KM6]:VVPYD]K;& M\-5XXJ'+PIG(RR12Q5I#/K@JAG08C7!G/ *=*H"D%[G\0:U$Q:X#D4.VO>+F4NHMBYSHVMC161N*$6% :T\5 * M2A0S8CDNMI(W5:,8@(VYX#3O]T?+D*,Q?#')I46L:CYO@&3G5/A*6&AYNFAL M\I@'C?=@X-16,A'D MJ5N*/E-<2\,N+G#A [M*BH54TLNV+]A4-TZ\%*K-1&BG6FSHRR1T\)".P?1) MN85I(*:A?FDP;I\1J69[1,H7KR MCK1F63K;FZ4[V=OAXV5G8ONTYHK*&\M![3#*U1JI0E.F MW:Q=(+4;+,G]8.%6[BP'&;8LB,=MLWHM?JBQ$ZW)M]L0@B&%FVG3 8?%1F_/FS8.#$I,.VCL:M)*;@#N@: 6@D].$-9(J9V2W+&L.T[;S+X%J_0KL*-PS')VL?/\GZU MO]0_%X(_HL[$IJ'J5+4LW&K_=&,<3NQ9LZ?-DOC*=[0G@LZ6*&E@5H M?VGHO&I?V$!_U3O\%U!+ P04 " U:&Y7VV7@*KX& "%$ &0 'AL M+W=O*L\0J96G' M[W;[G8R)O'5^:L?NU/FIW)A4Y/Q.@=YD&5-/%SR5V[.6U]H-W(O5VM! Y_RT M8"L^X^9S<:?PJU-;243&4W^KA. MSEI='C@4]XFI(A=..ORF:K7I(4F^\[ZU>G2FY!D31:HQ<;JM5&YT1.29D9A;,"]\:$/0=<'O^L$+]H(ZO,#:"WX67A[+C,..G_WB]?O?GC!WU[M;^\EZ_^:CA>U#_LV MO9U'CN?!NU^&ON=]@.82,%]SIU#R0=@BPQH'42)FV"/7$$NL/FUX G()9LU1 M(L4R%OGJ!&:3C]'EYYL(;J\ +=[=3J/I?$9?SRM ]/M=-)U%#J63KL6\1J$J>VV:5'@RR6W3<>Z1A-.9>N),Z7! MYB@G='%9&L9O;"8[K#/Q2*]50E C)\D<'I@2,(-*#GGB M-5-O4)7'RYAL^8#.70PG$%/(VF;.M:;W8(HJNY--^A!$B> M<@$;N4-X-F"WU!M\L-AJD0CL_A54!&PO1U54TF5]_ MB9HLILG74QB>)6^DUK#@6%=\O[#>P)$7]MW ]^$]??A^UQWY/7COS PS&R,1 MH>\C\4-X:W\.$1XQT+6F%3\*1FYWZ*']HS!T_0#?G"DW#>!3\JZ2*D5^7DK' M\%'F*^=7_/E/F24ML%H_YO9Y[D[)I3#:)A:+5)>6\#*T3\XEF -X:/)?*I/K)"E MP8QB?C>Q#8=9#[ GQFAWUR^MKUA4I/)_LJPA>40T>[_CRP]TLV0;#-T!40 _ M_-#M^J,7B$; (M7*QRO)YO7<02]$^[[;[8>.363R%<\O>(!#X#TW"'KX.^IZ MATCH!6X/MZA7M?)Z"T(IRJWFACJ9,FN;"RU6U EBAFE$6X7,K0-5NTB:>P<1 MY'EJU^"8'3E0T2Q/X)+'=M0)/#OJ[^^#E]%5='\?7=I\CF>S:#YS]BWM# : M<([&FT0@5=_O[VFE7R>'@(J94D\8[):I1#O'V+1)'RB7MJMX8<_MCGSP>B-W M..@YQPV>UR ?VZX9]) 2GH]>C=Q^<# M>ZM!Z/5=WPNA%X[+FG;W8:T-2 (UPHQ>Q7C:>0!FDJ6&JW;XS!"MEM&WL0 M]C3+/BP(EF)3Q&*GFTBRZWF&Q^L M\[(=:BUC89OE5E3ULQ=7&W/RBFJ 737L'16<1"3VK+!F> 0B9)JUN>?189"J M8]0.UYTYFR)K[S X>(Q*;4RX-=2X.ALZWA1,[)T0JAZCZTZ>OV9KI]4H6OO" MD%"U:QB8B$5!'?'[>'%5O#3C6HZD/:7Z(.KM(4%>U?FI>)GS1P-(OLHON_G] MZ%8;#MT_.HVK(9)C92_ =+#?Y*:\)=:C]1U[7%XMG\7+"_HGIE8"N9[R):IV MVX.P!:J\])8?1A;VHKF0!J^M]G7-&<). CB_E)B-ZH,6J/_S&PO=V]R:W-H965TK8F7U3 MVG^_:P"QTL:/DI*H/D]3GY=8"=^U-1I> M*:RK!/'0K5)?.Q0R)E4ZS7J]T[02RB3C89R;NO'0-J25P:D#WU25<$^7J.UZ ME/23[<1,K4H*$^EX6(L5SI&^U5/'HW2'(E6%QBMKP&$Q2B;]\\N3$!\#OBM< M^[T^!"5+:^_#X$:.DEX@A!IS"@B"FP>\0JT#$-/XL\%,=EN&Q/W^%OU3U,Y: MEL+CE=4_E*1RE)PE(+$0C::977_&C9YW 2^WVL=8=V'0.X:LEPT.X UV8@<1;_":6-2"4,)4 M.'J"A1/&BU@<'GY-EIX9GI[M[CN]#,X>G.6]?L7\/J&\,G9JD/\*($LA/88 MJ$2XLE4MS%,$>'_A02K'C\XZ$/)!F)Q/O&B,]#'I.1S84N*;568%N:@5"0UU MXVKKL0N+DILM@ ?A$!KC,6\)P@4,823(!H$?NV3K,K(+ MDYJONE,P[;@S[5]Y"%\*W>)+)*$T,T7M<5TR,"@3<@*)/&\9ATT:(QJI0A7E MELN<*<6>MUK)6%R%,@RI6(LGGF #(Q^/J;/570K/ L#R'-NC6AE5J%P8 CX/ M]AET(=EM:K6.M?H/<=E$N4%0S<&63S;>)I\'2WZIY-(]@ZC0K:(->N;=&&J] M8C>[<]I):S#/X:U-?Q5NI9B$QH)3>]WW[Q)PK?6U [)UM)NE)3:OV"WY;X$N M!/!Z82UM!V&#W?]G_!=02P,$% @ -6AN5Y1\9LM$!@ YP\ !D !X M;"]W;W)K&ULM5=-<]LV$+WS5^RH32:942R)DA/; ML3UCJ\XDD\;QV$Y[Z/0 D2L)"4FH &C%_[YO 8J2'=E-ORX2"0*[;Q_>+A:' M2V._N#FSIZ]E4;FCSMS[Q4&OY[(YE\KMF 57^#(UME0>KW;6Z725>?X,(Q=V.-#4_M"5WQAR=5EJ>SM*1=F>=09=%8#EWHV]S+0.SY< MJ!E?L?^TN+!XZ[56JRNE3E;'U MT*O7[.BWDXGS%N+X?5O0T>9HNTU)F .W4!D?=9 1CNT-=XZ?_C!XV7_]".)1 MBWCTF/6_L36/VMF.\OSC]5DR&-+3'_;2P> U;7=&UW-.QJ9&O M-)8%B4QO8@C1OGKM4$YNN*K9)6)5>R"NO?-XD6 L9ZQOU*2 /":J4 B-%+3C M:<%6F_P%,%*N/+LN*?@(K ;OF!4Y<0=T-7Y[]M.GG\^$R^WL)M>!@D$OUM_&V(ENFO9IM/IT;;PJ#K!D,.P.]@!]A ]A,'[^%WR;L^_16VS.0Y3M].B^)XB@'Q[R#7F_UW/ MUW,$$^TD]RK(@ ;8ISWJ_[-JE?YO;)T41?+ K-6V;I<#!) ]3\:6<^U#<:8W MND)ITZI(=(4CL$:K!5T#BX]5S7C!J(KB%BW;Y#/:**G[V88%5'VG'7!(9)OV@5YJ\S?VA%9 DH+= "RUU[,0 M\>0VUO-J9L+!%,WQC2KJX -@3<8NM@*6"R5=H80X-]8#3M'TBXEG6]Y#GAN6 M_?0TXXIM<&SYCUI;#@OA'X,TM:9<9^=="PV.)OB*&[UA^Y4<&^&HD8' M0B^1!B-B!=NQQT?P$$O^/#G#YI@2!F3.PA3@6!8&^P_7)=P75FV "L14>9W= MUZ*442O B]MXGK?FN\2-VV[P6_ ,/KFZT=944:)K0YCBDB5:>CEY9:S9&((T M?'OX8V*+,1J'8-2M!%S4+)1O2Z=)C;2%4+HT725*"$9+;-U&/@[-O[0[R3IJ M<,?@[BLRML+A8 7(?,;#4B-&RW+(0&RY? MMZ]CA9G&^M'4&@4>G=,3#3)OUS9;KZ8N9">=#R7-J1(5K11]"55(C"GD(_+S M2R2Z++*2;TW;$[4RX4S5KN46#&9>,@L:O M9R;BDB/B#\&:B,=B&S/$0G24Y MXW89! Q=WUT/!YG\=/6C3 R!20,6D^ONNACD"A?3'1=Q8I!0 MJ[C0 ZY$=U=I2^WGZ PEYW4&;]NZ^M[&Y0M)-@M73$,]K!UM;[$G\?*V MGAZOP!^4G:$60_-3+.WOO,*ET<9K97SQ9A&N&ULE511;]HP$'[OKSAYTIXZ$@+MN@XB 64K#T!5 MV/8P[<$D![$:VYE]E/;?SW8@8Q)%VDOBL^_[[CO?G7L[;9YL@4CP(DME^ZP@ MJFZCR&8%2FY;ND+E3M;:2$[.-)O(5@9Y'D"RC)(XOHXD%XJEO;#W8-*>WE(I M%#X8L%LIN7D=8JEW?=9FAXU'L2G(;T1IK^(;7"!]JQZ,LZ*&)1<2E15:@<%U MGPW:M\.N]P\.WP7N[-$:?"8KK9^\,YK+C%D2Y_B)R*/KMAD..:;TMZU+M[W.=SY?DR7=KPA5WM M>Y4PR+:6M-R#G0(I5/WG+_M[. +>]HS>@?'>CLTO M0JH![<0)Y8NR(.-.A<-1.II/IY/E=#Q;+F PNX/1?+:-&+R(7P MCE&VIQO6=,D;=)]@JA45%L8JQ_Q??.2D-?J2@[YA_?M:_CSV=2Z#8I=,^Q_W_)SM*=%CN;+\<7 M[2Y\@+/18& O]!I5IK<](5EX9X[--[!G:^UIH/A S0/:/H'4$L#!!0 ( #5H M;E=].1VG,P( .,$ 9 >&PO=V]R:W-H965T NM,/(.,6"R@XOD>F3-1<%57HI M-HXL!=+$BHK<\5SWQBEHQD@PMGMS$8QYI?*,X5R K(J"BO(3UQC"'&-E"%0_MCC#/#<@;>-UQR3ME49X.-_3O]K<=2XK*G'&\Y]9 MHE*?# DDN*95KIYX_0UW^0P,+^:YM"/43:QW2R"NI.+%3JP=%!EKGO1M]QX. M!$/WA,#;"3SKN[G(NOQ"%0W&@M<@3+2FF8E-U:JUN8R9CQ(IH4\SK5-!M)Q& MX8]E^+B \%F/T=A1&FL.G7B'F#8([P3B%AXX4ZF$D"68_*MWM)W6D[?W-/7. M B,L.]!SK\%SO=X97J_-L6=YO5.\:B7QM4*F(-SJ4<*OR4HJH2OB][%T&UK_ M.,UTR4B6-$:?Z#:0*+9(@JO+[HU[=\9KO_7:/T?_O^]Q'O'X?1%>= ?P"3[ MX)Y=T#CF(J$L1EUJ*H5)-(,%+[,8AH/!-5Q=#CW/O8,/+^U8!)4[A_PYOV?Z!BDS$).:ZUU.U\'A 034LU"\5+6\8KKG13 MV&FJ_T(H3( ^7W.N]@MS0?M?"_X 4$L#!!0 ( #5H;E<]T4:T+AX !1= M 9 >&PO=V]R:W-H965TJ5G2[6*="]?JPS>S/-B%97P MLUB\TNM"13$-6J6OAOW^Z:M5E&0OWOY,S^Z*MS_G59DFF;HKI*Y6JZC8OE-I MOOGEQ>"%?7"?+)8E/GCU]N=UM% 353ZN[PKX]C >O MWPU'.("^^"U1&QW\+7$ITSS_BC]NXE]>]!$CE:I9B2 B^.])7:HT14B QY\& MZ LW)PX,_[;0KVGQL)AII-5EGOZ>Q.7REQ?G+V2LYE&5EO?YYJ,R"SI!>+,\ MU?2OW/"W)\55%JNX/OX5H.SP'EJ\WPU; 4[4NB='_8X<]H>C%G@C1X<1 MP1L=@#>>S?(J*Y-L(>TRY?^.I[HL0&[^KVG!#.^X&1YNIM=Z''!,P )]N.XCH5L:YS/(2H,[2*E82UF@IE&2LE2TWYGE>PJ>P MGD+]625(J>G64T98RLAFRB"JR+Q4E:J1,SUYP\3+UTF&DP(>JR@#Y8VO"=UO MLEPTLAR^*,&",&O+9:(-F5'OH_ZF54?Q'Z />4"YC.!AH8 T0(&4EE^H6544 MN"@ DD5E!:^MD":Q0G)D:J:T!NM#?(GD/$J*NE0;TGHLU[E.'(7Q%7P-&I_$ M%&QC0<.8>,P3%AAXD^2QML!5W,/M(;)D%J$YM?2R(-7S&MB%.!MH\PI0PE73U/H'!:3C9+NV/&1)#K,4M:V@EWF5 MPI(1JX@D"N#_467L!M 6K;,XH*IALN!MA*!5F5ORQE9Y&-6$FF)P]D;+<995 M .>>918FL3O^5T<')(%4:/SD>Z#D:@I(CP9DOH: 2@K/8=SGJ)@M[?,1D4S\ MF!)%MCG90[P?)_)]GJ91H8W>8HE!W(PZV-.\]!T\UM44-E "O%>Z)\; 4)TL MLF0.,I"5+"_=F1UC81$EBRC3$6O"0(^K- %/)C*(U6Q(3[98QQ-G'4]:K>.C M)KE4NDQ6J-Z;S& KA&8S"&!%"):XPS;)Z8Y&7O B44"3F%]*!\UTPT"3J:G;(BX\;; M>$8[*$Y@EH)U4;G,=8!53TX"$0!ABT@%BLTR 0$.UE-I6()?C!&[U^(??[LX M/;MX S,^J:S"K3K+ 2!KVE*L\X1$2\) UN+Y$Z""O]ZXL3I*2<>!I@>Z %5H ME A'@4+,-ZAHM1^69#!EF1=;_\@B&,L4E)K1YE&V2*8IN#2T7>Q/Y(4J]1L$ M'X $DL)FBI[E4Y16QB2[N5GU"4\&PWFVF"RM?U3Q@BB&E*S(>"%IO$Z2BGG. MFU2[U\ !U,]3VN^@EW$5)&,S5:!1+;>L]=WL8I/ %IXM84&X&M#L&PLKGX$) M[>##58X(/*,14.C9@$F.9L:8L$3R)Z'B19=TRG:\)W]'!(D6S(EJC=I*YE41 M2C,1U].%S"S\N\A1-J?DY>(7&P4RM255 ?()0$JTZ(P?>@,YPDPT$:_)W+>J ME5.G5DY;UM@)IYJ&% M+#QDV?0,^88JKXB9<>QX/>4)Y*V"_%C,!W-V"R 'D2 E9SZ) ; M["$.0#7=DPW\(AT .AE#)9F"QD#K #+.LQPB!>\7IR#$.H+] C3LR3OSEW7, M-1L<2REG@2*IP<,%PQ?PB7CYE*@-&=\X>4KBBJC-$56*$4PT3=($5?&8F8TQ M /D+>A:E KW#3LWW,K/,"(Y5I#H _YU$9SI;4G:<,<%0"% MG@2.#,QRKC793=3_R'+CE."N,:1%9%"E6;IHYTNY*,C( N!W;=86(.UC2BL5 MH)\$[SZ*E*,D-K$^_@3@.[N,5K8&:D%,35;/.+X(L@0\,ARCGI=1I3F@72EP MCQ%M3]&.\9!P!JW45Y)NM0 1@:7G:<5V-L,]!Y:4G($TVK@=XJ67!'T9%0O< ML7-@TR)"-;Y#_FA>HDPWXQ)Z[(PU)E6,_*S!;\Q*%#9D(:HRV!U;5!>!_2W4 M"CZK2X.+60DZ/@'TN@;O+H?#1FC!O%.@!W!2D@(,Q4(.0S!".$\PK<$AE#-_(S^+(P*7$68!L]:#["V,YMLQM*]+#1 MN\D$!V]N'GD]GKP#@N@*, _2BQ/46E$1:_G(+I%-/HTGCR[WA%"Z?0!DWM6Q M:$55? O5%@-Z[@SH>:L!O3$N=-(<7+4.;C:< 409_"U0CBE^<6829!=82I(* M\@S"MXJ*KR TJ".!F)G"K%&4)O\F,T%/CSK\,6_D6.&&I6P3^IN@-PM==I.L MRW^ 88'= /$..+&7,,H%+0)549&8;!/X4=4<;0QEG%#ZEYAMP'EV]!]H!%#9 MI+Q-X!&&!MZH/L^L& M3 ,YV3FA;:=?R\GEQZOWCY^NL+YT-7FX^3Q^N'HO'R=7UX^?Y*>;WZXFXJH1 MV?L:)'$-(7Z"07$'MNNS2^UZOHSDB?R[^)RCT_*DEI1A'_5&(WE,+SZ!IE3+ M/"7ZPWYDG3G$=Q(10-\'4XJ"K1FR2)MMCFYWQM;2A,24@HM(+Z 7A<'N$N6= M$@.!U2S JT8S""!AS\3& _8A&@O$(N0BH0 M*TDI=$JI_-NGA!H3OW6Y$V:!+G') 1O.EJ',FBX30T,^KYJV?^& =K)QS26)%MA'+)#/N_#_-Q_ MXH)K12E.U+K%5^L>4T$ACZN9Y=%W* P()(H2#)97&,18S[ZZS@"W)QR0:&MB M8J\,T%9XC JU2%!WL$-*5J]!E=C $@ .^C*G@F M1^>GK=(5U,0'[=+EZ8T.-D27W93*,BVRU@KQ@*RY:433-.A3[M8633SVE&CF MY+S9L[S,8PH>23Z\?WGI_,N'? TQW^BT[SS,<,V%?)]H\+TC+#6"/PF(?2+$ MQH28@=)*ZZ&G];"5UO?[">!&^K9":::O 2W"W#+F[%U](\ZI' J$D:?]4^=6 M&XI8S$CW7IJ4@DEO7=H0Q-#"9X)C#(OFVUH>@L8(GR5YNR05@L3NG\$Y[Y4T9JNB(@L-9H&:@WWTN5S26)M'QH=1#'L)77*3^**L09BIVG'FW9*U M'V$7;Y6O,*73Q+I8E,1TGU.*@0F$9!AS_<8[;8# 5(7J/_)3F%P?(C@86MWH M'3]\OE=99L=EEF**G/-6VJ5_J)>!$SFQFJN"HW:>R\Q3*Q?5"H]F)DDS:;\2 M#!_L:L1?LQK9NII=U"$>4:2ZS3*%62875+%LQ,E5M(G)M H+_TLG75C"&1EQ2. AXODS@^003=J P63SE=0X" "_@C7DRJ=;KE/U.W$,O MDR<8!"XUSM7!K4&=%1GXWP=V3Y79_!FXP"KNSM%,%@66< T"#[(-.%-,(,0>4+"C M.-_N\I,42B%6IEEE#V>@K=4:G+E=J'Q11&M0*@)=.MB,M@N),A0PA&B9S9(T MJ?6S-.-#IHSKQK0@KV3#N.W]S63\X*W>ZO?KNZ?;R2O]\\?(0?=U_N M'\;OX,/)U8?/5[G\/])9W1Q M0E]IK[IK&Q,^/8&XHBL>OCR,/]&0X<7(#;U%P+4YY?XC< ;(%L!FVPI#;(D[ MRY1T?Y)=]"Y')YWCDR%A(_9P'O8[%V<#.1IU3L[.&&-Q .-19W0:8CP\[HQ& MYSC#Z46G/[P@.9MBKZS;"+2C7):(C3&H6&UT;B!C%EY(,.]S#>9ZRVH[P0,]'T?Z8>K+Q_NQW7AJ_,U>_AM=SG=2-TRU:3E(M_0TV77_^PX%J:%0*V4I;%\ M/7$7%1')%Z+0'?2[PY/N8 0>JLZ]0EU4"0<]9(ZZ@0/?<::?HYN.*XN2(H10 M$C9=PNGO)"!S)VQZ3#*QVZ?'&1G3CP,#TRCJ'B$UDFP4MFYJ M@F_J.MBPL.U.H]E7;?HI\#>0:(/!ZT[RG/ACZJ!<9=6V^D]$.XA<DGR+@,6Q\\T',75SSW3Q##X]_J!+USP'5\AX11D]_LXG5-FKO9>=RF M[M"!7\=.KR[H[?J1!F[V=;'2X^0G%RO9&OX/GM4003]IV"* ,JQML_%/=%@ MHK:@^2? U2R0>_6]6S89WSOLT"ES%1A41*2_\YR-AC#U2?,=W]H,@(1XU"9.(M/%\V%HG>+!MCT6NQ49E3TF1 M9\3DT'.'8#PX26!:E#!>0/<=J&C:MSJFGR@\<@/:%'0SN#?BP+XR33%A"S=, MC+V\39LCX>0-L*]1/<#S3M.)%^=6BO-1OSORGN5#H+D $]^/,+$B9$C="?9E M;3/:F&=_+[IT!R_:E!&(?B) ''MZT$]HT%HRYN*][<_GS4V-,DS'YJ:C^IH. M'6&:&SU>HWR][0^E2G/[N*(V/-"1O/_#XA#K/WQ=J"4>AWQRP6F0/ZM/S@2D M^% O85*L?)ID]>#LC4 _E]J"_5(P8#6=Y+Q,V">\/SZ_<\R'[:YYMZ\B/&U2 M[M6=:VKTAXQUO69\_>7^ZN;#K;Q\O+^_NJ5CB _WX]O)I_'#S9=;>?6ORX_C MVP]7\G[\<#41! B!B#MR&^FD#2SD->)>%ZM^;S \@U"<_C\^-@.7@H.,AA)KP_\DQ!)]MSHOO71ZT-R_?*JX= MHD/-,M'HL/Q VS) %G7(-<_2-3%H2NCM?-FF3.0P*$]=192AX+$3'<1[MS MYSN"!^TMP9>U_858-M+G!UJ":Y"94M[GA:6Y)+H1TLI?'*SH]]]YKD$3:W<*"NZ8)^$(H=.$XY*EZBYY,L2%>3*LDC>DTIRIGO2/L9,JZ!T; @Q5& MAX6*PKZ0#M>35I0))0[ILA2-&T.U1J!"9 M^F3;GGC@HUPX'78JLZ% "UJ?$X_.E;Z@XHJ&GBB]VL9$BTU7(""2('L8CZ&K MC /CQ)PX ]Y,;169 1WB'>\Q8!">4-[C>3UU@RD]8>W!FR-S^R$Z9TL[_D))DXZ MOJ.!\;H# %NKC>],0@8KM=HD7'A<=]@W"J"V''_:^ C/(5*IR4?]!J$W7AB^C\&??O'2<>4KTWNV)QKGG*[AL&:>X7M M0UX?.<.X>*##[ A"ADJ7WA\VN3 ZH[I:I_E6J:#(O#97GJ#8LP_015\)A=C M<0<5.#-)+LO D,1TLGP.CT+1Q,=QEN387=%C%;3)$.38KTV&EDDF$L^[FHN@@!^.]0@MCSDT^<3O)CO@%: M%)T 92)A>%+>[>_Z0?ER_[AY+4''UW=,Z6!#\SET;3K[S7$H@HFIH/"*CX=E MG9PU0K]&G8]XU#L6V"T$7$ &7X)#B2<9TR<5DQ&(0 OH69&L0XU=9X7W5.MT MR(U:P6*#R4W (CE1G+J#[]0!&N$44[03J&55!*-L.X6I\(4VB"*K0[]?+H$5H/!DL=D=I'OM>42KE\+ZV\Z:K6_=Q"^(R3<7*KZQ MT)V3Y1Q;8+UA/^[( MGIJ,;3],3AIFU\?P1X+M26!::CT-6%L)G:- ^2:F;1)-&?ZHL%?3"',"E,_N M9'R&R)>F6UV_H6],'[8WIH/U P?=7[: ]@Z(P+6,)D>P'=[!E(*=1.Q-\AUN MX?$)^G;^<)D'YT+T.?5DHG^MM74#HF B=PF,-7A\5AB"VRE55%B'>4U,>0^7 M/K0G)WPI@H7"!D*LZ?&'+@=N->/9@ MT6Z-PJS''7M,MSMKJY&&%:TC!M[50U%NI/,,GFRQH*KQ2$$'Q3^D&W[J;W38 M6;?8;Q9STY:>#!USAL -=WJ:]C6V$ICIPR-(MIF8SZ?3+N'U=3Q9C6' N@2> M,A1UP=L[^4GJQA\^QT4Y"* R*3(N\?B1,1AR48%QRTK%>1&CKF<4V2[#MTT8 MB<]!G=Z&BU,PH6!O.Z:!BOI2:MUZ6 K@%:-O@UV8>'4(<;ND6S;@PQ*=9#K% MS!Y7V/4!MES[JSDRT2YMMH[>.7"+%#G%$-O.<=,&SD))I^I(K.CV#,H7,99D MIVI(PKK=4<64;_$Q>.(O?W',+IK62>DT(LSQ^7<@W:9&_0F,8?L)C&L?T06' M7!OUYP\3K0#03>WFE.>K*)IZ/#F N)\B"A,TZVKMGMGI,=3,S[5#>P41\ MI&]=E;5"^Y^$D,5D?_[P0BRSB/!6"I40J!B\S!E&%721GO\U13;PIK,XBF8< M1[LX.M?8:Y4 G/F(DU>8#RU K>8%-ZMO[4%AO&RMYVN1KG):NQI"6@0VQMX M8\.D)UV^X0\2<_5RS7*+#Y%VSC:DR3P\3/OFMM$R 9L5LN94+.F2)PH'WN&#$ M"+ASYS0X8W7VOZPR;O51\=&/RB+$R6380:'MS!4B;!CH++'A)[F5>)D#;ZD= MQ_E X7N.88LID%*@BH(MD)8I<9:#DBGZ(-,<+0194U,V\"?K:IEP@SX#8)*S M[Z-K#++=)Y[P8:(S9]:B)CA*UJ^:+F/;-R8'*OX^D30[=%]1I^G2 MCHZ_%,C'M\'U&,&@=;3E$<;+$CNL=OF0K1D9'%#G*3IA%$ )9=8.>6%\EYVW M-CIPM\SA-1O/[-OXO2G,WIRJ661NU7)IYYU+B)0..? -J^7/L@W;S[)-N%_: M7 0(S&PT6#]PDLT %@YP6$(\#PS0'@:M"_,-R\/VAN5[19V_M7M#\RS')L'5 MH1NPO@ND. A27D-P*-@;R\DKZ]!-98<'4#V9K]LPR5C?;])X2O)=#O^YOA^\ MKL,?)[&W8&GSMP@HMKDUI5'=GY]J(JF MHL+VJ7JK%)5OS.T_,2D;5A[PEJ^"0RU7$"DQ>\>KUVZ%P36II=R"[?-X6%=Q MSZ>UL+FQJN$B5#HA3XZ@J#N"Y%T34;#EKTGP7@4758,^6-!UW)H/-/"=U>ZI MN_)[S!==^\_YOO#/4;' 1IU4S6%HOW=V\D(6? 4W_RCS-5U[/&ULE55M;]LX#/[>7T%XN&$#@MI) MVJW7)0&2-%V"K4T0M]L!A_N@V(PM5)9TDMRL^_5'R8G7 5VP^R)+%/GPX8OH MP4Z9!ULB.OA6"6F'4>F MKPR=XA8EYQ5*RY4$@]MA-.Y>3LZ\?E#XPG%GG^W!1[)1ZL$?%ODP2CPA%)@Y MC\#H\XA3%,(#$8U_]YA1Z](;/M\?T*]#[!3+AEF<*O&5YZX<1A<1Y+AEM7!K MM9OC/IYSCYJO3$QJ+ALONS;/@^_8]#;&_0"[\918'G% M'!L-C-J!\=J$YC0W+U6P]OELL;U-X M<\S(A5>,LSW4< 4 M]2GTDP[TDE[_"%Z_C;7"E7YO,\/U(6=>-%659O+I]:N+7O?]!TN/ M?F-YSIGA:"_A=VB>W+(*824H51Z4RTP9K.W?D#U;,.)[5@AGK#0P6W#HTF,>@&<^AUF!+9A RIKDCV]EVBV%".8J/I%UA\-(I,/_.*I#E,OBPZP$#LCX*S#1>>4];D A;RD9!\ M"T&I1.YS>9YTDB2!+G1I_>-D+'3)X"O-*(G6PIOYI[3?M)X M.7P;7Q]K)HOOI:KA+\Z47TAUCDRXDD!R&CWFZ5#&E@1U JS6T^,44D;#PR>Z M#&B9SZPV*J]]OZQO)G#1^8G*2WT?/QMI%9HB#&Y++FKIFNG62MM_P[@9B3_4 MFQ_+#3,%EY;Z9$NFR>G[\PA,,ZR;@U,Z#,B-&ULI59MC]I&$/[N7S&B:=5*Y.!L7L+U#LG'^3A4WH1- MTJKJA\4>\*JVE^RNX?+O.[OF"$DX%*4?8%\\\\PSLS.S>[L7\E^5(FIXSK-" MW=52K;(%S":K,UZ]K+QH)O4FTV&OW;+=M@B'JYG4M:-8XH M"<^Q4%P4('%]5_.O;^X[1MX*O.>X5R=S,)ZLA/C7+$;)7:UI"&&&L38(C(8= M#C#+#!#1^'C K!U-&L73^0OZH_6=?%DQA0.1?>")3N]J[VJ0X)J5F5Z(_1,> M_&D;O%ADRO[#OI)M]VH0ETJ+_*!,#')>5"-[/L3A1.%=\Q4%]Z#@6MZ5(M-I'CA3F44$OZRDE/]\/E9.(O_H+9(X2CX73T.!KX MTPC\P6"VG$:CZ1#FL_%H, I"^#5BJPS5;[<-38:->B,^&+FOC+BO&.G!1!0Z M51 4"29?ZC>(\)&U^\+ZWKT(&.+V"KQF'=RFZUW \XY1\"R>]PJ>'\>B+#0O M-C 7&8\Y*OC;7RDM*6O^.>=PA=%R.83QZ'X3G&/]?3"=XWE(I M80*EPG6904;EI&"!BBBL14:M MT.2:-@4%QDV>4"AY4359VZU6U$$AX8IM-A(WS,1=X@Z+$F$M17[H#2B-FA:@ M4X2"V7B+M5T1;%+&6MGX&_,\1E6WJPV*C61;"KY#V&3NL,^+."L-$T:V8E'$ M/.,5G0/F>3Y[KE-:;(6L'%*X,:>FKN#'X^U$J40$*G2-^0JEK?:O]AS:2+LUMN]+KQUHEGDCZV*V_.. MJE,#_(5-^';+&5 0Z2)@1?S).00;UD260DJG1&!OZ7?MM>NMMFO9.-]P=IOU M7O<:/*_>[G8KQLXKC+VZUSEE[+;JGO?.6.CTZDVW!Q=JI7.LE35]83F>OHJY\P-8VW1Q+V!'XZ*8X$,B#-'R47REJP91VX,]R_( M0?/JVNW2 =NQU3HH -NAI(?21:56-79[IU8H3.<5O&ZS;<96SVM^;>55I99+ M"49CNT4I=R[1&B?/$>I0&_OH4F"OV.IE=:GGRNJA52VTV-K'S4IH:H=V2@63H#0"]'TMA'Y9& /'UV[_/U!+ P04 M " U:&Y7.>&DL/L% "V% &0 'AL+W=O8\O*YI,E=*BZ!';#GJ+)"\[_1,U=EOU3]A* M%'E);RO$5XM%4OUU1@NV/NTXG7I@F,\S(0=Z_9-E,JB%EY4^) M2/HG%5NC2DH#FFPH5Y4V&)>7,B@C4<%L#GJB/[JXO+[X/$;#B]N;X?CCYTO4 M'2>3@O+#DYX ?"G52PW6F<8B>[!B=,U*D7%T44[I=%N_!W8UQI':N#/2"CBB MRR/DVA@1F[@M>&[CK*OPW+UX<\@G@89TR2J1EW/TVV#"106I\?LN=S6:MQM- MTN68+Y.4GG: #YQ6WVBG__:-$]CO6VSU&EN]-O3^Z,OU]6#X*[KY8&(S./MT M@4RX1KNL_1X\ZXHFA9RBB#P%+0Q816 M,E"6#-0SL8;T&RU7%,TJMD#T3M"J3 J3\K3BQ]8Y*SEP2X9);FZ>4I27*4RB M _3V340S>X$:>8#\.-[2@ M9RG#H11IP[6$QO,QB5VPF N)9R3:7*B!'SR?,+[K>QXZ-(]6\[L.MD,?9!M5 M,V"<2+=-O9>OEW!PX,0@?EDQSB7N+!?(P3XAX++C$^3B(/2LFR6M$N4@O8.# M@E,(W AJK!Q)RBF:YL"O?+)2);BQA7B17$,]K$M: D:AQ),IU#BIDLABC;IA M@",22%G/QDZ@+7,"',=VXPI[9,(#/<\A6B_$Q)4KUHE82-<.0-K'KBVQH>U& MF 2V;CN.BWVYZ"O2@_RWZ0$[$?OZMS6_]N7O-D5VH;Z )%V(6&B[6UEL1IXB MBH?#6*6S:7R',X^I4EMUOPHAV(NCABY=F5F'-6ON%0+;5CU'N? B[KR3?ZU< M@03S/&5-$.%(T 3+5$C>MAUHQ]PEC@.)B34E5&WGCI1/"6^ M<:*H@?TGBK<-#RTX+7WO\:D2>S:*<0@G#\@&T;\]5J!:VZKHFT8K78A+L$T< M99;KX"C2FH&+8SML9D MS0\Y7Z3;'KP#;-+&C#V1=2Z$)@S-XQ5.F-H2@^L$,80F;MC#88%67[J>KUAW M".6U:>_QX9T,)8Y<_>YB6J]YL#2V;*P##D7VHQ>Q*,8>9!1PQHT15&M"[)<> M)UW@(E&9:QJM;(D],"W6IH78]E33542(6LFRJ1C#*Z.C%3TH!/8.KOCZ'%6T M(3&.76(Z,LXN:+1\6OG-IY7_W$^ARXN;R^'@]NKC>>NG52O>[@_!<4:MB;SS MJ,/+D4P->8,P11 D5%(@%4)(8&IO$3K+$\S/6Q(B'(.^Y(F@DZ/T$C=FN1_ M@_8L+Y,RS6'#\U)?R\B(IJQ,@<1R]R7(G+)YE2P!U.)ZC[G$XQE;EW(Y*3-C M!1BH--0W_S%JWQKS@MO4'$O6G!UCUA4#S)_ESP%D&OQ;YQD8K3^3S'O@^&8\ M^ 1S>NS C*H*MWF-\&"UEGFT:^6Z*NGU]=E:5Y_: C-Z4%>/%^X"VK$+.VUY M9]T.SY^[!]OPCX?V>BK7>*:?N[C4V[A+@AR-6$*CJEE12 ^1ECHN[( M!9JKROX_4$L#!!0 ( #5H;E=.ZD:ZI ( .P% 9 >&PO=V]R:W-H M965T. MH^(4"Z:N1(F<;M9"%DR3*S>.*B6RI (5N>.[;M; "88M$U\%?"2X4X=V6 R60GQ:IS[9&2Y1A#F&&O#P.CWAC>8YX:(9/S:XSZ=C^&*1J^H+NSJV M[5L0;Y46Q1Y,"HJ,UW_VOJ_#$:#O?@+P]P"_TET_5*F<,LW"H10[D"::V(Q1 MI5JA25S&35.66M)M1C@=3J/Y;'G_M(3QCRG,GNZB!2RBF^C^93QYB)9P\<16 M.:K+H:/I,0-QXCWQI";V/R&^AD?!=:H@X@DF?^,=$MDH]0]*)_Y9PB665Q"X M-OBN'YSA"YK,@XHO^"QS+(7*M((Q3V"F4Y2PP!BSMRKC4PG7?.W3?&9Z!JID M,8XL&@^%\@VM\-L7K^M^/Z.VW:AMGV,/ES=WT?3Y(8+9+9SMV2GA9ZE/"S]4 MI\6H.J*JCORH#L2"QE)II+LUT"VL14[SG?'- /Y;:HM:JK%8$;?IZY3X:\>S M6Q?C;9(1_V5K@5RSG"9MWZZOT';M7L>K#<_KM.9;&:,67: M?&1RDW$%.:X)ZE[U.A;(>K?4CA9E-<\KH6D[5&9* MZQBE":#[M1#ZX)@'F@4?_@%02P,$% @ -6AN5[X+R2N, @ G04 !D M !X;"]W;W)K&UL?53;3N,P$'WO5XP"0HO4);?" MEM)&:FD12,M%E,O#:A_<9-)8.';6=BC\_=I)&KJKM@^)/?:SPQ70KZI M#%'#1\ZX&CF9UL7 =56<84[4B2B0FYU4R)QH8\JEJPJ))*E .7,#SSMS7X($&5>4[DYP296(T7U2#Z:>]@ ]+T=@* !!)7N^J!*Y91H M$@VE6(&TWH;-3JI0*[011[E-REQ+LTL-3D8/(OWC6*6EG!6M8DV$LXQ^($0J\+@1>$ M>_C"-LRPX@MWAQ>]M$=>$O>V$ME8&JB Q MCAQ3# KE.SK1T8%_YEWLD=MKY?;VL4?SR^O9]/GG#.ZO8"-#VV3N)=HN&W^U\&Y<)-6S' MG2O*J7F6"2R%2!0<'?0#W[^ :R1,9S$QUU](D92Q5G (W^VW"_)J8OIR]OWS M;A &X(?][FD_^!]TV#H M-ZY;(I>4*V"8&JAW\N/4 5DW@]K0HJ@*<"&T*>=JFIG^B=(ZF/U4"+TV[ %M M1X[^ E!+ P04 " U:&Y711Z,3I," #O!0 &0 'AL+W=OQX_E\O=8,/%L\P0%;SFK)!#*U.J[-NV MC#/,B;S@)1;Z).4B)TJ[8F7+4B!)*E#.;,]Q>G9.:&&%@RKV(,(!7RM&"WP0 M(-=Y3L3;&!G?#"W7V@8>Z2I3)F"'@Y*L,$+U5#X([=DM2T)S+"3E!0A,A];( M[8\#DU\E?*>XD3LVF$J6G#\;9Y8,+<<(0H:Q,@Q$OU[P!ADS1%K&KX;3:J\T MP%U[RWY;U:YK61*)-YS]H(G*AM:5!0FF9,W4(]_<85//I>&+.9/5$S9U;M"S M(%Y+Q?,&K!7DM*C?Y+7Y#CN *^< P&L 7J6[OJA2.2&*A /!-R!,MF8S1E5J MA=;B:&&:$BFA3ZG&J7 ^'453^+@@2X;R;& KS6E.[+C!CVN\=P#_&>YYH3() MTR+!Y#W>UEI:0=Y6T-@[2AAA>0&^TP7/\?PC?'Y;H%_Q^8<*1-VS?775L& _ MS,Q"7Y8DQJ&E?W:)X@6M\/3$[3G71T0%K:C@&'L8W=Q-)T_S*7R[AIY;*/M-AO50_PGO5Z%]T2L M:"%U:U(-=2X^75IU75M'\;(:Z257>D%49J8W,@J3H,]3SM76,1>T.S[\#5!+ M P04 " U:&Y7(K^AI0\# "%!@ &0 'AL+W=OU1I&W057I\R!(_$H4TIM-VK6EGDU48\M"XE*# M::I*Z.\76*K=U!MY+PMWQ69KW8(_F]1B@_=H'^NEIIG?H^1%A=(42H+&]=2; MC\XO(N??.OQ6X,Z\L<%5LE+JJYM\RJ=>X AAB9EU"(*&)[S$LG1 1./;'M/K M4[K M_8+^G5;.]6R$@8O5?E[D=OMU$L]R'$MFM+>J=U'W-<3.[Q,E:;]PJ[S MC;@'66.LJO;!Q* J9#>*Y_TYO E(@W<"^#Z M[R[1"W+*V'%;*+5#K3S)C1G MM*6VT42ND*XI]U;3;D%Q=K:\F7]^@/GG*UC\^OAI>;N@V?!!K$HT)Q/?4@;G MYV=[M(L.C;^#-H9;)>W6P$+FF/\SWB=F/3W^0N^"'P6\Q_H4PH !#WAX!"_L MRPU;O/"] MO0Z#^@F]V<\_C9+@ER.\HYYW= Q]=G_Y<7'U>+. +]>PO/NR7-P] M_$$U_+MYAX@?A3Y,'/YWP@&UR&*U0MWW":XPVZ^,V& X;_+"8GXRN%56:7C" M;9&5"!^ IQ'CJ MS*&H:JV>L/7A9RR,T_TPH+=++U,"]56:4G12D/]-+ZMU'HY2%J0AG, P8L$X MAI/!Z\WH\[+!1BMCJ,(Q.PM3"#EGXS0D L:V0]02P,$% @ -6AN5U2#K!!O M! XPP !D !X;"]W;W)K&ULQ5?;QI53"2Q*GXM;82KGKU.MBM:4)$3=L1U/<63.>$(E3OJF+ M':F_)>E^UE'*5TRD'LDX3PUSL:L\.M81NGA5FT MV4JU4.]U=V1#YU1^WDTYSNHY2A@E-!412X'3]:W1MSMW+26O!;Y$]"#.QJ \ M63+V34U&X:UA*8-H3%=2(1!\/=,!C6,%A&9\/V(:^9%*\7Q\0K_7OJ,O2R+H M@,6_1Z'BL5"/^&0R39\ U9[(5ER5$8+DBC- MWN3E&(P 7$DCFAIH5[4V&A>E*BESR7$W M0CW9&XT'DZ< %OVOP1RJ"[*,J;CNUB5"*X'ZZ@ASE\$X[\"TX8FE>_A#1Z"X>?' ";W@!Y/ M)^-@O)BKV5L$(/@Z#<;SH,C]4G1U&2*T[G%K@,(D?<55M7(1R \%)4:?$Z5/LPED4C&*[!]S[3:#MA>VVPU/91X8*C[23ULU_1L M&]E0@^EL *[7,INV@U:US89K_^UIX-L-T[%]\/RVZ5M^Y9$*T8%G$N])5II5 M7DBZHE ]B5Y#]2@-A3Z:D.*I&15K933T$@4Q>:] M9/SU3 &0EQ0<'W[6CZ**1B2(7%.+5]VV:;5L14/?-QT71T4T/TIE(N_7RE*" M-G,N-$NY\# 9_P:?\%&4U%+5'R1I*S>L]9^3M/3$_YVD9Y)5Q=+K$]W^PE;- MU2:62\4@G#B^:3GM$IZV;C13L]<'N6I[9M-3)=,QK89?6:@B&?Z!O6.B/V"V MZ;H>/MM68:G.B_L/?.KK9XUG0OE&M]>JM=FG,NM!\]6\@^]GC>N;>-;^/Q&^ MB5(!,5VCJG73Q+K+LY8ZFTBVTVWLDDELBO5PB_]"*%<"N+]F3)XFZH#\?TWO M3U!+ P04 " U:&Y7=[JP<,P" -!P &0 'AL+W=O:Z52?C26Z%S4(VD&%3+'6:Y#B0 MH)99QN7O#J9BU;(\:R,8)O-8&X$3-A=\CB/4]XN!I)VS19DF&>8J$3E(G+6L MMM?H!,:^,/B6X$KMK<%D,A'BP6QNIBW+-80PQ4@;!$Z_1^QBFAH@HO%KC6EM M0QK'_?4&_:K(G7*9<(5=D7Y/ICIN634+ICCCRU0/Q>H:U_E4#%XD4E5\857: M^A4+HJ72(EL[$X,LRWQSUQ_!W14,;T9?X..83U)4GYJ. MIB#&U(G6@)T2D+T 6(=;D>M802^?XO2YOT/DM@S9AF&''04(E# \RGC[G7O\OYKSW3G<+\.,3Z*>9@Q MO![I9!Q+1,C*'J/I\4FW.*8H88B/F"^IE@.4$>::;C6(V4[?AO? ['K5A4H5 M3D_ZQ.D9$E"O-683,MTT_(#HM7C0CB*QS/4;:'@,3N$,SG:Z+GBNS9@+P48U M%IJG#7+Q?-NK$?6 %(6P5/]#/3J$6K%9_0+JM;?5@QT0_9=Z>'[%#BH,*,&_ M*M(!KV[[]XYWD/R^% :+*2ZUQ%C M!K[$(M''K*GF'9TJ1L/<*1:=7K>[WXDI M3UK#07[O6@T',C.")^Q:@<[BF*K'4R;DXK@5M+[>N.'SR-@;G>$@I7,V8>8V MO59XU:E00AZS1'.9@&*SX]9)\)KTB7#OU-'79+A]V@N3V]/)F(Q/;L9G$QA?OKVZ^7#R<7QU"3N$&O^I3I*)EH*'.9MMN&!:@XEH I\C*<0C7"T2.Q*S M.\U#CL6K#=?8D8G)'R@=\13&B6'8,-.&L]D,2XX&.8,18LR9;L,EUM??+S J MC V+=6/7]'UVC4\PX@FLUC6[5=?L.D?ZM4!DRR5/IE*E4A4CGB8AW',\X!/! MYE1@M3#JWC> M<_.LD&">(I'Y0LD-;ZQVIVZ41-]'C#(CV'4*-JO*-IW M@DZ,G-X#USK#/@@S)&P.*5-#*M>#[\[U@8J,?9/JBZ8LBQ#[*RT+OLG0V8AMRY0G ML!I?AQ5?A^X%.2_Z*#"Q3A4+ 41,A):S*8Y"%+A-!!681PZ"UEH0ET4ME:,J ME2-G*B0;@.OW+G4S@WLIL*CS6 MP&RF/'R D!\$J?.TW*($3IGM4WV4D58E0[_;H#\VM"/K[>HY+[5_X-:]7E2( M.\;6I6_W7Z*FF1-/4>O,+=5\X!; WZ='2E"7(%EO0IPF]7R6TCMP:^]W&2YV M?T4R@U\YE?: 0^&<46$B7!W#3!OU"*.B+&VD5MSQMAX5/M&(+[0ZUTOI'QS\ M#P2+SZW!R"L:\856[Y_E5B-P[S5\"!9WA(\1@^N;T?9RY5E@B7?8.O'+C5'@ MWAEM+%7<,!,J6#XAHKQ^37'R0*IDF.$\:635*QSQ!E=_<[W<#_6<>G[K1;UX M>=[X,MOKIL8K&BG1[-ZF6@4/7:JHM]RP]-SB_/O6]A+4M;:O-R%.DR*?SLJW M(OME[P-5A.&B/C_!3'7LB4-<#G,RG- MUPO[1:KZ9#G\!U!+ P04 " U:&Y7K)"LM"D# #E#0 &0 'AL+W=O M^,3-Q="/J@84<-3 MPE/5\F*MLS/?5Y,8$ZJ.18:I>3,5,J':=.7,5YE$&A6@A/MA$-3]A++4:S>+ M9R/9;HI<3-9.ZIPDO!?[!(QRVOX4&$4YIS?2T65[B: M4,WR3017Q146R['5F@>37&F1K,!&0<+2Y9T^K19B Q"^!@A7@+#0O0Q4J.Q0 M3=M-*18@[6C#9AO%5 NT$<=2FY6QEN8M,SC='E]>=3NW@RY\[T%W?-,?GM]T M.W [[O9N!S#HWW7'\*6#FC*NOC9];2):G#]9L5\LVO_?D3J0??',(KI?!*P5YY1?A(FN](ZNF"&0U]CHK8JKQQ >;547G4N>5=I9HH?(\@53G,.W'Q%:IM*-T\%GI%*Y5!4 M*Q75G$S7J%B44PYSRG/)%AOW<$!<[TB_V#Q&[Y#/FA?V4&TVEB@ HE(=:P@/(6(/KMV&K+V M&^(V'$=YT*>=Y>$FWW>)UYY##FDZY!"N0]:V0S[*=W8057<:#UD[#W%;SP#- M#V L> 3]))-BCG8EW6;@9MQW&=>N1>J'K(%#6!E9>QEQ&LY;:L!-%.ZN@;5- MD??Z%/DOH_(W?MKM 6A(Y8RE"CA.#2PX/C&%(Y=GBF5'BZSXC[\7VIP*BF9L MSF$H[0#S?BJ$?NG8HT%YLFO_ 5!+ P04 " U:&Y7'[+_&-T# #!% M&0 'AL+W=O\J^\PV 0#_3).-]8R/$]L(T>;2!E/ SNH5,/EE1EA(AAVQM\BT#LLQ% M:6(ZEN6;*8DS8]#+[TW9H$=W(HDSF#+$=VE*V*\1)'3?-VSC^<8L7F^$NF$. M>ENRACF(^^V4R9%9499Q"AF/:888K/K&T+[ MJL$N<77&/;\X!JI4!XI_:X& MDV7?L-2,((%(* 21/T\PAB11)#F/'R74J'PJX>'U,_TR#UX&\T@XC&GR$"_% MIF^<&V@)*[)+Q(SNKZ$,R%.\B"8\_XOVA6TW,%"TXX*FI5C.((VSXI?\+!-Q M()"<9H%3"IQC0><5@5L*W+=ZZ)2"SEL]>*4@#]TL8L\3%Q)!!CU&]X@I:TE3 M%WGV<[7,5YRIA3(73#Z-I4X,YN-K'-[?8'1WB<+)?'AU-<-7PP4.T0Q_Q5_N M,7J8+*[E8'HW6PQ'TG".KV[QE\4HD^_?^Z90LY)DRT9;K4ZW)SGOL*;,KK<10)-LJ(EJ5?[VXTT0A,! M*?^GJ=X%L=-,5'WO@F])!'U#-C8.[ F,P1^_V;[U=U.R=<)"G3"L"58K2Z-/EC<+88W3;DO9'XN4_\BG@:>$\AU]'28TP8C-_#J1N&ID=-QW?.Z%3ZU MLOW 5X7GM88W)PD@ND(/:J&52Y"C;[>0/@)K7'.MO/>N.9VP4"<, M:X+5BN)71?&UMP)?9UETPD*=,*P)5BM+MRI+]V.MH)!YAR^P'_A'K>#4J*$5 M-)"LH&L?M8)3*]?UNMWF3G!>17?^GYV JU9P#201FXBP-S:$5NQ[5YY.6*@3 MAC7!:K4)JMH$VAM"H+,L.F&A3AC6!*N5Q;9>ONBMC[6$4E=[D[V@>]03VNG- MLT>-'^ZG[ES7/W*'-;BKY^E@YV.WYFE,,RZWDR2+?J&Y!,<1H$N0RS>+: JM M[:6=_-Z%K)46:J5A7;1ZC9R7&CG:FTR)U%44BN>!Z!HA!EZ2.*4];UM#V"_-HM69B M07>[&5RA!6(/V8SPF5ZJA%&"4AKA%!"T[&G]1L=O";P$_(C0CAZ,@7#RB/&3 MF-R&/#=&A1]'Z 4XIO()=CG6X1&##64X*9>(\R*#;)7@'B$!S-3&0 MV9=LGJ\H%76R8(3O1IS'W,7#9-*?_P+3&S#RIZ-Y?S:^'8*%/YKX=_<+<.$A M!J.87H(OX&'A@8N/EUV=\;B"K0=%C$$>PWPCA@4F.&5K"OPT1*&"[U7SVQ5\ MG?LM39M[TP.S4G"!LBM@&9^!:9B6XCS#\^FFRL[_1???'?TH&599 9;4L]_0 MNY_>][^K?M2W:EO?'T;@2^\8?*8B557-$=FL$ ]31^!U-$MDAS/WUH-(VOJJ*I M4\RK4\RO2>PH_TZ9?^=]Y55)4Q\*J-)>DXY7DXZ?ZSB'96PYMF.JR[A9IK%9 MF<;A^/:NKTIC)>U?2[A.,:].,;\FL:/GW9X+Q:'S0ZPX9BW>.=8=[( M_97/V\H))*LHI2!&2Q[*N&KQSX#DK5H^83B3O<@C9KRSD<,U[VX1$0"^O\28 M[2&PO=V]R M:W-H965T/[SD_-K[&EM!GM@+@Z,7W M94 M5IR'=55ELQ7XF)5("(&861#J8RZZ=*FRD *>1TZ^IQJ:5E%][ 9*JQ&-C6BK M0=;<D)EB!AWB_73G?-54J@J:PP*O/>Z0;0]B0F6) M-R,>BW[1=F=;$<:S->/$CYU%!+X;[+[X)4[$@8-NY3@8L8-QKH,9.T294W>1 M1;1N,,>M!B5;1*6U0).-*#>1MV#C!G(;QYR*65?X\=:XT^O>3.Z[:'B+;H=. MMW\W0)V)XW0'G7YWC!Z=]F!\WW[L#P>H^ZO3:P_NNLAI/XJI3S? L>NQSPV5 MBT DG#J+%[W>+6KD+0IA"9G:%V1HAIGAWCG?W4B[JX)^D@,CR8$1X5DY>".@ M+IE_A6".>M^OZI/Q%>J^S%8X6 )R, ?T] #^%.CO+*8GH>4AK+,0SZ"IB%/& M@&Y :7W\H%>T;UF\"P)+9<%,LF!&Z&9.%H:+!0/.W6")VDRT&'JZ%R:HS\%G MF=3-(JD7!):B;B74K9,"$!>"..Z!.&^40C![19SB@'DXNFA@+P4JI,"R\K # MUW='3-Z;FY96T@V[8C?4S2''/$/+2@Q3\9>3^,MG"!BU-T#%U?L/(CX)?^E. M%@26RD0ER42E8!%7BJ1>$%B*NIU0M]]3Q':>B*TC$><9VK5L$5>3^*OGWL+. MP_6% CX)?>DN%@26RD(MR4*M8 '7BJ1>$%B*NJZ]O46T]Y1PC'XL3=/6RD<: MSK&T:F:VAO6#YY1^R55\N9)/XU^ZGT6AI;/Q]K#2C8+5K!?ZGBH*+4W_[46E MGWRU_+>>S6R5&D;M6,_9EF7+K!X)6CTH%62=]H#IT@T8\F A/+62+?Z]Z:[T MV74X":/J84JXJ$6BYDJ4BT"E@9A?$,+W'5F0) 5HZR]02P,$% @ -6AN M5P3GNW%*! NA( !D !X;"]W;W)K&ULK5A; M;^(X%'[?7V%E+VJEV28A7+N 1$DRBS1M42F[6JWVP20'L.K$C&TNG5^_=@(9 M"&EZF;Q XISO._9W3LZ)W=TR_B26 !+M(AJ+GK&4F;4=@S+#TCH!!(38'5WP:&0*EF4O/XNB'Q]8/>3 MQ:O%S+" (:-_DU N>T;;0"',\9K*![;]$_8+:FB^@%&1_*)M:MMR#!2LA631 M'JQF$)$X_<>[O1!' ,53#*CM ;4\H/X"P-D#G!R@;;T J.\!];=Z:.P!C;<" MFGM ,]$^%2M1VL42][N<;1'7UHI-7R3A2M!*8!+KS)I(KIX2A9/]R?3V=O#P M#[KWT63T^6[DCX:#NT/H[O/:'S_930<>1-TX8+$A ITASG'.B$N MT>]H.G'1Q2^775.JV6A.,]A[ODD]UU[P[*!;%LNE0%X<0EB =\OQG1*\J53( MI*@=I+BIE1).8'6%'.L3JEDUIV ^P[?#:T7+^3'OWH]Y]\OA+@0*;A?!3[1T MLK1R$C[G!;Y!$+!U+$F\0&-&24! H'\',R&Y*B7_%25+RE$X *3: M&PK9>B;G:ZHZ11)X413BE+"9$.J.M^E;77-S'+=2E^^-VZONO"K=^67N3A1N M9 HW2A5V0;D-"$XZ,.S4MX2 (ED;9X[;;2>O[+F17:]W6J=6[KF5TW+J=DZV MER/>F[H>GX54Y#;\BLI,0MK(0MLKKRW' V!R1?$B+PM.*>F7G0N55Z=&OB.PD7ITL7IW2>(TY"]>! M1"*)&P>YYG%ADI?2O#=@59*YG5<[[JL6?D43.@F!;7W?#5FO-(Z 18 >U5OC M[;#:;R7UYQ/Z0IZ DB5CH:Y%TWB.-XQC78S4WEM24'MM6;@%*G7WWF!5RN:^ M(L6" Y; ?Y)+'*,YFRT>R@99 <+^3&;^SKH5TP M[MK77GJ,\IT^/=6YQ7Q!8H$HS)4KZZJE>@U/#TK2&\E6R<9^QJ1D47*Y!!P" MUP;J^9PQ>;C1#K+CJO[_4$L#!!0 ( #5H;E?59:#V/P, +T- 9 M>&PO=V]R:W-H965T%+&-+V";<\Z]EWO!OOT=98]\C9 MSW%$^$!;"Y'T=)T':Q1#?DX31.23)64Q%'+*5CI/&()A2HHCW3*,MAY#3#2O MGZ[=,*]/-R+"!-TPP#=Q#-G+)8KH;J"9VNO"+5ZMA5K0O7X"5VB!Q%URP^1, M+U1"'"/",26 H>5 NS![OJ/P*> G1CN^-P8JD@=*']7$#P>:H1Q"$0J$4H#R MMD5#%$5*2+KQE&MJA4E%W!^_JD_2V&4L#Y"C(8WN<2C6 ZVC@1 MX282MW0W M0WD\J8,!C7AZ!;L,ZTAPL.&"QCE9>A!CDMWA<_X>]@A2IYQ@Y03KF-!Z@V#G M!+LNH9436G4)3DYPZA+:.:%=E^#F!+?N6^KDA$Y="]V M#\>W9]>&>V MC2]E-=:DV*A)L7&38I,FQ:9-BLV:%/,;$CNHXE91Q:TJ=6\N3T:8!#1&(**< MEU5N)M!.!=0I:.N9INTX9E_?[M=D"P;LOLV(>H MR2G*=EWK"#4]1;GMCM4Z1,U*M&20]A',/X591L>UC0)VD :G2(-3F89[>;A3 M/Y )EC J"P-SJE_W;9C&$=IJ+3SM[^&)L7&38I-FA2;-BDVJYV>Y&+%5V@AP$- -$=F.5JP6O<9%>L0^6K\T>U.S9'TF>Y.LE?@CGS4VRO$%, ^7Q)J7B=* -%Q^;] M!E!+ P04 " U:&Y7\AA-X@0* V5P &0 'AL+W=O3:XKZK5R7!83N_U,BT_Y"N=F;_#\=/W957%^FC]4BWFFKPJO?%@NT^+O"[W(G\X&P>#Y@^OYW7U5?S \ M/UVE=WJBJV^KJ\*\&^Y09O.ESLIYGGF%OCT;? Q.5"CJ!6N)?\_U4[GWVJM- MN?VU!!SN=]<+]U\_HG];& M&V-NTE*/\\7O\UEU?S88#;R9ODT?%M5U_O2KWAHD:[QIOBC7_WI/&]G('WC3 MA[+*E]O%YALLY]GF__3[UA%["PP.O(!M%[#F G%@ =\NX%TUB.T"T56#W"Y8 MFS[/%%^5-U"^7ZE]?)]Z[1%?I?%'^Z+WWODT2[]T_?SP= M5D9OO7HXW>JXV.A@!W1P[S+/JOO24]E,SX#U";X^1M8/C;T[H]FST1<,!9SH MU0>/^S]YS&<<^#[C[LL99,[;M*M7:W>_ +[&XP?Q[LS&K[QKO9^S30*J-_(?7XRX][G2R_*_4.0WV +&KK/<2;E*I_IL8-)8J8M'/3C_X1]! MZ/\,N9T2+*$$4T1@3H#$+D "0S__FE?IPB3E1YT]:"@&F^7A>GE]87@\ERPV MOZS'?=\"0CR6KE#2%F*"\Y$KI=I201C[+-Z).6;*G9FR@YG3O*R\_!8S=P,C M]]2_#\(@;M@+2#$FXH8M"03&0BD:)@-B83SR#Y@<[DP.49-_*?*R]%9%?CNO MO'<+\P;,KF%+.0^CQC<!U'@-WX&25LL",)1T]RV5!PSYL/61CMK(]3: MB:D&ZO229C-O-B^K8G[S4.<8R.0(B)YHQ&Z,JH,WI0=E"D 9EW[8\ GTE<(Z M T,^&>U\,L)_ 3K3A?G9USY)9^;Z7OLEK6LGR"LC(,9FZ\5^PS& 7!QSO[%% M$D",ASSVHX;ED!PW5Y\1;'N\LSWNL.%-R5L;;'X7^KNI?DM=0I;'D.41:Z:F M,2 '60Z(U5LJ:.P6! VC[.L]*4\6DV_=N;F&TYGVKO MDS9%1C;-E]K[XU(O;W0!5ALX4,?E)'K@B![;<#KK4VQT* M41RGCW,%5+Q%K>*-2J&"% H91\$!W]D:/L"+^$FZT+77?J\3Q%61SQZF58FG M=!2P=ZZ@1$M(T105FAL:RS6"\)@I'64RO<-$B9:0HBDJ-#=,EB0%.$MZ.:6W MB0@+X[!9$+:E +X/8?G[:6#KDK88YS**#F0+2WX"G/UTS[0 !9&B500#4B)J M&PW2*,::M >2,XR#'Z ]@>4] 4Y\ZB19UA;_JM-%=3]-BZZY$L7MO0DIT1)2 M-$6%YAX/6WK&_"/F2H9RO[YA(D5+2-$4%9H;)LLD&]@OW CH/TB59&)M#G M>LX2+883K;U,_9P;L$2-H_7. *1]$5(T187FQL5R-2:.F:A?P:>0,%&B):1H MB@K-#9.EA:Q+;P=+..T&"Y2H7\&@X'S35@-^G>QZ&NCI M'@:;/^WS U .2+. &'(ZP"RW83BWZ=CO8FVZ$4C&FD8##1G0: M%G[3YK;4 M*!:C0R9;BL-PBM.GZ85#]3A/H@)*J( 4 9 ; $NV&$ZV^G78&-#QB<(1:])K M2([[0C2Y)B3'ZMY9DV)#@K&(HP,=9FZI#,<[37VZ;!SH^4#60W*0]9 <:#TD MB%EO&0+'&4+'/AMO%^[O(VE,:AH.R)DDT>Q,)Y &SIPN-[> S^DK1U2-$6%YD9P;RKKJ&-9M'-9M(-9M)-9QR @ MW!(0_L;A+'Q]CXLZ%5!"!:1XNXN$U'3/AOV(8#@D3)5I"BJ:H MT-PP64+'N_2LL)Q$Q>*H@!(J($4 Y'K=LCC>95:PRQ7A%8TCV/M$0 D5D"( MER*++]&.'BX)HCPI" MQ^BXNCZ.@_2US]D)]+F>V[NC"&>MZ_*_2R,3Q^F]]TD[9*1HB@K-C8BEO$(> M,T63#E&2HB6D:(H*S0V39=>B2^<.2S7MWADPG0=(07?C 5C =!X@ADSG"4M( M19=)Q"[I%>C$M:?S("E@.@\2@Z;S(#ED.D]8@B=>N"6K6Y-2M*<#62";34I M*O3]ILEMH3AJ^D^!4OQ AT189B5>&$;LT: 44#>K=5L>KK#/911JLK5OS ._ MU<$[\Z1E/1)G/?TZAQ)H80D_:-VI!:MJ6"3+?+%H?MQ M+6V07<;KNK4.)=09\UOWGXTA.=!\0"[@)DFRIOE@JRT.#YVD2EN.2[P<[]@[ ME,#L&A^QL'E3)B17]U9;ED.S<$R&S7VF($'&XI@?^N7;PEKBA358'KZM;XAK M[%NAD*(EI&B*"LV-G2WMY3$GXB1IO4^*EI"B*2HT-TQ[#SMXXT0MW0U[#(_V26;4\U14@$E5$"* &CC_>'>\OIQ_6C3QN<7P82KA=\\4?8R M+>[F6>DM]*U1Y7^(S!6PV#RD=?.FRE?KIY#>Y%65+]Y1N>?_!U!+ P04 " U:&Y7JFJZ(BT" "D! &0 'AL+W=O M_+O(8&RPEO@>F3DHL&*QV*RI>M %Q844/], AN_083YJ6QW=N*-.:= MHH3!5B#9-0T6?Y9 >9]X4^^XL2-5K&\/+.97V%_4N M-]+)>2<5;P:Q=M 0YI[X97@/)X(PO" (!T%H?;N+K,M[K' :"]XC8;(US2QL MJ5:MS1%F_I2]$OJ4:)U*]ZN']6KSA':K[=?=T^/F ;VY!X4)E6B#A<#FG;V- M?:6O,@(_'[!+APTO8#^B-6>JEFC%"BC^U_O:XN@S//I!>V@G* K>H3 ( M([2'2C>&NL*-QOHCRXTN9B9H+EN< M0^+I$9$@#N"EKU]-;X-/5[S.1J^S:_1TTS49",1+/0W&+2]OE>XF7"!XJWMPXPKW=5V6>O/" B3H,]+SM4Q,!>,'Z;T+U!+ P04 M" U:&Y7!TCBZI4" )!P &0 'AL+W=OL]I(?I6)F5Y9]LBS2#'XH:54*@O2\9S M+-64KVQ18%%8/GQ]$434?#T=/KX%X%7"4@ M,:'B&GU!+[,$77V\CFRI)&@B.ZW3W5?IO'/IH+Q!OO,9>8[GM\"'E^$)I KN M&KAW"+>5\<:]U[CW#)]_EJ]D@DB!!L4"C64&'$TA!;+!X&F[CC= ,WLC?[)MJB7#=HH@[4=1IUG8OJ)FN>9NIT7M17401[F=WN;=@] MTG<:Y?D]_XR^H-$77-17U0J_7"O!26;?[?:.Y)T&N4XO]-OEA8V\\%]+IREY MK$J>'=EH_-_0[=V&1S9.H[J=GGMLP]YK5/J2^([YBA0"45@JG'/35?O MJ\9;320K3>^:,ZDZH1EFZJX"K@/4]R5C(_4$L#!!0 ( #5H M;E>%9!TW8@( +0' 9 >&PO=V]R:W-H965TW#M >37(A5)\YL ]V_G^V$#*0T M8EO[DOC:]YR<,/XH$0**GE&9B8"52YCW;%E$"*18MED.F5M:,IUBJ MD&]LD7/ L0&EU/8<)[!33#(K[)NY.0_[;"LIR6#.D=BF*>:_KH"R_R M#D< ]SF 5P*\F-@:MW)!,=W$AN5HE M"B?#Q7 Z'BV_CM'M!,UN[L M$#V1XP@&EOKC!? =6.&[-V[@?)Z0C*@BQFC#6"SJG!;4@:'66V,7NNXGSU>Z M=L>.:M+\;J?[)^U$N5\I]YN4AU/ 5"81YH#FG,7;2 KT_1K2%? ?=6(;V9KJ M4->D%R([,=ZNC+=?KV7_0(WJ"O#_/"?>.Y7W3F/3'U1\7KL;>?ZVW2]$=F(Y MJ"P'K]?NX+P=6I-6MT/MHS-5WV?7F&]()A"%M0(ZK8^J3KRX(XI LMP GUR5Q=U^!M02P,$% @ -6AN5\,"HOJ) @ MM0< !D !X;"]W;W)K&ULK5513]LP$/XK5C9- M(&TX30+;NC12VP2-!QBB@SU,>W"3:V/AV)GMMO#O9SMI5E H:.,EL<_W?>?O M+KF+-T+>JA) H[N*<37R2JWK(<8J+Z$BZDC4P,W)0LB*:+.52ZQJ":1PH(KA MP/=/<$4H]Y+8V2YE$HN59I3#I41J555$WD^ B:Y@"8Y;(7.-WR^EU(2UP=[UE/W7:C98Y43 5[ ,;!1[*5TJ+J@6;&U24-V]RU^9A!V!X^@%!"P@> M Z(G &$+"%\:(6H!T4LC'+< )QTWVEWB4J))$DNQ0=)Z&S:[<-EW:),ORNUW M,M/2G%*#T\G9Q4UV\?W;U5DV0P(@^H.M9B@[>'L98FW 6 MA/.6>M)0!T]0A^A<<%TJE/$"BAY\NA__>0\>&YF=UF"K=1+L)9Q!?81"_ST* M_"#LN<_TY?"@3\[_1<_^.?J#9(1=X4/'%SY5>+X&KH6\1RE5.1-J)0']',^5 MEN;G_=57[H8PZB>T#6VH:I+#R#,=2X%<@Y>\>S,X\;_TY?HUR=+7),M>B>Q! M5:*N*M$^]F3,3.,F/ =D1@ 28AO/$<=K!L$[\&*]WL_VL M1_JL1[;/HQ&+=_I0!7+I!H!"N5AQW7R9G;6;,6/76A_9)X/A=-!C3\U,:D;( M7_IFH)T3N:1<(08+$\H_^FC:I&R&1+/1HG9=<"ZTZ:EN69JY"M(ZF/.%$'J[ ML0&Z29W\ 5!+ P04 " U:&Y7T_%?($P" "2!0 &0 'AL+W=O^U[CL^Q*57V M'$=F.\B)[/ 2"KVRX2(G2J=BZ\A2 %E;4,XTP$ELY^8BB?E>,5K M7""YSW,B?M\"X\<^]O#3Q#W=[I29<)*X)%M(02W+N="9T["L:0Z%I+Q C9] M//!ZP]#4VX+O%([R)$;&R8KS!Y-,UWWL&D' (%.&@>CA $-@S!!I&;]J3MQL M:8"G\1/[G?6NO:R(A"%G/^A:[?KX(T9KV) ]4_?\.(':3]?P99Q)^T7'JC:* M,,KV4O&\!FL%.2VJD3S6YW "\,)7 'X-\/\5$-2 P!JME%E;(Z)($@M^1,)4 M:S83V+.Q:.V&%N864R7T*M4XE:3#R7BTG(W1MSMT/_T\69A@F8[1($W'BQ0- MOH[0;#JXGQH[0,0^9D]9:WU9;^:UM"V4&! M^Q[YKA^TP(>7X2/(--RS M+$D&?:S;1X(X $[>O?$B]U.;I_]$=N8P:!P&E]@3VYHW?'.SEX"(E*!DF]^* M)+(DIOD/21"&72]V#J=&7E;Y;A#^K3I3*PXL*[1T@1LF*,JHHM.H+6_1% M4?A,W\LJWW/]\)D^YZ1CS&OUA8@M+21BL-$XM_.ABY&H7H J4;RT3;3B2K>D M#7?ZT01A"O3ZAG/UE)B^;)[AY ]02P,$% @ -6AN5Q:J+'"H @ I08 M !D !X;"]W;W)K&ULI55=;],P%'WG5UP%A#9I M+&G:M6RDD=9M"*05II7! ^+!36X::_X(MM.L_Q[;:4,G=9$0+XVO?<^YY_HV M)TDCU:,N$0T\<2;T-"B-J2["4&<4!&DB=^[4VDB:\.HP#L%NN:4H-)4"%!;3X')P,9NX?)_PG6*C]];@.EE*^>B"S_DTB)P@9)@9 MQT#L8XU7R)@CLC)^;SF#KJ0#[J]W[!]][[:7)=%X)=D/FIMR&KP/(,>"U,S< MR^83;OLY1R\ XBT@]KK; M0E[E-3$D391L0+ELR^86OE6/MN*H<$-9&&5/J<69]/;FH,T4K]SKMX-;5\;2'NN_' MQK!!HG2/BK-.Q=F_3 4JLK$OOSDDJ24:>R+G.NMT.!J/1TFX/E!_W-4?]]:? M4T%YS>'G'/D2U:]#A7L9G']>Z(ID. VL06I4:PS2MZ\'X^A#S_U,.GV3_YA2 M/W;@IW1(1+AG'1S5RANDADS6PK0NTNUV'GS96L_?]-; YT2MJ-!V?(6%1J<3 M.R;5FF(;&%EY(UI*8VW-+TO['4'E$NQY(:79!:Y ]V5*_P!02P,$% @ M-6AN5R, 5]3P P !1( !D !X;"]W;W)K&UL MM5AKCYLX%/TK%KM:M=+, .81,IM$FB89=:1,FYU'5ZMJ/WC@)F$+F-I.,OWW M:P,AD!"Z63%?$AON/9QSN38'!EO*OO$5@$"O<93PH;82(KW6=>ZO(";\BJ:0 MR#,+RF(BY)0M=9XR($&6%$!,4210I(\OA>@6GE-E5@= M[]!O,_%2S OA,*;1GV$@5D/-TU "[*.Q /=?H1"D*/P?!KQ[!=M\U@7:\A? MO12$J":9](@$7"?B_)EA%@I4)S9EELB9$D-& T2UB*EJB MJ4%6FRQ;J@D3=1L?!9-G0YDG1H_CC]/)\VR*/M^B^/@%?IIM9.JZGZU)XJ1Z7ZG&&9YW FS.Y'ICX(15')!&( M) &:?E^'J6Q4@;[.9#BZ$Q#SOYNDYMAV,[9:?]<\)3X,-;G .+ -:*/??C%= MX__&P$W^!EHQRWB0[QW(S++5+;$:6T>]9WD#?5 4U MA&'<]ZPRK$;5+JG:K51GP/FU7/S^.EY'1$ @UZRLB!\2M2LTTXA=@C2NT%>?<%=H16$VR5TKVWG"C\KHL0T=@M3+TRS+T.]RH M^D?-AST;.\Y!C_XTK$;5-/9/5J-]Y:]9$HHU@PMT&[ZJP>%M:^G<=NQS[UE7 M:/5*5#R&^8;=6X!W58J.T.JEV!L.L_5!?F8'%V"U7=;%QN&CMBG,L4\]NT2A =W'*Z 847=[>MZV(9]^LCM#J^O=>P[3?LF];G@( MK5Z*O8LQVVW,F7U[;$]PSW*.^O9G876R>QMCMON8G>=ZJGBN2;A8 (/$;W<, M[6_=NI>^H*K5Z*O7\R6WW)_[#A!6#U!>;2](S*"TPA MK"'.-HX\KEYY1UZ(P &PO=V]R:W-H965TQA!=8B:];M8=B#8C.Q4%MR)>72OY\D.U[2ND&Q]246J7,.14HAPS7C M]R('D&A3%E0,K%S*JF_;(LVAQ.*454#5SISQ$DME\H4M*@XX,Z2RL#W'.;-+ M3*@5A<8WX5'(EK(@%"8@#00&IU I8 M?58PAJ+00NH8#XVFU8;4Q-WU5OVSR5WE,L,"QJSX23*9#ZP+"V4PQ\M"WK+U M%VCRZ6F]E!7"_*)UC>TY%DJ70K*R(:L3E(367[QIZK!#4#K=!*\A>$\)P0L$ MOR'XKXT0-(3@M1%Z#<&D;M>YF\+%6.(HY&R-N$8K-;TPU3=L52]"]3N92JYV MB>+):/)U>/,=#6]BE'R[NYI<)\HZBD%B4@AT@SG'^B*/T4=T-XW1T?OCT)8J MK";;:1-B5(?P7@CAHVM&92Y00C/(.OCQ8?[E ;ZMTFUS]K8YC[R#@E.H3I'O MG"#/\?R.\XQ?3_>ZTOF_Z,D_1]\KAM\^ -_H^2\] *YZ#I>/)VA28"H1IAE* M'I:D4LU HE_#F9!<_9M_=]U[K1QT*^L.UQ<53F%@J18F@*_ BCZ\<\^<3UU% M?TNQ^"W%DC<2V[N>H+V>X)!Z%(,230DV714V:CP(Z+J*6N7,J.C9L(HN+GPG MM%>[)7X.=^X.ZCDN>HGNOZ08NJL[5W.E,)?&%&@D I6U)9 MO]'6VTZ=H6FV3_PCMS]V._RQFE+U4/DK7X^X:\P7A I4P%R%/D]=BH M#&ULK55K3]LP M%/TK5IC0D%CS:@.#-!*D151L@U'8-$W[X":WC843!]MI8;]^MA.BE@56I.5# MXL<]Q^?,YEJK+%[8H M.>#4@')J>XX3V#DFA16%9NR*1R&K)"4%7'$DJCS'_/$4*%L-+==Z&K@FBTSJ M 3L*2[R *:-5G5LT+=04@G)\@:L%.2DJ+_XH U &];@-\ ?&.T5F9LC;#$4 M^H#>(1N)#',0H2V5%$UH)\VRI_6RWDO+0ME#OK.//,?S.^#QZ_ 1) KN&KBW M";=5 MHL>&T6/,/GO\ WOJ^(?$0_3V9"1NO_F%"%TTX,(2Z,"PCUVF>T%ZN&]LFGUG>? M2?UGV(;.0:MS\.;L[B,B1-6=VL%?"5.;>N#YSL=G$9Y@( M -X* 9 >&PO=V]R:W-H965TH*C5'-Z:FQ,G1[)>1RE,*:(Y4F"Z=\AQ&35UUK:9N VFB^X'-"= M7H;G, %^GXVIZ.D5)8P22%E$4D1AUM<&K:YOR_EJPL\(5FRKC60F4T(>9>,D*<5B!4F4%D^\+GW8$K1V M"U !^0]C M?S3QT9$''$L/V_0ZR+[R@)S8\'0; 1.(#M%EO$5F89IU:S'W5]NUJ7SL>C^NZ,_,\.J MSH.E>-8.WE4:D 30'5XC+V)!3%A. ?T>3!FGXD_]IVZ_"V*[GB@ONB[+< !] M3=QD#.@2-.?+IY9M?*\S^Y P[Y P_T"P9]O2KK:EW41WW)Q22#GB>%VW XWB MM^[ (6'>.V"HSOR"8RN._/8M'>O*)K_.EK-0=6W/M@)T+FJE!@*2)[RXJZN1JMB;*!JD!?CPU;7;=6,>Z)X M*VJM__BB\KO&=!ZE#,4P$Z&,TS-Q!FA1314=3C)5+DP)%\6':BY$ 0I43A#O M9X3P34<&J$I:YQ]02P,$% @ -6AN5\#*JWY6! %1@ !D !X;"]W M;W)K&ULK9GK/N=+(SW=B2+T *S!#L M-$P3R 2R[5\%%'#7MEA+A.S;5[[$8!!:G-6?X(O.)^FS+!\IW2U-O[$5(1R\ MQ5'">L:*\_65:;+YBL287=(U2<2=%YK&F(O3=&FR=4KP(@^*(Q-9EF?&.$R, M?C>_]I#VNW3#HS A#RE@FSC&Z8]K$M%MSX#&^X7'<+GBV06SWUWC)9D2_K1^ M2,6965$684P2%M($I.2E9PS@50"]+" O\34D6[9W#+*N/%/Z+3L9+7J&E;6( M1&3.,P06/Z]D2*(H(XEV?"^A1E5G%KA__$Z_R3LO.O.,&1G2Z)]PP5<]HVV M!7G!FX@_TNTM*3OD9KPYC5C^%VS+LI8!YAO&:5P&BQ;$85+\XK=2Q%Z X,@# M4!F #@.<$P%V&6"?6X-3!CCGUN"6 7G7S:+ON3@?<]SOIG0+TJRTH&4'N?T\ M6O@*DVR@3'DJ[H8BCO>GP]O ?[H+P.0&/ ;#R7@XNAL-9J/)&,P&_X+'P2P MLPD(;FZ"X6ST-0"C\7!R'^QN7OB$XS!BG\$7\#3UP<6GSUV3BY9E?'->MN*Z M: 4ZT0H;W-.$KQ@(D@592.)]=7Q'$6\*(Y46]*[E&BF!4[*^!+;U!T 6LB7M M&9X?CF3=^;7:@P_77I-A5V/$SGG."=XHF=.8 ([? 'D3,Q0CLB>L9&3SW15; MXSGI&6)"8R1])48?R,P6'"_G9-/<:_\+\JQ6UWS=%ZBIMN"X-KOC>55E-5]. MYCL8#F2)EF+S1O_\&/>M/F2>=,%\G+- $J[EW*_>NTOW%'65B+@J+ M(?M,Q*>4O)^) 2Q[*DI@TZ>B$^:[QZ\"=#T[>ZGW7X9 4@XAJX,<^3CV*I>> MTN648[[A-/VQ)Q"DF$M??R6JJ46=,+^ =?;L6)?(/5#XDT(U?ZW*7ZOAO DP M!ZRR>DJEDMI4I4Z8WSH>:';':L,#F9)BKHML*-?9KG2VE3K'(FT6";*P%B9+ M$(GW7"9/R6@J3R?,+V!N[5-S[.ZXE$)=IU+7T? %5S*:JM,)\S\ DW[M?YU3 MTP^M799M*1_ [63\%_A;_)'FQLK8IN*UTGRMM$ 7K?X4]M8Z4'=RH"8V?C8Z M:7Y)J^<'K7;+/IQ3) 61:Z&.?%*!:.<3Z4L0U*S&)G72_)(&4>W[;[6/TH0S M"M9=[M98L.DBZ[QD08UMK%4GS8>2M1QT6LZ1U>-RR/).*=TMPZ!Z'79>PJ"& M-!:H=5E6TO:S 6@[\.C]_D"ERN_:;K4%UV$N!N#0;5B["94(L7_VT8CTG"Y2-8Z]I+*\TO:5YM!-O.X0"6E.I8ATFO MN;?-&9-TF>\O,S"GFX07NUG5U6H/>Y#OW!Y&PO=V]R:W-H M965T:>/M9%*4U8T5E#3;OMJ MTMLVPHDSVVWAW\].0F@A1$/KE\2/>X[/L7V3V]M1]L#7 (])B3E?6TM1-;5 M=1ZM(<'\@F:0RIDE90D6LLM6.L\8X$4.2HAN&8:G)SA.-;^7C]TQOT\$.N^UM;0 I9X0\24[L90&G(57T0)SY]H M5\2ZEH:B#1(4,Y1A!E[DDFQ MPVS!ZPP6C%[.J%)CZ[NF9YEN3]_N&WD;YK@=UW@).Q!L5X+M1L$WP'D7;3'9 MX.+N$YE].(V@3FE!Y>Y).*^56A/7I-6IM#J-6@-8 F.P0 (_(LPY"'Z&4A!U M4AN9U >LRS,<05^37R@.; N:C^JNS__S'%AU*ZMNH]7YY'HFLR6<#6:CL,Y? M([Q>UY=/IF=\K3-Y)+(#IU[EU#MZQGAO[I?I.D;'>G4-:\*<3KOEU-_"5B6X MU2AX?#OYAK[+1YVR1NA'C^5(9 #.I4-\(^>F1'(CMP:!HO/USCZ(=64N[_5VRGW3)?)U-=G-'Q;/-5 M-NE[!8.JUGY@MHI3C@@L)="X:,G[P8H"J.@(FN4UQ#T5LB+)FVM9- )3 7)^ M2:EX[JBRI"I#_;]02P,$% @ -6AN5XVG&ULK5?9"RY[2M,@A(:DF !T++_OA<@36TT4FOTP@6\Y^"<2^ "&*X8_RF6A$CT ME*6Y&%E+*8M3VQ;1DF18=%A!-Y7)D]2T4DP27J;QC MJRM2&PH57\12H:]H5<4&OH6B4DB6U6!0D-&\NN.G.A$;@+[S"L"K =X. #+3 M#O!K@*^-5LJTK0LL\7C(V0IQ%0ULZD'G1J/!#CKY<7.) MYF=_7\[0QPLB,4T%FF+.L>T;"&2DZR'<^(\_Q_!8]$S/\@D0 =S7<,\CQ MF]SYFB]XE2\AG),82?R$L!!$BK8D521=3:)FU>,X=+N>&P[MQTWM^V%!. B= M==B6QJ#1&!@U3JZNIV=MJHPP53Q.18$C,K*@.@C"'XDU_O#.[3I?V_)^)+(M MAV'C,#0ZO,XCEA']#V(B(DX+51_:+)MYYDMR,F%9@?/G#^_ZGMO[*J"X/0@: M4ZAO" JGFA+Y M$S0M7P-8\F)%[[OM&79J/_ +'>;+'?-XZC,RE27!)3#XK+.1LI@ MX+>.^^[>@';]0= /^CL#W]CQ@;9ZC:W>,:9P;\^*'_1[KK?CI H+-\.<0==W MVZ=PO]'8-VJ<[N4;15"?GV$-7V$>"R0)S]I4FVE#]$PP;[,[,0(/_".#QNW M*.OJQ_0/] TN;8Z,T+<6K2.1;;ETG?6ZZQRI;/V"Z"UUZXK!_9NZ[%>N];=; MSA(JA2Y=4*O41[EB7R0E:J84]=>7BB50PEF&^ATH6R? Y78[X7O$JB))A*2P MUP*8FEQ"X(>4- R84[$G+"ZY:E/@J(2IF4L]3C\CG, XAUS%9:3M8*T@8GD$ MO&I'"/.ATHJ?3A2DM8::DWGH7]_8;;G'J# M+S3V?*BS]>[0-6\/_^]X#/;'8Q@X@]T%L"TN&/1[P*9/2/8ZO#IHWF"^H+E *4D ZG1ZD')>G=VJ%\D*??QY8!(. M4_IQ">==PE4 ?$\8DR\OJH/F!#W^#U!+ P04 " U:&Y7(D:%,3@& - M.@ &0 'AL+W=OKJ=#U,( M/H_M\QJ;UTZZZSAY2N>,>AXO6"0^F<5)Z''Q M-GFLIXN$>=,\* SJV+*:]=#SHUJ_FU^[2_K=>,D#/V)W"4J78>@E_PQ8$*][ M-;OV?&'D/\YY=J'>[RZ\1S9F_'YQEXAW]9(R]4,6I7XK5+^X(ZS2P@ M+_&7S];IUFN4=>4ACI^R-U?37LW*6L0"-N$9PA-_5FS(@B CB7;\**"ULLXL MO]+!*Q%2 X^@!_UN$J]1DI46M.Q%GOT\6N3+C[*!,N:)^-07<;P_'GZF MY/X+1;>?T/#V9DAOOHXNOU[=WHRS*Z.K\9_H V'<\X/T(_H=W8\)^O#KQVZ= MB[HS0GU2U#/8U(/WU..@ZSCB\Q31:,JFFGABCN\8XNNBSV7'\7/'!]@('+/% M.7*L,X0M[&C:,SP^'.NZ\[K:ZL/7:XA8002 M1H%@BBINJ8IKHO=';,6B)3M#$>,Z"3;1S3PZ6Q!6_0;NB-&TVDZMII#3::B% MR,M"V'66?$?_HJ+O M:);$(1+#4XS-"1=S(Y^C,F# HLE<+&]/VX'EI[HQ7133)=/8R*KC&1)&(&$4 M"*8HW2R5;D+/,DU(52!A!!)&@6"**JU2E=:K9IG6R[FAT[1V9AEC%553>TR- M]&4AVVFX#:R?C-IE,MKFR4@9HHD8HF=HP9+LFOC9K$O/AM?9:H=UWFA:V__L MG609FU U6;KZ;;R3+%VAMCY3G3)3G1.F[UU9&T@: :51*)JJC73PMMG"'[(0 MYO#*0H"ZZX*F& D+XUV[ 56IFF'IG&VC!3QE_0>USJ T4M!4/^+NFA:H.M64 M2UMLFWVQ?H%Y(X-C;DMEM4#M."B-0M%45:6_M]O@RPBD7Q^"T@@HC4+15&WD MCH)]8$NA^B0'NC$ 2B.GT/2_L=]B6P#+;0%LM+;'FAPSI8+).06T7P6H9E&H M9JDJR T ?& #X'EA>4^S8VYCU:\;*(V TB@4355;;BQ@#+U*X1.HKO!E8.9N@'KZ@[9S]N+O)U)7J[#FGPM)SXR./S=_>G)A;4ED#4/L.2J-0 M-%53Z?(Q^ $Y!K7YH#0"2J-0-%4;N1V #VP'5)^Z0#T]*(V<0M/_+'X]2!5$ M.GEL/JH_UI>' MRCT !_S6 ?TU@!0&@&E42B:JHW<&7#,.P.'_(@YO+(0]@MKT,"=UL[]I*!U M4DV==F?[)E8U<])E.^;C^^I+NAE8.9=8YPS:N[D$-<_:.NT];L39NG_\R-/X MP?_@1\QMJ:P"[,WGL'>?O\69NR/MN@-^YNZ ^G50&@&E42B:JHWT_\X!_U]] M\@*U\: T DJCI]!,/XP=Z> =\SG]D:;$3*DLQ0DTK3,!;18%:-9&A?K6XVUB MN7C,GRM,49[IS3-.Y=7RV<7+_(F]G>L#^V)H:ZX3^X)NGDR4^,V#DM=>\NA' M*0K83%1EG;?$R$HVSQYNWO!XD3]<]Q!SL9;E+^?,F[(D*R ^G\4Q?WZ355 ^ M =K_#U!+ P04 " U:&Y7,7F20_H" !B"@ &0 'AL+W=ODYB*MA5*F9[; MMO!#3(BHL!2IFIDQGA"INGQNBY0C"0PHB6W7<>IV0B)J=5IF;,0[+;:0<41Q MQ$$LDH3PIQ[&;-6VJM9F8!S-0ZD'[$XK)7.!-P'^%*;+5!.YDR]J [@Z!M.5H0QNA+S4#4WQ+[&,>:2,GXL^:T M\B4U<+N]8;\RWI67*1'89_'/*)!AVVI8$.",+&(Y9JMON/9SJOE\%@OS"ZMU MK&.!OQ"2)6NP4I!$-/LGC^L\; %<=P_ 70/A3+[#T05* M$L4"AH1SHC-]#)]ALDC3.$(.?49]I%+/J*T81^(!?EUC,D7^6X7=(PT8ST=: MME1"]7*VOQ;5RT2Y>T1Y<,VH# 5FXIX033 M"GC.";B.Z\'=Y *./AX7Z?IOFAUY7KZ)GN&M[=M$)B2P&7QE+!! : 3Y,O( M1^@A]4-U/1]*=Z.47;\CYR(E/K8M]5 (Q8Q6Y].':MWY4I2" Y'M)**6)Z)F MV+V]B7AY+G^H&!A(3$2A]]HAO1^(;,?[:>[]])5#\-S["8R0ZS'U'!=9+^5[ MK_6,K&G(]*=CV7$JU6K+7A98JN>6ZJ661@ONA^J-+A*?(>M;ZU6]9B-?+Q/U M2M".J+-?-N.I]F.%YEMOCAISK.S6!:1R;*W/N,)\KFI;@28Q;,O>CZ:%U!= M4S?8_\*SZNN:\'E$!<0X4U"G\>WW./SQ?B=E#I%:AX&C&\N,#L.[L[<_%E)?O@G<_>3=R4GK[OQR MWW]F@?,P\I)VGT!ZT3(7RFQ1C#YY&OTABT_P>EVN%M45+?+:)!+L>F:.'0.PTX*&MP3/@S' MA+.)8A"5DX+QE7-WP#&57*I FW8UZ=K@J1XVJ- IGBJS:G6ZX"; WDV0B M5495DZ8=KEVC :[EF4$H-:R,(.,D9D4Q&I81]0#0SNEG-_ 8_X] MW^%>YEO[9G=--$,CJ!XZ&F< _S:;X]ZFC9_%&Y3L7NI/"[,<86WH4WJM:,Z6 MUE[FC0",O8VSD[+DJX^*?G' T(.NX8"X5>S#9H%6FQD%5&-Q3I=ET MV_-3D?*6+O6ZG98YKKESA)K_;9UG5%!%^+9HT_NONDTFYH^A'7XS/Z,Y67!]VX##<#/^2C.V M*-)FUC44HIZU&7^!Y;63YK1J?ZG]?31]3@,T];W(GTTIH_&N"@?,K8?+(\_)C67?Z5I M&L=)@E5T//8J&&-U2Q+X\;-AVB "RP.9_J[6^&[C'7*X#[ ]/=0AV$KQ3L16 MBM<:$'_=(")-_;N-Y8$(;!>PWH'\_CS04_Z8.(9=Q;1A3S".I"F&0"_Z>S1) MD.HD\/'O#_:4Q'&:^A' _ KB&$/@:<013 %HP) XMN_!O?=1M'Y/19O_$([^ M %!+ P04 " U:&Y7EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y M;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI M0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:W MO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%B MM/XU@LD/['X 4$L#!!0 ( #5H;E>S!II6W@0 .4C / >&PO=V]R M:V)O;VLN>&ULQ9I;;YM(%(#_RLA/K;1:FXO3-JHK$1CC43&X XXV3Q4QXQH5 M@P4DZ?;7[PPDS:&A1_LRSI.YV/CCP)SO'(:/#U7]_;:JOI,?QZ)L%I-#VYXN MI]-F=Q#'M/F[.HE2[ME7]3%MY6K];=J<:I%FS4&(]EA,S=GL8GI,\W+RZ>/3 ML3;U%*Y4K=BU>57*C6K#=2X>FN?]:I79D?\Y\B M6TQF$](<_J[)-BWA75T6QF!C]CFM1M_GNQ>9802;I;=-M:=-;GDJ0 MQ>1B)@^XS^NF[;[1'3^5C/="?KE?NVNK95ZTHO;25OAU=7?*RV_J,/(LIN T MNC@\??9!O*S_3QBK_3[?":_:W1U%V?9QK$6A ,OFD)^:"2G3HUA,W.I>U.I\ MY!^PK#^W5D*!2-67N=Q1LZS#TXE29J)L1$;D4E,5>28Y,G*5%FFY$P1 F@BD M^8J07TT :2&0UJM Q@I'_A1 V@BD_8J0@TC.$EI(D(@[QF+S! MY+7L "& MF<'4; :T/!F4H";:F9I_ &F$,SL(\8FGVR+B*1S$QJUBZK>*NJ+<-NH2MU"=[2Z<;)BQ<1GP- M,3&K6)JM C%IG+!U5XAM8[K ML71[Y5E_/HU\[FQ6S"6/MAED;0N3BZ6[4P'1E#<;2[9D_/SF27:" F)AX+,WB ='LRQY528S?FYA[K',_YE(Q;-.\ M:$B8UG"2PL8L9.ON9F!">EFK04S,0O89+32HU?J80DS,0K9F"XV@]9<[51-F MT.DV9B'[C!;BS%\E:D&ZDCAQ3 <-K8U.J6BVT&/AB\<1\X]]1O]LN&IGDYN_ MR*_*&&)B_K$U^V>T5'^.*L3$_&/KGEY!GSL.4A'F'UNW?\!%E^W%)@H[[W2) M2:Y#3,P_MF[_P#%.E<=9P+I>0_5#,)ISS#_SL_IG267QYG6 +U+1'///7/NL M"^PD7V0DB(GY9W[&+FBDOX28F'_FNF?T_]#Z/L858F+^F7?^F3Z]5I*)?5Z* M+)1_T )/[F/!00D5#B]B %28/D<269Q#)[HE"$8Y% M08/F5-;8\O5?6)^LD>6;7?(FVV?)\?][I 7S::4_B&$O-RD?9MONCX= MSE=6W;!ORWDYK$/?+M_;=0HZG<["\'-&\SC_.7/R>NK37R9VJ]5VF9ZZY<<^ M''Z3)M0.4@C2 M^D$&058_R"'(ZP=%"(KU@V80-*L?= M!M_6#[B#HKG[0/03=UP^2*B MWDJ@MZ+>2J"WCCZV"?16U%L)]%;46PGT5M1;"?16U%L)]%;46PGT5M1;"?16 MU%L)]#;4VPCT-M3;"/0VU-L(]+;19@F!WH9Z&X'>AGH;@=Z&>AN!WH9Z&X'> MAGH;@=Z&>AN!WHYZ.X'>CGH[@=Z.>CN!WHYZ.X'>/MKL)M#;46\GT-M1;R?0 MVU%O)]#;46\GT-M1;R?0.Z+>D4#OB'I' KTCZAT)](ZH=R30.Z+>\3_USN6T M2_G:\[W&Y_\GU>5\;[H^_K+\/CEZ>R\X!_B3X/$+4$L#!!0 ( #5H;E @=!&S:;EL6_0$W>4!$$ENVH?#W=<(@M:*HB$J]&R)B^]T76SJ;9/2V MM>1[F[IJ_#A9A& ?&//Y@FKM4V.IB2,SXVH=XE\W9U;G2STG)@:#(F&2>.*I_T'G<3VZQQHJVMRER'.,[63?$MI;]/ M2./*;HY?E-;?Q D).YG0COPJ^C87(A?+\(QX38^FKGX_:TRZH^&5VW-X/XY;=>7C67:[?XZ]G M?*Q_81\"I \)TH<"Z2,#Z6,(TLX K @ M$0 @ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 M" U:&Y7F5R<(Q & "<)P $P @ ', 0 >&PO=&AE;64O M=&AE;64Q+GAM;%!+ 0(4 Q0 ( #5H;E=9MO$HAP4 /0= 8 M " @0T( !X;"]W;W)K&PO=V]R:W-H M965T&UL4$L! A0#% @ -6AN5WG!/?N0 @ .0< !@ M ("!910 'AL+W=O(*V 8 +8B 8 " @2L7 !X;"]W M;W)K&PO=V]R:W-H965T&UL M4$L! A0#% @ -6AN5\U-:9_C!@ LQ\ !@ ("!W"8 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN M5P1T+@: P O0< !@ ("!%E 'AL+W=O&UL4$L! A0#% M @ -6AN5\G.=URJ @ !@8 !D ("!@EH 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN5]MEX"J^!@ A1 !D M ("!V6\ 'AL+W=O&PO=V]R M:W-H965T4?&;+1 8 .&UL M4$L! A0#% @ -6AN5[I.3SA8 @ 3 4 !D ("!AX M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M-6AN5[..89]N P /0< !D ("!Y:, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN5R*_H:4/ P A08 !D M ("!!KL 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ -6AN5]6KS;82!0 OAP !D ("!]<4 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN M5WR"@AO@ @ .PL !D ("!LM( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN5]5EH/8_ P O0T M !D ("!N-T 'AL+W=O&PO=V]R:W-H965TJ:KHB M+0( *0$ 9 " @6GK !X;"]W;W)K&UL4$L! A0#% @ -6AN5P=(XNJ5 @ "0< !D M ("!S>T 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ -6AN5]/Q7R!, @ D@4 !D ("!\O4 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ -6AN5[HC M !RD @ QP< !D ("!>_\ 'AL+W=O&PO=V]R:W-H965T$9Y@( -X* 9 " @2$% 0!X;"]W;W)K&UL4$L! A0#% @ -6AN5\#*JWY6! %1@ !D M ("!/@@! 'AL+W=O&PO M=V]R:W-H965T-IW+:.00 M $T/ 9 " @?H/ 0!X;"]W;W)K&UL4$L! A0#% @ -6AN5R)&A3$X!@ #3H !D ("! M:A0! 'AL+W=O&PO=V]R:W-H965T3P, "X4 - M " 0H> 0!X;"]S='EL97,N>&UL4$L! A0#% @ -6AN5Y>*NQS M $P( L ( !A"$! %]R96QS+RYR96QS4$L! A0#% M @ -6AN5[,&FE;>! Y2, \ ( !;2(! 'AL+W=O7!E&UL4$L%!@ ^ #X Z1 (@K 0 $! end XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 184 195 1 true 41 0 false 8 false false R1.htm 00000001 - Document - Cover Sheet http://chinafoodsltd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://chinafoodsltd.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://chinafoodsltd.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) Sheet http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://chinafoodsltd.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS Sheet http://chinafoodsltd.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - LIQUIDITY AND GOING CONCERN Sheet http://chinafoodsltd.com/role/LiquidityAndGoingConcern LIQUIDITY AND GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - SEGMENT REPORTING Sheet http://chinafoodsltd.com/role/SegmentReporting SEGMENT REPORTING Notes 10 false false R11.htm 00000011 - Disclosure - DEPOSITS AND OTHER RECEIVABLES Sheet http://chinafoodsltd.com/role/DepositsAndOtherReceivables DEPOSITS AND OTHER RECEIVABLES Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORIES Sheet http://chinafoodsltd.com/role/Inventories INVENTORIES Notes 12 false false R13.htm 00000013 - Disclosure - LEASE Sheet http://chinafoodsltd.com/role/Lease LEASE Notes 13 false false R14.htm 00000014 - Disclosure - PLANT AND EQUIPMENT Sheet http://chinafoodsltd.com/role/PlantAndEquipment PLANT AND EQUIPMENT Notes 14 false false R15.htm 00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Sheet http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? (DEFICIT) EQUITY Sheet http://chinafoodsltd.com/role/StockholdersDeficitEquity STOCKHOLDERS??? (DEFICIT) EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - INCOME TAXES Sheet http://chinafoodsltd.com/role/IncomeTaxes INCOME TAXES Notes 17 false false R18.htm 00000018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://chinafoodsltd.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 18 false false R19.htm 00000019 - Disclosure - CONCENTRATIONS OF RISK Sheet http://chinafoodsltd.com/role/ConcentrationsOfRisk CONCENTRATIONS OF RISK Notes 19 false false R20.htm 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://chinafoodsltd.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 00000021 - Disclosure - SUBSEQUENT EVENTS Sheet http://chinafoodsltd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 22 false false R23.htm 00000023 - Disclosure - NATURE OF OPERATIONS (Tables) Sheet http://chinafoodsltd.com/role/NatureOfOperationsTables NATURE OF OPERATIONS (Tables) Tables http://chinafoodsltd.com/role/NatureOfOperations 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://chinafoodsltd.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://chinafoodsltd.com/role/SegmentReporting 25 false false R26.htm 00000026 - Disclosure - DEPOSITS AND OTHER RECEIVABLES (Tables) Sheet http://chinafoodsltd.com/role/DepositsAndOtherReceivablesTables DEPOSITS AND OTHER RECEIVABLES (Tables) Tables http://chinafoodsltd.com/role/DepositsAndOtherReceivables 26 false false R27.htm 00000027 - Disclosure - INVENTORIES (Tables) Sheet http://chinafoodsltd.com/role/InventoriesTables INVENTORIES (Tables) Tables http://chinafoodsltd.com/role/Inventories 27 false false R28.htm 00000028 - Disclosure - LEASE (Tables) Sheet http://chinafoodsltd.com/role/LeaseTables LEASE (Tables) Tables http://chinafoodsltd.com/role/Lease 28 false false R29.htm 00000029 - Disclosure - PLANT AND EQUIPMENT (Tables) Sheet http://chinafoodsltd.com/role/PlantAndEquipmentTables PLANT AND EQUIPMENT (Tables) Tables http://chinafoodsltd.com/role/PlantAndEquipment 29 false false R30.htm 00000030 - Disclosure - INCOME TAXES (Tables) Sheet http://chinafoodsltd.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://chinafoodsltd.com/role/IncomeTaxes 30 false false R31.htm 00000031 - Disclosure - CONCENTRATIONS OF RISK (Tables) Sheet http://chinafoodsltd.com/role/ConcentrationsOfRiskTables CONCENTRATIONS OF RISK (Tables) Tables http://chinafoodsltd.com/role/ConcentrationsOfRisk 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails SCHEDULE OF SUBSIDIARIES INFORMATION (Details) Details 32 false false R33.htm 00000033 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Details 33 false false R34.htm 00000034 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details) Details 34 false false R35.htm 00000035 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details) Sheet http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails SUMMARY OF GEOGRAPHIC SEGMENTS (Details) Details 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Details 36 false false R37.htm 00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 00000038 - Disclosure - LIQUIDITY AND GOING CONCERN (Details Narrative) Sheet http://chinafoodsltd.com/role/LiquidityAndGoingConcernDetailsNarrative LIQUIDITY AND GOING CONCERN (Details Narrative) Details http://chinafoodsltd.com/role/LiquidityAndGoingConcern 38 false false R39.htm 00000039 - Disclosure - SUMMARY OF REPORTABLE SEGMENTS (Details) Sheet http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails SUMMARY OF REPORTABLE SEGMENTS (Details) Details 39 false false R40.htm 00000040 - Disclosure - SEGMENT REPORTING (Details Narrative) Sheet http://chinafoodsltd.com/role/SegmentReportingDetailsNarrative SEGMENT REPORTING (Details Narrative) Details http://chinafoodsltd.com/role/SegmentReportingTables 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details) Details 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 42 false false R43.htm 00000043 - Disclosure - INVENTORIES (Details Narrative) Sheet http://chinafoodsltd.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://chinafoodsltd.com/role/InventoriesTables 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details) Details 44 false false R45.htm 00000045 - Disclosure - LEASE (Details Narrative) Sheet http://chinafoodsltd.com/role/LeaseDetailsNarrative LEASE (Details Narrative) Details http://chinafoodsltd.com/role/LeaseTables 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 46 false false R47.htm 00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative) Sheet http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative PLANT AND EQUIPMENT (Details Narrative) Details http://chinafoodsltd.com/role/PlantAndEquipmentTables 47 false false R48.htm 00000048 - Disclosure - STOCKHOLDERS??? (DEFICIT) EQUITY (Details Narrative) Sheet http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative STOCKHOLDERS??? (DEFICIT) EQUITY (Details Narrative) Details http://chinafoodsltd.com/role/StockholdersDeficitEquity 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Details 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 51 false false R52.htm 00000052 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://chinafoodsltd.com/role/IncomeTaxesTables 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details) Sheet http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails SCHEDULE OF CONCENTRATIONS OF RISK (Details) Details 53 false false R54.htm 00000054 - Disclosure - CONCENTRATIONS OF RISK (Details Narrative) Sheet http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative CONCENTRATIONS OF RISK (Details Narrative) Details http://chinafoodsltd.com/role/ConcentrationsOfRiskTables 54 false false All Reports Book All Reports cfoo-20230930.xsd cfoo-20230930_cal.xml cfoo-20230930_def.xml cfoo-20230930_lab.xml cfoo-20230930_pre.xml form10-q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 69 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "CFOO", "nsuri": "http://chinafoodsltd.com/20230930", "dts": { "schema": { "local": [ "cfoo-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "cfoo-20230930_cal.xml" ] }, "definitionLink": { "local": [ "cfoo-20230930_def.xml" ] }, "labelLink": { "local": [ "cfoo-20230930_lab.xml" ] }, "presentationLink": { "local": [ "cfoo-20230930_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 170, "keyCustom": 25, "axisStandard": 12, "axisCustom": 0, "memberStandard": 18, "memberCustom": 23, "hidden": { "total": 138, "http://fasb.org/us-gaap/2023": 133, "http://xbrl.sec.gov/dei/2023": 4, "http://chinafoodsltd.com/20230930": 1 }, "contextCount": 184, "entityCount": 1, "segmentCount": 41, "elementCount": 343, "unitCount": 8, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 28, "http://fasb.org/us-gaap/2023": 678 }, "report": { "R1": { "role": "http://chinafoodsltd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://chinafoodsltd.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:InterestIncomeExpenseNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-03-31_us-gaap_RetainedEarningsMember", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R6": { "role": "http://chinafoodsltd.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-09-30", "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://chinafoodsltd.com/role/NatureOfOperations", "longName": "00000007 - Disclosure - NATURE OF OPERATIONS", "shortName": "NATURE OF OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://chinafoodsltd.com/role/LiquidityAndGoingConcern", "longName": "00000009 - Disclosure - LIQUIDITY AND GOING CONCERN", "shortName": "LIQUIDITY AND GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:LiquidityAndGoingConcernDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:LiquidityAndGoingConcernDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://chinafoodsltd.com/role/SegmentReporting", "longName": "00000010 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://chinafoodsltd.com/role/DepositsAndOtherReceivables", "longName": "00000011 - Disclosure - DEPOSITS AND OTHER RECEIVABLES", "shortName": "DEPOSITS AND OTHER RECEIVABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:DepositsAndOtherReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:DepositsAndOtherReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://chinafoodsltd.com/role/Inventories", "longName": "00000012 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://chinafoodsltd.com/role/Lease", "longName": "00000013 - Disclosure - LEASE", "shortName": "LEASE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://chinafoodsltd.com/role/PlantAndEquipment", "longName": "00000014 - Disclosure - PLANT AND EQUIPMENT", "shortName": "PLANT AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany", "longName": "00000015 - Disclosure - AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY", "shortName": "AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:AmountsDueToDirectorAndRelatedCompanyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:AmountsDueToDirectorAndRelatedCompanyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://chinafoodsltd.com/role/StockholdersDeficitEquity", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "shortName": "STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://chinafoodsltd.com/role/IncomeTaxes", "longName": "00000017 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://chinafoodsltd.com/role/RelatedPartyTransactions", "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://chinafoodsltd.com/role/ConcentrationsOfRisk", "longName": "00000019 - Disclosure - CONCENTRATIONS OF RISK", "shortName": "CONCENTRATIONS OF RISK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://chinafoodsltd.com/role/CommitmentsAndContingencies", "longName": "00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://chinafoodsltd.com/role/SubsequentEvents", "longName": "00000021 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://chinafoodsltd.com/role/NatureOfOperationsTables", "longName": "00000023 - Disclosure - NATURE OF OPERATIONS (Tables)", "shortName": "NATURE OF OPERATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://chinafoodsltd.com/role/SegmentReportingTables", "longName": "00000025 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://chinafoodsltd.com/role/DepositsAndOtherReceivablesTables", "longName": "00000026 - Disclosure - DEPOSITS AND OTHER RECEIVABLES (Tables)", "shortName": "DEPOSITS AND OTHER RECEIVABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CFOO:DepositsAndOtherReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CFOO:DepositsAndOtherReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://chinafoodsltd.com/role/InventoriesTables", "longName": "00000027 - Disclosure - INVENTORIES (Tables)", "shortName": "INVENTORIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://chinafoodsltd.com/role/LeaseTables", "longName": "00000028 - Disclosure - LEASE (Tables)", "shortName": "LEASE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CFOO:ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://chinafoodsltd.com/role/PlantAndEquipmentTables", "longName": "00000029 - Disclosure - PLANT AND EQUIPMENT (Tables)", "shortName": "PLANT AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://chinafoodsltd.com/role/IncomeTaxesTables", "longName": "00000030 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://chinafoodsltd.com/role/ConcentrationsOfRiskTables", "longName": "00000031 - Disclosure - CONCENTRATIONS OF RISK (Tables)", "shortName": "CONCENTRATIONS OF RISK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R32": { "role": "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails", "longName": "00000032 - Disclosure - SCHEDULE OF SUBSIDIARIES INFORMATION (Details)", "shortName": "SCHEDULE OF SUBSIDIARIES INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2023-01-012023-09-30_custom_EliteCreationGroupLimitedMember", "name": "CFOO:EntityPlaceOfIncorporationAndKindOfLegalEntity", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_custom_EliteCreationGroupLimitedMember", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfSubsidiariesInformationTableTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R33": { "role": "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "longName": "00000033 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-09-30_custom_FurnitureFixtureAndEquipmentMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_custom_FurnitureFixtureAndEquipmentMember", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "CFOO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "longName": "00000034 - Disclosure - SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details)", "shortName": "SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R35": { "role": "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails", "longName": "00000035 - Disclosure - SUMMARY OF GEOGRAPHIC SEGMENTS (Details)", "shortName": "SUMMARY OF GEOGRAPHIC SEGMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-09-30_country_HK", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R36": { "role": "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "longName": "00000036 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-09-30_custom_PeriodEndHKUSExchangeRateMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_custom_PeriodEndHKUSExchangeRateMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:AllowanceForDoubtfulAccountsReceivable", "span", "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R38": { "role": "http://chinafoodsltd.com/role/LiquidityAndGoingConcernDetailsNarrative", "longName": "00000038 - Disclosure - LIQUIDITY AND GOING CONCERN (Details Narrative)", "shortName": "LIQUIDITY AND GOING CONCERN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R39": { "role": "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails", "longName": "00000039 - Disclosure - SUMMARY OF REPORTABLE SEGMENTS (Details)", "shortName": "SUMMARY OF REPORTABLE SEGMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-07-012022-09-30_custom_ConsultancyServiceFeeIncomeMember", "name": "us-gaap:CostOfRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R40": { "role": "http://chinafoodsltd.com/role/SegmentReportingDetailsNarrative", "longName": "00000040 - Disclosure - SEGMENT REPORTING (Details Narrative)", "shortName": "SEGMENT REPORTING (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R41": { "role": "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails", "longName": "00000041 - Disclosure - SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details)", "shortName": "SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "CFOO:RentalDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "CFOO:DepositsAndOtherReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "CFOO:RentalDeposits", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "CFOO:DepositsAndOtherReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R42": { "role": "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "longName": "00000042 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "shortName": "SCHEDULE OF INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R43": { "role": "http://chinafoodsltd.com/role/InventoriesDetailsNarrative", "longName": "00000043 - Disclosure - INVENTORIES (Details Narrative)", "shortName": "INVENTORIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "CFOO:AllowanceForObsoleteInventories", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "CFOO:AllowanceForObsoleteInventories", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R44": { "role": "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails", "longName": "00000044 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details)", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "longName": "00000045 - Disclosure - LEASE (Details Narrative)", "shortName": "LEASE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R46": { "role": "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "00000046 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R47": { "role": "http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative", "longName": "00000047 - Disclosure - PLANT AND EQUIPMENT (Details Narrative)", "shortName": "PLANT AND EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R48": { "role": "http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative", "longName": "00000048 - Disclosure - STOCKHOLDERS\u2019 (DEFICIT) EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 (DEFICIT) EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "longName": "00000049 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2022-01-012022-09-30", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-09-30", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R50": { "role": "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "longName": "00000050 - Disclosure - SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details)", "shortName": "SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2022-07-012022-09-30", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_country_CN", "name": "CFOO:LossIncomeBeforeIncomeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R51": { "role": "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "longName": "00000051 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R52": { "role": "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "longName": "00000052 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_country_CN", "name": "us-gaap:IncomeTaxExaminationDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R53": { "role": "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails", "longName": "00000053 - Disclosure - SCHEDULE OF CONCENTRATIONS OF RISK (Details)", "shortName": "SCHEDULE OF CONCENTRATIONS OF RISK (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30_custom_CustomerAMember_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R54": { "role": "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "longName": "00000054 - Disclosure - CONCENTRATIONS OF RISK (Details Narrative)", "shortName": "CONCENTRATIONS OF RISK (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2023-01-012023-09-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_VendorMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_us-gaap_CostOfGoodsTotalMember_us-gaap_SupplierConcentrationRiskMember_custom_VendorMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r170", "r171", "r172", "r191", "r382", "r440", "r449", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r476", "r477", "r478", "r479", "r480", "r482", "r484", "r485", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r568" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r158", "r160", "r161" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "auth_ref": [ "r169", "r332", "r333", "r334", "r335", "r372", "r540", "r616", "r619", "r620" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r72", "r113", "r404", "r562", "r604", "r611", "r627" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r169", "r332", "r333", "r334", "r335", "r372", "r540", "r616", "r619", "r620" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 (DEFICIT) EQUITY" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r227", "r382", "r424", "r425", "r426", "r427", "r428", "r429", "r544", "r558", "r563", "r599", "r614", "r615", "r622", "r641" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Selling and distribution expenses", "negatedLabel": "Selling and distribution", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r470", "r527", "r568", "r640" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/NatureOfOperations" ], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r64", "r108", "r438", "r439" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r232", "r233" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "auth_ref": [ "r227", "r382", "r424", "r425", "r426", "r427", "r428", "r429", "r544", "r558", "r563", "r599", "r614", "r615", "r622", "r641" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r167", "r168", "r367", "r368", "r369", "r370", "r457", "r458", "r459", "r460", "r461", "r480", "r482", "r510" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r577" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r156", "r175", "r176", "r177", "r178", "r179", "r183", "r185", "r187", "r188", "r189", "r190", "r344", "r345", "r397", "r411", "r552" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r580" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r581" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r111", "r141", "r165", "r196", "r217", "r223", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r332", "r334", "r346", "r400", "r475", "r562", "r575", "r617", "r618", "r631" ] }, "country_HK": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "HK", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r585" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r145", "r547", "r562" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets, net", "verboseLabel": "Right-of-use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r357" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r26" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "negatedLabel": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r85", "r485" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock $0.0001 par value, 100,000,000 shares authorized, 20,252,309 and 20,252,309 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r67", "r401", "r562" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r131", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r543" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r55", "r109", "r148", "r150", "r155", "r396", "r410" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for doubtful accounts", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r143", "r236", "r241", "r242", "r243", "r640" ] }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES", "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts." } } }, "auth_ref": [ "r58" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r261", "r262", "r263", "r264", "r300", "r302", "r303", "r304", "r305", "r375", "r376", "r430", "r454", "r455", "r511", "r513", "r515", "r516", "r522", "r541", "r542", "r555", "r557", "r561", "r564", "r567", "r612", "r621", "r634", "r635", "r636", "r637", "r638" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r261", "r262", "r263", "r264", "r302", "r376", "r430", "r454", "r455", "r511", "r513", "r515", "r516", "r522", "r541", "r542", "r555", "r557", "r561", "r564", "r621", "r633", "r634", "r635", "r636", "r637", "r638" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "auth_ref": [ "r261", "r262", "r263", "r264", "r300", "r302", "r303", "r304", "r305", "r375", "r376", "r430", "r454", "r455", "r511", "r513", "r515", "r516", "r522", "r541", "r542", "r555", "r557", "r561", "r564", "r567", "r612", "r621", "r634", "r635", "r636", "r637", "r638" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails", "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, net", "verboseLabel": "TOTAL", "terseLabel": "Total revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r197", "r198", "r215", "r220", "r221", "r227", "r229", "r231", "r297", "r298", "r382" ] }, "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentSalvageValuePercentage", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Residual value", "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r589" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r261", "r262", "r263", "r264", "r302", "r376", "r430", "r454", "r455", "r511", "r513", "r515", "r516", "r522", "r541", "r542", "r555", "r557", "r561", "r564", "r621", "r633", "r634", "r635", "r636", "r637", "r638" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r301", "r367", "r368", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r457", "r458", "r459", "r460", "r461", "r480", "r482", "r510", "r630" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r589" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r43", "r379", "r380", "r381", "r383", "r550" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r159" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r159" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currencies translation", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r347" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r89", "r90", "r91" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cumulative net operating losses", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r53" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operation", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r196", "r216", "r222", "r225", "r553" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r231", "r596" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONCENTRATIONS OF RISK", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r29", "r30", "r32", "r33", "r61", "r110" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r590" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r6", "r107", "r129", "r326", "r327", "r605" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net loss per share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r27", "r28" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r193", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r225", "r231", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r257", "r258", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r556", "r599", "r641" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, value, new issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r13", "r66", "r67", "r102", "r448", "r503", "r524", "r574" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r301", "r367", "r368", "r457", "r458", "r459", "r460", "r461", "r480", "r482", "r510" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r68" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r606", "r607", "r626", "r643", "r645" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r30", "r32", "r61", "r62", "r231", "r528" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent accounting pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, shares, new issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r13", "r66", "r67", "r102", "r442", "r503", "r524" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r24", "r138", "r546" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value Measurement", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r8", "r14" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://chinafoodsltd.com/role/Lease" ], "lang": { "en-us": { "role": { "label": "LEASE", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r356" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r25" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r21", "r22", "r78", "r142", "r402", "r435", "r436" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r578" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "PLANT AND EQUIPMENT", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r97", "r124", "r127", "r128" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Customer deposits", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r377", "r603" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r317" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r622" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r46", "r140", "r406" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r184", "r189" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deposits and other receivable", "label": "Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF GEOGRAPHIC SEGMENTS", "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r40", "r81" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r183", "r189" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r576" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r578" ] }, "CFOO_EliteCreationGroupLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "EliteCreationGroupLimitedMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Elite Creation Group Limited [Member]", "documentation": "Elite Creation Group Limited [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r98" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 (Deficit) Equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r67", "r70", "r71", "r94", "r464", "r481", "r504", "r505", "r562", "r575", "r604", "r611", "r627", "r645" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 (Deficit) Equity" } } }, "auth_ref": [] }, "CFOO_SaleOfWineProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "SaleOfWineProductsMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Wine Products [Member]", "documentation": "Sale of Wine Products [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r364", "r365", "r366", "r368", "r371", "r445", "r446", "r447", "r486", "r487", "r488", "r507", "r509" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/StockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r101", "r164", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r342", "r506", "r508", "r525" ] }, "CFOO_AlphaWellnessHKLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "AlphaWellnessHKLimitedMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Alpha Wellness (HK) Limited [Member]", "documentation": "Alpha Wellness (HK) Limited [Member]" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r589" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r590" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r592" ] }, "CFOO_FurnitureFixtureAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "FurnitureFixtureAndEquipmentMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture, Fixture and Equipment [Member]", "documentation": "Furniture, Fixture and Equipment [Member]" } } }, "auth_ref": [] }, "CFOO_GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "GuangzhouXiaoXiangHealthIndustryCompanyLimitedMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Guangzhou Xiao Xiang Health Industry Company Limited [Member]", "documentation": "Guangzhou Xiao Xiang Health Industry Company Limited [Member]" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r578" ] }, "CFOO_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "MotorVehiclesMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Motor Vehicles [Member]", "documentation": "Motor Vehicles [Member]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of lease liabilities", "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security", "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation." } } }, "auth_ref": [ "r23" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r151", "r310", "r311", "r315", "r316", "r318", "r320", "r441" ] }, "us-gaap_OffsettingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTable", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Offsetting Assets [Table]", "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements." } } }, "auth_ref": [ "r76", "r77" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r100", "r259", "r260", "r529", "r613" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r528" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://chinafoodsltd.com/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of reportable segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r609" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of presentation and consolidation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "auth_ref": [ "r231", "r560", "r622", "r641", "r642" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r587", "r589", "r590" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r30", "r32", "r61", "r62", "r231", "r528", "r597" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r95", "r548" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of revenue", "negatedTerseLabel": "Total cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r84", "r165", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r346", "r617" ] }, "us-gaap_CostOfGoodsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsTotalMember", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service Benchmark [Member]", "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r596" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r29", "r30", "r32", "r33", "r61", "r110", "r528" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r594" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r583" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "verboseLabel": "Deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r54", "r625" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRisk" ], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS OF RISK", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r93" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows", "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r6", "r42", "r44" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets, net", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r624" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Income tax expense at statutory rate", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r313" ] }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherReconcilingItems", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments." } } }, "auth_ref": [ "r623" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r89" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r69", "r102", "r403", "r434", "r436", "r443", "r463", "r562" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation adjustment", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r628" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/PlantAndEquipmentDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfCashFlows", "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation of plant and equipment", "verboseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r6", "r45" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r89", "r162" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of plant and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r87" ] }, "us-gaap_OffsettingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsLineItems", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Offsetting Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "verboseLabel": "Common stock, shares, issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r67" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r65", "r112" ] }, "us-gaap_IncomeTaxUncertaintiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxUncertaintiesPolicy", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Uncertain tax positions", "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax adjustments", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r623" ] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r47", "r530" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r586" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r67", "r462" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheetsParenthetical", "http://chinafoodsltd.com/role/StockholdersDeficitEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "verboseLabel": "mon stock, shares, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r67", "r462", "r481", "r645", "r646" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r582" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVENTORIES", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r16", "r73", "r74", "r75" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r98" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r360" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r306", "r307", "r308", "r448", "r606", "r607", "r608", "r626", "r645" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r453", "r455", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r476", "r477", "r478", "r479", "r491", "r492", "r493", "r494", "r497", "r498", "r499", "r500", "r518", "r519", "r520", "r521", "r565", "r567" ] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r63", "r639" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r209", "r210", "r211", "r212", "r213", "r214", "r229", "r554" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r34", "r35", "r36", "r122", "r123", "r125", "r126" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax payable", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r5" ] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets amortization period", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r383" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r5" ] }, "country_CN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CN", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "CHINA" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "verboseLabel": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r30", "r32", "r61", "r62", "r231" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r83", "r382" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r30", "r32", "r61", "r62", "r231", "r528" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Income:" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r30", "r32", "r61", "r62", "r231", "r437", "r528" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r92", "r163" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r86" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-Current Assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r165", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r332", "r334", "r346", "r617", "r618", "r631" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r121", "r137", "r144", "r244", "r245", "r246", "r378", "r551" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r135", "r146", "r165", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r332", "r334", "r346", "r562", "r617", "r618", "r631" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r13", "r20", "r132", "r152", "r153", "r154", "r170", "r171", "r172", "r174", "r180", "r182", "r191", "r239", "r240", "r286", "r306", "r307", "r308", "r322", "r323", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r348", "r349", "r350", "r351", "r352", "r353", "r363", "r431", "r432", "r433", "r448", "r503" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued liabilities and other payables", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r132", "r170", "r171", "r172", "r174", "r180", "r182", "r239", "r240", "r306", "r307", "r308", "r322", "r323", "r336", "r338", "r339", "r341", "r343", "r431", "r433", "r448", "r645" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r579" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r19", "r136", "r165", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r333", "r334", "r335", "r346", "r562", "r617", "r631", "r632" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Current tax", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r107", "r321", "r327", "r605" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r373", "r374" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r57", "r58", "r59", "r60", "r453", "r455", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r476", "r477", "r478", "r479", "r491", "r492", "r493", "r494", "r497", "r498", "r499", "r500", "r518", "r519", "r520", "r521", "r549", "r565", "r567" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r528" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r132", "r152", "r153", "r154", "r170", "r171", "r172", "r174", "r180", "r182", "r191", "r239", "r240", "r286", "r306", "r307", "r308", "r322", "r323", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r348", "r349", "r350", "r351", "r352", "r353", "r363", "r431", "r432", "r433", "r448", "r503" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r192", "r193", "r194", "r195", "r196", "r208", "r219", "r223", "r224", "r225", "r226", "r227", "r228", "r231" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r11", "r22", "r337", "r340", "r363", "r431", "r432", "r600", "r601", "r602", "r606", "r607", "r608" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-Current Assets" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expenses", "totalLabel": "Income tax expense", "label": "Income tax expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r120", "r130", "r181", "r182", "r204", "r312", "r325", "r412" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF REPORTABLE SEGMENTS", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r37", "r38", "r39", "r41" ] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r244" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r37", "r38", "r39", "r41" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful lives", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r117", "r118", "r119", "r234", "r235", "r237" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit (loss)", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r82", "r165", "r196", "r216", "r222", "r225", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r346", "r553", "r617" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Plant and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r98", "r139", "r407" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Plant and equipment, net", "totalLabel": "Plant and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r399", "r407", "r562" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common stock" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableMember", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Plant and equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r7", "r124", "r127", "r405" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain from sale of plant and equipment", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r5" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary." } } }, "auth_ref": [ "r12", "r56" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r31", "r231" ] }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyExchangeRateTranslation1", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation exchange rates", "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency." } } }, "auth_ref": [ "r354", "r355" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r79", "r114", "r196", "r216", "r222", "r225", "r398", "r408", "r553" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/LeaseDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r170", "r171", "r172", "r191", "r382", "r440", "r449", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r476", "r477", "r478", "r479", "r480", "r482", "r484", "r485", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r568" ] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "auth_ref": [ "r610", "r644" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r9", "r48", "r49", "r50", "r51" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "CFOO_ForeignTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ForeignTranslationAdjustment", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Foreign translation adjustment", "documentation": "Foreign translation adjustment." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advances from (repayment to) a director", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "CFOO_IncreaseDecreaseInDepositsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "IncreaseDecreaseInDepositsAndOtherReceivables", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deposits and other receivables", "documentation": "Increase decrease in deposits and other receivables.", "label": "IncreaseDecreaseInDepositsAndOtherReceivables" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r589" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivables", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r5" ] }, "CFOO_IncreaseDecreaseInIncomeTaxRecoverable": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "IncreaseDecreaseInIncomeTaxRecoverable", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income tax recoverable", "documentation": "Increase decrease in income tax recoverable." } } }, "auth_ref": [] }, "CFOO_LossIncomeBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "LossIncomeBeforeIncomeTax", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "(Loss) income before income tax", "documentation": "Loss income before income tax." } } }, "auth_ref": [] }, "CFOO_DisclosureLiquidityAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DisclosureLiquidityAndGoingConcernAbstract", "lang": { "en-us": { "role": { "label": "Liquidity And Going Concern" } } }, "auth_ref": [] }, "CFOO_LiquidityAndGoingConcernDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "LiquidityAndGoingConcernDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/LiquidityAndGoingConcern" ], "lang": { "en-us": { "role": { "label": "LIQUIDITY AND GOING CONCERN", "documentation": "Liquidity and going concern disclosure." } } }, "auth_ref": [] }, "CFOO_DisclosureDepositsAndOtherReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DisclosureDepositsAndOtherReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Deposits And Other Receivables", "verboseLabel": "Schedule Of Deposits And Other Receivable" } } }, "auth_ref": [] }, "CFOO_DepositsAndOtherReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DepositsAndOtherReceivablesTextBlock", "presentation": [ "http://chinafoodsltd.com/role/DepositsAndOtherReceivables" ], "lang": { "en-us": { "role": { "label": "DEPOSITS AND OTHER RECEIVABLES", "documentation": "Deposits and Other Receivables [Text Block]" } } }, "auth_ref": [] }, "CFOO_NetOperatingLossCarryforwardsTerm": { "xbrltype": "durationItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "NetOperatingLossCarryforwardsTerm", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards term", "documentation": "Net operating loss carryforwards term" } } }, "auth_ref": [] }, "CFOO_DisclosureLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DisclosureLeaseAbstract", "lang": { "en-us": { "role": { "label": "Lease", "verboseLabel": "Schedule Of Right Of Use Assets And Liability" } } }, "auth_ref": [] }, "CFOO_AmountsDueToDirectorAndRelatedCompanyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "AmountsDueToDirectorAndRelatedCompanyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/AmountsDueToDirectorAndRelatedCompany" ], "lang": { "en-us": { "role": { "label": "AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY", "documentation": "Amounts Due To Director And Related Company [Text Block]" } } }, "auth_ref": [] }, "CFOO_DisclosureAmountsDueToDirectorAndRelatedCompanyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DisclosureAmountsDueToDirectorAndRelatedCompanyAbstract", "lang": { "en-us": { "role": { "label": "Amounts Due To Director And Related Company" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/DepositsAndOtherReceivablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEPOSITS AND OTHER RECEIVABLE", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "CFOO_RelatedPartiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "RelatedPartiesPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Related parties", "documentation": "Related Parties [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r629" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss):" } } }, "auth_ref": [] }, "CFOO_ScheduleOfEstimatedUsefulLivesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ESTIMATED USEFUL LIVES", "documentation": "Schedule Of Estimated Useful Lives [Table Text Block]" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "CFOO_ScheduleOfSubsidiariesInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ScheduleOfSubsidiariesInformationTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/NatureOfOperationsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SUBSIDIARIES INFORMATION", "documentation": "Schedule of subsidiaries information [Table Text Block]" } } }, "auth_ref": [] }, "CFOO_ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ScheduleOfRightOfUseAssetsAndLiabilityTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/LeaseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY", "documentation": "Schedule Of Right Of Use Assets And Liability [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity", "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign currency adjustment gain (loss)", "verboseLabel": "Foreign currency translation adjustment", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r4", "r10", "r109" ] }, "CFOO_EntityPlaceOfIncorporationAndKindOfLegalEntity": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "EntityPlaceOfIncorporationAndKindOfLegalEntity", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Place of incorporation and kind of legal entity", "documentation": "Place of incorporation and kind of legal entity." } } }, "auth_ref": [] }, "CFOO_EntityPrincipalActivities": { "xbrltype": "stringItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "EntityPrincipalActivities", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Principal activities", "documentation": "Principal activities." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r96", "r383" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "CFOO_EffectiveInterestHeldPercentage": { "xbrltype": "percentItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "EffectiveInterestHeldPercentage", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfSubsidiariesInformationDetails" ], "lang": { "en-us": { "role": { "label": "Effective interest held percentage", "documentation": "Effective interest held percentage." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r591" ] }, "CFOO_SalesTaxPercentage": { "xbrltype": "percentItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "SalesTaxPercentage", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sales tax percentage", "documentation": "Sales tax percentage." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r116" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r104" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Statutory income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r166", "r313", "r328" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/LiquidityAndGoingConcernDetailsNarrative", "http://chinafoodsltd.com/role/StatementsOfCashFlows", "http://chinafoodsltd.com/role/StatementsOfChangesInStockholdersDeficitEquity", "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss for the period", "verboseLabel": "Net loss", "negatedLabel": "Net income loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r80", "r91", "r115", "r134", "r147", "r149", "r154", "r165", "r173", "r175", "r176", "r177", "r178", "r181", "r182", "r186", "r196", "r216", "r222", "r225", "r238", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r345", "r346", "r409", "r483", "r501", "r502", "r553", "r573", "r617" ] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r598", "r603" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r105" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r103" ] }, "CFOO_ProductSalesReturns": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ProductSalesReturns", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product sales returns", "documentation": "Product sales returns." } } }, "auth_ref": [] }, "CFOO_RentalDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "RentalDeposits", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Rental deposits", "documentation": "Rental deposits." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of long-lived assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r99" ] }, "CFOO_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/LiquidityAndGoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital", "documentation": "Working capital." } } }, "auth_ref": [] }, "CFOO_ForeignTranslationDifferenceNet": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ForeignTranslationDifferenceNet", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign translation adjustment", "documentation": "Foreign translation difference, net.", "label": "ForeignTranslationDifferenceNet" } } }, "auth_ref": [] }, "CFOO_PurchaseDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "PurchaseDeposits", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDepositsAndOtherReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Purchase deposits", "documentation": "Purchase deposits." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Amount due to a related party", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r18", "r562" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities and other payables", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r588" ] }, "CFOO_AllowanceForObsoleteInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "AllowanceForObsoleteInventories", "crdr": "debit", "presentation": [ "http://chinafoodsltd.com/role/InventoriesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for obsolete inventories", "documentation": "Allowance for obsolete inventories." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "CFOO_NonCashLeaseExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "NonCashLeaseExpenses", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash lease expense", "documentation": "Non cash lease expenses." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Sundry income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r157" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "negatedTotalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationDescription", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income tax description", "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings." } } }, "auth_ref": [ "r52" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r229", "r230", "r450", "r451", "r452", "r512", "r514", "r517", "r523", "r526", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r545", "r559", "r567", "r622", "r641" ] }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Examination, Likelihood of Unfavorable Settlement", "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority." } } }, "auth_ref": [ "r52", "r106" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxesDetailsNarrative", "http://chinafoodsltd.com/role/IncomeTaxesTables", "http://chinafoodsltd.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://chinafoodsltd.com/role/ScheduleOfReconciliationTaxRateToEffectiveIncomeTaxRateDetails", "http://chinafoodsltd.com/role/SummaryOfGeographicSegmentsDetails" ], "auth_ref": [ "r229", "r230", "r450", "r451", "r452", "r512", "r514", "r517", "r523", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r545", "r559", "r567", "r622", "r641" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease payment", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r359", "r362" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r590" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r562" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r88" ] }, "CFOO_SalesOfHealthcareProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "SalesOfHealthcareProductsMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Sales of Healthcare Products [Member]", "documentation": "Sales of Healthcare Products [Member]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "CFOO_PeriodEndHKUSExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "PeriodEndHKUSExchangeRateMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Period-end HK$:US$ Exchange Rate [Member]", "documentation": "Period-end HK$:US$ Exchange Rate [Member]" } } }, "auth_ref": [] }, "CFOO_ConsultancyServiceFeeIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ConsultancyServiceFeeIncomeMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfDisaggregatedRevenueWithReportableSegmentsDetails", "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Consultancy Service Fee Income [Member]", "documentation": "Consultancy Service Fee Income [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Comprehensive loss", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r133", "r193", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r225", "r231", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r556", "r599", "r641" ] }, "CFOO_PeriodEndRMBUSExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "PeriodEndRMBUSExchangeRateMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Period-end RMB:US$ Exchange Rate [Member]", "documentation": "Period-end RMB:US$ Exchange Rate [Member]" } } }, "auth_ref": [] }, "CFOO_PeriodAverageHKUSExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "PeriodAverageHKUSExchangeRateMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Period Average HK$:US$ Exchange Rate [Member]", "documentation": "Period Average HK$:US$ Exchange Rate [Member]" } } }, "auth_ref": [] }, "CFOO_PeriodAverageRMBUSExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "PeriodAverageRMBUSExchangeRateMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "lang": { "en-us": { "role": { "label": "Period Average RMB:US$ Exchange Rate [Member]", "documentation": "Period Average RMB:US$ Exchange Rate [Member]" } } }, "auth_ref": [] }, "CFOO_HealthcareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "HealthcareSegmentMember", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Healthcare Segment [Member]", "documentation": "Healthcare Segment [Member]" } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r593" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Customer deposits", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r287", "r288", "r299" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescription", "presentation": [ "http://chinafoodsltd.com/role/LeaseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease, description", "documentation": "Description of lessee's operating lease." } } }, "auth_ref": [ "r361" ] }, "CFOO_WineSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "WineSegmentMember", "presentation": [ "http://chinafoodsltd.com/role/SummaryOfReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Wine Segment [Member]", "documentation": "Wine Segment [Member]" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "CFOO_HealthcareProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "HealthcareProductsMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Healthcare Products [Member]", "documentation": "Healthcare Products [Member]" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r578" ] }, "CFOO_WineProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "WineProductsMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Wine Products [Member]", "documentation": "Wine Products [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets", "http://chinafoodsltd.com/role/ScheduleOfRightOfUseAssetsAndLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r358" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net loss per common share" } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r578" ] }, "CFOO_MotorVehicleMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "MotorVehicleMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Motor Vehicle [Member]", "documentation": "Motor Vehicle [Member]" } } }, "auth_ref": [] }, "CFOO_AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities", "calculation": { "http://chinafoodsltd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://chinafoodsltd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Adjustments to reconcile net loss to net cash used in operating activities, Total", "documentation": "Adjustment noncash items to reconcile net income loss to cash provided by used in operating activities.", "label": "AdjustmentNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r578" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative", "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r231", "r560", "r622", "r641", "r642" ] }, "CFOO_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "CustomerAMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer A [Member]", "documentation": "Customer A [Member]" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r31" ] }, "CFOO_ForeignTranslationDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "ForeignTranslationDifferenceMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Translation Difference [Member]", "documentation": "Foreign Translation Difference [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://chinafoodsltd.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r156", "r175", "r176", "r177", "r178", "r179", "r185", "r187", "r188", "r189", "r190", "r344", "r345", "r397", "r411", "r552" ] }, "CFOO_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "CustomerCMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer C [Member]", "documentation": "Customer C [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://chinafoodsltd.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r166", "r309", "r314", "r315", "r319", "r324", "r329", "r330", "r331", "r444" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r578" ] }, "CFOO_CustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "CustomerMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Member]", "documentation": "Customer [Member]" } } }, "auth_ref": [] }, "CFOO_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "CustomerBMember", "presentation": [ "http://chinafoodsltd.com/role/ScheduleOfConcentrationsOfRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer B [Member]", "documentation": "Customer B [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r584" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "CFOO_VendorMember": { "xbrltype": "domainItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "VendorMember", "presentation": [ "http://chinafoodsltd.com/role/ConcentrationsOfRiskDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vendor [Member]", "documentation": "Vendor [Member]" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r595" ] }, "CFOO_DepositsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://chinafoodsltd.com/20230930", "localname": "DepositsAndOtherReceivables", "crdr": "debit", "calculation": { "http://chinafoodsltd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://chinafoodsltd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits and other receivables", "documentation": "Deposits and other receivables." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://chinafoodsltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(19)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a),(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4M", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482669/740-10-15-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r544": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r551": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r552": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r553": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r554": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 70 0001493152-23-040898-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-040898-xbrl.zip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end